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Abstract 
 
Metal nanoparticles offer a useful platform for a wide range of biological applications 
especially for biosensing, bioimaging and drug delivery. This thesis presents a body of 
original research describing the synthesis, characterisation and development of a novel 
and convenient biosensing assay for detection of dipeptidyl peptidase IV (DPP-IV) 
enzyme activity using peptide functionalized gold nanoparticles. 
 
The distinctive optical and physical properties of gold nanoparticles (Au NP) were 
harnessed for the development of a colorimetric assay for rapid sensing of DPP-IV 
activities and screening DPP-IV inhbitors.  The citrate reduction method for Au NPs 
synthesis was optimised and several potential peptide substrates (GPDC, VP-EN-DC, 
C/G dipeptide, GPG-EN-PEG4-LA, GPDCALNNC) were designed to provide 
substrates that mimic the DPP-IV natural substrates.  The performances of the substrate 
functionalized Au NPs were assessed for their appropriateness for the detection of the 
enzyme activity.  
 
Addition of DPP-IV to the solutions containing the functionalized Au NPs resulted in 
cleavage of the substrate and thus causing the aggregation of the Au NPs which in turn 
led to a shift of the surface plasmon peak toward longer wavelengths, and a change of 
the colour of the colloidal suspension from red to blue. Overall, real-time detection of 
DPP-IV activity over a broader range (0-40 U/L) with high selectivity and stability was 
obtained, thus providing a method that can be used to determine the levels of DPP-
IV/CD26 in biological fluids such as serum and plasma. 
 
Further assay developments were conducted to overcome limitations encountered with 
the original Au NP assay, especially the narrow dynamic linear range and stability in 
high ionic strength solutions. Validation and comparison of the Au NP assay developed 
has revealed that this method is highly correlated to the gold standard chromogenic Gly-
Pro-pNA method for detection of enzyme activity in biological samples. Very good 
recoveries (in the range 83.6 –114.9%) were obtained in spiked serum samples, which 
indicate that this assay could provide a suitable alternative for enzyme activity detection 
with the naked eye and without the need for sophisticated instruments. 
 
iii 
 
 Investigations into the effects of incorporating different stabilizers in order to improve 
the stability of the peptide functionalized Au NP in high ionic strength solutions were 
also investigated. Gold nanoparticles have different shapes and structures and an 
alternative approach for detection of DPP-IV activity using gold nanorods due to their 
higher refractive index sensitivities was explored.  
 
As a conclusion, three out of five approaches, all utilising Au NP-ligand conjugates 
were demonstrated useful for the detection of the DPP-IV activity. The system 
developed here is portable and would permit on-site analysis of samples, which offers a 
real alternative approach from traditional assays and reduces the need for laboratory 
testing. The logical next step in this research would be the continuation of experiments 
to transform this test into a point of care testing device that could offer an early 
detection tool for disease management. 
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1. Introduction 
 
Nanoparticles (NPs) (derived from the Greek word nanos, meaning dwarf) are defined 
in a variety of ways, but the most widely accepted definition refers to stable colloid 
solutions of clusters of atoms in which 50% or more of the particles (small clusters or 
large molecules) are in the size range 1 – 100 nm, and have properties that are not in 
common with non-nanoscale particles of the same chemical composition (Royal 
Academy of Engineering & Royal Society 2004; Ahlbom et al. 2009). Although most 
definitions focus on the dimensions as the critical property that defines NPs, some 
scientists argue that the unique electrical, optical, magnetic and catalytic properties 
found at nanoscale dimensions are more relevant for their classification (Weller 1993; 
Alivisatos 1996; Storhoff & Mirkin 1999; Niemeyer 2001; Oliveira et al. 2015).  
Metallic NPs have distinctive optical, electronic, chemical and magnetic properties that 
are remarkably unlike those of the individual atoms or their bulk counterparts. The main 
factors that account for these characteristics are high surface to volume ratio (Schmid 
2011), quantum size effect (Kubo 1962; Lemire et al. 2004) and electrodynamic 
interactions (Pinchuk et al. 2007).  
The possibility of controlling and tuning these unique optical and electronic properties 
make these materials prime candidates for a wide range of technological and biomedical 
applications. These attractive and unique properties make nanomaterials 
physicochemically altered and often superior to both the atomic and bulk materials of 
the same element (Hadjipanayis & Siegel 2012). For instance, aluminum which is stable 
at macro scale turns combustible at the nanoscale (Shafirovich et al. 2007); gold (Au), 
which is practically insoluble in water at the macro scale becomes more soluble at the 
nanoscale (Pengo et al. 2003). Platinum, which is chemically inert at macro scales, can 
serve as a potent chemical catalyst at the nanoscale (Cheong et al. 2010). While a 
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known insulator, silicon turns into a conductor of electrical current at the nanoscale (Hu 
et al. 2003; Szczech & Jin 2011).  
 History of Gold Nanoparticles 1.1
 
The first reference to the use of soluble Au compounds is found in Egyptian 
manuscripts from the Greco-Roman era in the 5th or 4th century B.C when “soluble” 
gold emerged in Egypt and China (Daniel & Astruc 2004). One of the most remarkable 
aspects of the behaviour of gold was the unusual optical effects displayed by glass 
containing colloidal gold, which was observed in the Lycurgus Cup (Freestone et al. 
2007).  The cup is made of a dichroic glass, which changes colour when exposed to 
light; ruby red in transmitted light and green in reflected light. Colloidal Au was also 
employed in the manufacture of ruby glass, in a process described by the German 
alchemist, Andreas Libavius, in his textbook, Alchemia, in 1597, in which he described 
how to make red crystals out of Au dissolved in liquid or oil (Hunt 1976). Gold has 
been used extensively for cosmetic, decorative, and for medicinal purposes. In the 17th 
century, a formula for mixing tin oxide with gold particles in a crude form of aqua regia 
was recorded in the Bologna manuscript, to yield "a beautiful purple" pigment. The 
above process was used to impart glass with a red coloration, as well as to determine the 
presence of gold when used as a chemical test (Habashi 2016).  
Colloidal Au was used in the last century in one of the laboratory methods for the study 
of the cerebrospinal fluid (CSF) by using the reaction of Lange (Green 1925; Dykman 
& Khlebtsov 2012). A chance discovery made by Zsigmondy whilst looking for a 
method to prevent colloidal gold nanoparticles (Au NPs) from precipitation; he 
fortuitously found that only healthy CSF kept homogeneous Au NPs in solution, while 
precipitation occurred in pathological CSF samples (Green 1925). The value of the 
colloidal gold reaction in detecting and differentiating an infected from a non-infected 
condition of the central nervous system was a useful diagnostic tool, not only for early 
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diagnosis but also for the prognosis of obscure neurological conditions. Briefly, a series 
of diluted spinal fluid samples in aqueous saline solution were treated with a colloidal 
gold solution and the reaction was allowed to stand for 24 hours to get a final reading. 
Depending on the pathological conditions investigated, a certain pattern of colour 
change of the colloidal auric solution occurs. This application may have been the first 
recorded practical application of extremely small gold particles for biosensing. 
Modern scientific evaluation of colloidal Au began with Michael Faraday’s work in the 
1850s, which recognized that the colour observed was due to the size of the Au particles 
(Faraday 1857). Faraday’s rationale in investigating colloidal phenomena followed his 
interests in the interaction between light and matter. A few years later, the term 
"colloid" (from the French word, colle which means glue or gum) was linked to the use 
of Au particles in aqueous suspensions (Daniel & Astruc 2004). 
 In the 20th century, Ostwald and Zsigmondy’s research on colloids (Svedberg 1909; 
Ostwald 1927; Hauser 1955) and Gustav Mie’s theoretical explanation for the optical 
effects associated with nanosized metal particles by solving Maxwell's equation for the 
absorption and scattering of electromagnetic radiation by spherical particles laid the 
theoretical foundations for the use of NPs. Technological advances in the development 
of molecular beam techniques such as Transmission Electron Microscopy (TEM) and 
UV-visible Spectroscopy have made it possible to study and determine the 
morphological, physical and chemical properties of Au NPs (Mulvaney 1996; Link & 
El-Sayed 2000). The chronology of the historical events that led to the development of 
nanotechnology is listed in Table 1-1. 
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Table 1-1 Chronological development of nanotechnology and nanoscience 
 
 Synthesis and Functionalization of Gold Nanoparticles  1.2
 
Since the first experiments on the production of Au NPs by the reduction of gold 
trichloride by phosphorus were developed by Faraday in 1857, a variety of approaches 
have been used for the synthesis of Au NPs but these mainly involve reduction of Au 
salts such as potassium or sodium tetra chloroaurate in the presence of a stabilizing 
agent (Frens 1973; Dykman et al. 1998; Chen et al. 2010b; Duan et al. 2015). Over the 
years, modifications to the synthesis of Au NPs have been tailored to make them 
suitable for further use (Schmid 1992; Grabar et al. 1995; Manea et al. 2008; Chen et al. 
2010b; Hayat 2012; Hong 2013; Ren et al. 2015). The three commonly used synthesis 
Period Authors Achievement Reference 
4th A. D Romans Lycurgus Cup (Freestone et 
al. 2007)  
17th 
Century 
Andreas 
Cassius 
"Purple of Cassius" for glass staining (Habashi 
2016) 
1857 Faraday Scientific evaluation of Au NPs colour change (Faraday 
1857) 
1902 Zsigmondy Invention of ultramicroscope (Champness 
2001) 
1951-1973 Frens-
Turkevich 
Synthesis of Au NP preparations (Frens 1973) 
1960 Feynman Mention of nanoparticles in a famous lecture in 
which he stated that "there's plenty of room at the 
bottom" meaning developments at the nanoscale 
are possible. 
(Feynman 
1960) 
1971 Faulk and 
Taylor 
First biomedical use of Au in immunochemical 
staining  
(Faulk and 
Taylor 1971) 
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methods are (i) citrate reduction, (ii) Brust-Schiffrin and (iii) seed-mediated growth 
method. 
1.2.1 Citrate Reduction 
 
Citrate reduction, which was introduced by Turkevich and co-workers (Turkevich et al. 
1951; Enustun & Turkevich 1963) is the most popular method, which involves the 
reduction of hot chloroauric acid (HAuCl4) solution with trisodium citrate leading to the 
formation of Au NPs (Figure 1-1). Frens reported the synthesis of Au NPs of sizes 
between 16 and 147 nm by varying the ratio of the reducing/stabilizing agent (in this 
case trisodium citrate) to Au salt to control their formation (Frens 1973). The resultant 
colloidal Au particles are nearly spherical or spheroid and have an overall negative 
surface charge due to the carboxylate ion coverage. 
 
Figure 1-1 Schematic representation of the preparation of citrate stabilized Au NP in an 
aqueous medium.  
The HAuCl4 solution is boiled, and the trisodium citrate dihydrate is then quickly added 
under vigorous stirring. Reprinted with permission (Zhao et al. 2013). The interaction 
involves coordination of one or multiple carboxylate groups to the surface Au atoms 
(Al-johani et al. 2017). 
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Numerous efforts have been made in an attempt to elucidate the mechanism of Au NP 
formation. A number of models have been proposed, many of which involve the 
formation of an aggregation phase, at the initial stages of the synthesis (Kumar et al. 
2007; Mikhlin et al. 2011). These mechanisms misinterpreted the cause of the gray-
bluish colour during the initial phase of the synthesis and attributed it to formation of 
aggregate intermediates, contrary to this explanation; further studies demonstrated that 
large Au aggregates are not formed at any time of the synthesis (Wuithschick et al. 
2015). 
The classical nucleation theory (developed by Becker and Döring more than 80 years 
ago) (Becker & Döring 1935), is considered as the basic model to describe the 
underlying mechanism for NP growth, which goes through the LaMer burst nucleation, 
followed by simultaneous growth of all the particles (LaMer & Dinegar 1950). 
According to this theory, nuclei (seeds) function as templates for crystal growth. Nuclei 
growth is governed by two mechanisms: (i) the monomer’s diffusion (a “monomer” in 
the case of AuX clusters studied here is defined as a single AuX unit, where X = Cl4,) in 
a thermodynamically unstable state, onto the surface of a nucleus and (ii) the rate of the 
reaction of the diffusing species on the surface (Finney & Finke 2008; Thanh et al. 
2014).  
According to the LaMer theory, the process of NP formation can be divided into two 
separate phases, which can be identified as spontaneous nucleation and isotropic 
growth. The essence of the mechanism, as illustrated in Fig. 1-2, goes through three 
sequential steps (LaMer & Dinegar 1950): (I) a slow increase in the monomer 
concentration in solution until it reaches some critical concentration (C), or more 
specifically a critical supersaturation point, C/Ceq where Ceq is the solubility of 
monomer in the solution, phase I in Fig. 1-2, (II) a “burst nucleation” which 
substantially lowers the free monomer concentration in solution, after this point 
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nucleation stops due to decrease in the free monomer concentration; (III) subsequent 
nucleation growth happens under the control of the diffusion of the monomers through 
the solution (Finney & Finke 2008; Thanh et al. 2014).  
  
Figure 1-2 The LaMer mechanism of (sulphur) nucleation. The (theoretical) curve 
shows monomer concentration as a function of time. 
 As a result of the consumption of the monomeric species by growth of a number of the 
preformed nuclei, the concentration of the monomeric species decrease until 
supersaturation is reached. At this stage the nucleation is stopped (the end of the 
nucleation stage) and the remaining stable nuclei continue to grow with a 
supersaturation below the critical level for nucleation (Stage III). Reprinted with 
permission (Polte 2015). 
 
A further step towards a more relevant explanation for the formation of transition-metal 
nanoclusters, was introduced by Turkevich and his colleagues (1953) based on the 
"organizer model" (the “organizer” in this case was proposed to be the citrate ion). In 
this theory, it is proposed that dicarboxy acetone formed as a result of oxidation of 
sodium citrate is responsible for inducing nucleation events and aids in the formation of 
large macromolecules of gold ions and reducing agent (Wuithschick et al. 2015). 
Shortly after LaMer suggested his mechanism, a growth model was proposed by Reiss 
(1951) which was known as “growth by diffusion” in which the growth rate of the NPs 
 
9 
 
depends exclusively on the monomer diffusion into the particles, leading to faster 
growth of smaller particles in the presence of large particles and slower growth of larger 
particles, which in turn leads to more uniform size distribution known as size focusing. 
Reiss's model was extended later to take dissolution effects into account. The 
dissolution effect is known as - Ostwald ripening - in which larger nuclei grow more 
favourably at the expense of smaller ones (Sugimoto 1987). The LaMer model has been 
verified experimentally and the application of the nucleation theory has been extended 
to the formation of metal nanoclusters such as the formation of AgCl and AgBr clusters 
(Sugimoto et al. 2000).  
The LaMer theory has since undergone modifications; a two-step mechanism was 
proposed whereby the process of nucleation and growth happen simultaneously 
(Watzky & Finke 1997). Chow and Zukoski undertook a re-evaluation of the formation 
mechanism for Au NPs by studying the kinetics of the Turkevich process (Chow & 
Zukoski 1994). They proposed that Au NP generation happens through a mechanism 
involving the formation of large particles that diminish in size over the course of the 
reaction. It should be noted that this mechanism agrees with the LaMer classical growth 
model, but allows primary particles to reversibly aggregate.  
Nevertheless, several studies have revealed that the nucleation theory for the growth of 
NPs has failed to explain or accurately predict the particle size or the size distribution, 
(Finney & Finke 2008; Polte 2015). Pong and colleagues proposed a fundamentally 
distinct ‘‘necklace-breaking’’ mechanism by indicating that the small Au nuclei (ca. 5 
nm diameter), formed by citrate-assisted reduction of HAuCl4, primarily self-assemble 
into a network of joined chains. When Au accumulation increases, these chains lengthen 
in size, which in turn causes the spherical particles to be released from these structures, 
establishing the nanosphere product usually detected from this synthesis (Pong et al. 
2007). 
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The use of the organic matrix during the initial stages of synthesis ensures dispersion of 
the Au NPs when nucleation occurs (Danks et al. 2016). The initial step of this process, 
with reactions occurring in series and parallel, is the oxidation of citrate that yields 
dicarboxy acetone, which is thought to take part in the reduction process of aurate 
(Au3+) and followed by further oxidation to yield acetic acid and formic acid (Scheme 
1-1) which leads to the presence of a variety of species in solution, all of which play a 
role in the formation mechanism of Au NPs (Doyen et al. 2013). Then, the Au3+ ions are 
reduced to Au1+ and Au0, and the Au1+ is assembled on the Au0 atoms to produce the Au 
NP (Zhao et al. 2013).  
 
Scheme 1-1 The Pathway of citrate oxidation/ decarboxylation during Au NP formation 
process. All species are represented in their fully protonated form (Doyen et al. 2013). 
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The citrate anion acts not only as a reducing and capping agent, to control the growth of 
the NPs and inhibiting their aggregation, but also serves to control the pH of the 
solution, as citrate has 3 protonation equilibrium states with respective pKa values of 
3.1, 4.8, and 6.4 (Ji et al. 2007; Polte et al. 2010). Between the pH of 4.5-7, nearly 
monodispersed Au NPs with sizes ranging from 20 to 40 nm were synthesized 
(Patungwasa & Hodak 2008; Li et al. 2011; Liang et al. 2011). It has been reported that 
citrate could also serve as a ‘‘molecular linker’’ which participates in the formation of 
Au NPs (Doyen et al. 2013) when Au3+ ions are reduced to Au1+ by citrate, which in 
turn is oxidized to dicarboxy acetone forming a multimolecular complex between the 
products of redox reaction (Kumar et al. 2007).  
Other parameters have been shown to control the size and size distribution of Au NPs 
prepared by the citrate reduction process. These include the effects of temperature (Li et 
al. 2011), ionic strength (Zabetakis et al. 2012) and the introduction of high-power 
ultrasound (Su et al. 2003). It has been also found that smaller and narrower Au NP size 
distribution can be obtained by reversing the sequence of the addition of citrate and 
chloroauric acid (Sivaraman et al. 2011; Ojea-Jiḿnez et al. 2011). 
1.2.2 Brust - Schiffrin Method 
 
The synthesis of smaller Au NPs (2 - 5 nm) has been demonstrated in the organic phase 
utilizing the Brust and Schiffrin method (Brust et al. 1994). Briefly, the gold salt is 
dissolved in water and then transferred to the organic phase using an appropriate phase-
transfer agent, such as tetra octyl ammonium bromide (TOAB). The addition of 
dodecanethiol to the organic phase AuCl4
¯ (1:1 molar ratio), followed by reduction with 
aqueous sodium borohydride (BH4¯) in the biphasic system, leads to the formation of 
dodecane thiolate-capped Au NPs and change of the organic phase colour from the 
characteristic orange to red or brown, depending on the Au NP size (Toma et al. 2010).  
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 The role of the alkanethiol is to stabilize the colloidal Au NPs (Figure 1-3). The Brust-
Schiffrin method was improved to a more facile and efficient procedure in which β-
mercaptophenol-modified Au NPs were synthesized in a methanol solution, without the 
phase transfer agent TOAB, thereby avoiding the introduction of TOAB impurities 
(Brust et al. 1995). Indeed, these Au NPs can be frequently extracted and redissolved in 
organic solvents such as toluene, chloroform and hexane, without irreversible 
aggregation or dissociation (Martin et al. 2010). Furthermore, the NPs can be easily 
handled and functionalized as stable organic and molecular compounds, because they 
form monolayer protected clusters.  
Au NPs are stabilized by relatively robust thiolate bonds, forming cuboctahedral and 
icosahedral shapes (Zhao et al. 2013). The sulphur-containing substances inhibit the 
growth process because of the nucleation-growth-passivation kinetics model, by which 
higher S/Au molar ratios provide smaller core sizes (Templeton et al. 2000). Highly 
monodispersed and smaller Au NPs can also be produced by increasing the rate of 
NaBH4 addition and reducing the solution temperature. Cheng et al. (2003) made Au 
clusters modified with cetyl trimethyl ammonium bromide (CTAB) that could be 
dispersed in aqueous solutions because of the polar nature of the capping ligands. 
Methods that can be used to transfer the NPs from the organic to aqueous phase have 
been reported, making it possible to produce platforms that can be used for biological 
applications (Gittins & Caruso 2001).  
The critical parameter that limits Au NP size using the Brust method, compared with 
that obtained by using the Turkevich method, is essentially the use of the more powerful 
reducing agent NaBH4 in the former resulting in a faster reduction reaction (Zhao et al. 
2013).
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 Figure 1-3 The one and two-phase Brust–Schiffrin method for the formation of thiol-capped Au NPs. TOAB: tetra octyl ammonium bromide, THF: 
tetrahydrofuran.  The coloured beads represent the thiolated ligands
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1.2.3 Seed-Mediated Growth Procedure 
 
The seed-mediated growth method is the most commonly used approach to produce 
other shapes of NPs (rods, stars, wires, cubes, etc.).  In this method, spherical “seed” 
particles 3.5 - 4 nm are initially produced in the presence of a strong reducing agent 
such as NaBH4 and are then added to a growth solution containing more of the metal 
ions that will be deposited onto the seeds. A weak reducing agent, usually ascorbic acid 
(vitamin C), is used in the growth solution. Surfactants can be added to induce 
anisotropic growth (Murphy et al. 2005).  
Jana et al. (2001) investigated the production of citrate modified Au NPs by the seed-
mediated method using a wide range of reducing agents and conditions. They found that 
even in the presence of seeds, further nucleation occurs. There was therefore a need to 
control the conditions in order to avoid undesirable nucleation. The rate of addition of 
the reducing agent to the metal seed and the chemical reduction potential of the 
reducing agent were all factors that they needed to be carefully controlled. 
Numerous physical techniques, such as vacuum deposition, electrical circuitry 
dispersion and laser ablation methods, have been used to split bulk gold into NPs 
(Rajput 2015). The shapes of the Au NPs can be modified and various Au NP forms can 
be fabricated by physical processes. However, the physical methods essentially rely on 
the use of expensive instrumentation with complicated sample preparation steps, with 
potential drawbacks, such as poor reproducibility, and they are time-consuming. 
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 Colloidal Au NP Functionalization and Stabilization 1.3
 
Attaching stabilizer /functional groups with molecular recognition motifs are of critical 
importance for the use of NPs in various biomedical applications. For this purpose, a 
variety of biological probes have been used for the stabilization and/or functionalization 
of colloidal Au NPs, which include nucleic acids, enzymes, receptors, lectins, 
antibodies, aptamers and superantigens (Figure 1-4) (Sato et al. 2003; Aili et al. 2009; 
Wang et al. 2009; Piao & Chung 2012; Liu et al. 2015a).  By selecting the appropriate 
functional group at the distal end of the molecule, it is possible to design and generate a 
distinct interface to interact with biomolecules and/or cells in certain ways.  
 
 
Figure 1-4 Schematic representation of gold nanoparticles conjugated with various 
functional probes both through the gold–thiolate bond and by passive adsorption. 
Reprinted with permission from Cobley et al. (2011).  
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1.3.1 DLVO and non-DLVO forces 
 
Since the dispersion and aggregation states of colloidal NPs influence their optical, 
electronic and catalytic behaviours (Snoswell et al. 2005), the forces that regulates the 
colloid stability and how to control these are essential considerations. The stabilization 
phenomenon of Au particles in a well-defined and controlled assembly has been 
generally explained by the Derjaguin-Landau-Verwey-Overbeck (DLVO) theory, 
usually expressed in terms of the balance between attractive van der Waals forces and 
the repulsive electrostatic interactions (Lyklema 2000; Kim et al. 2008). The DLVO 
theory accounts for the potential energy variations that occur when two particles 
approach each other with the resultant net attraction and repulsion forces as a function 
of interparticle distance (Glomm 2005). The van der Waals forces arise from interaction 
of particle–particle pair and can be expressed by the equation: 
 ω(r)=−A/π2ρ1ρ2r6……. (1) 
Where r is the distance between 2 particles, ρ1 and ρ2 are the number of atoms per unit 
volume of the two interacting particles, A is the so-called Hamaker constant 
(Israelachvili 2011). As the effective Hamaker constant is a positive value, van der 
Waals forces between like particles would become attractive. On the other hand, 
electrostatic forces are repulsive for identical charged particles, due to the overlapping 
of electrical double layers. These two forces typically interact to create an energy 
barrier. The strength of the energy barrier controls the colloid stability in the solvent 
medium. The strength of the energy barrier and hence the colloid stability is governed 
by several factors such as the Hamaker constant, surface potential and electrolyte 
concentration (Zhou et al. 2009). 
G = G vdW + G elec….… (2) 
Where G vdW stands for attractive Van der Waals forces and G elec stands for repulsive 
electrostatic forces. 
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Although there is considerable support for the DLVO model, it has long been accepted 
that the classical DLVO theory does not completely explain the results in several 
experimental settings, where forces acting between surfaces did not seem to obey, if not 
contradict the predictions of the theory, especially when two particles approach closer 
than a few nanometres (Lyklema 2005; Boinovich 2010). When two particles or 
surfaces come into close proximity, different hydrophobic, steric and solvation forces 
come into play, contributions from these are known as the ‘non-DLVO’ forces. These 
forces have been shown to be repulsive, attractive or oscillatory, and they can be much 
stronger than either of the two DLVO forces (Israelachvili 2011). Efforts to reconcile 
the theory and experiment have resulted in the inclusion of a variety mechanisms to 
account for the effects of long-range surface non-DLVO forces. One of the most 
commonly studied non-DLVO’-forces is called the Casimir force, which is a small 
attractive force that acts between two close parallel uncharged conducting metals.  The 
effect is due to quantum vacuum fluctuations of the electromagnetic field. As a result of 
the presence of these forces the traditional DLVO theory has been extended and the 
interactions were described as follows (Hertlein et al. 2008): 
G = G vdW attraction + G elec repulsion + G non-DLVO forces ……………… (3) 
 
1.3.2 Stabilization Strategies 
 
The key to the Au NP-based colorimetric sensing platform is the control of the colloidal  
Au NP dispersion and aggregation stages with a biological process (or analyte) of 
interest. Stabilization of colloidal Au is achieved either electrostatically or sterically or 
by a combination of both electrostatic and steric repulsion forces (Fig 1-5). Preparation 
of Au NPs by citrate reduction methods produce metal NPs stabilized electrostatically 
against aggregation induced by van der Waals attraction (De Vasconcelos et al. 2005).   
With respect to electrostatic stabilization, the surface charges, such as the negatively 
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charged citrate, attract positively charged counter ions in the surrounding solution 
forming an electric double layer with Coulombic repulsion that stabilizes the colloid 
particles, provided that the electric potential of the double layer is sufficiently high (Fig 
1-5A)  (Fendler 1996; Zhao et al. 2008). However, the double layer is very sensitive to 
variations in the ionic strength of the solution. The electrostatic repulsion decreases 
significantly at high salt concentrations, resulting in the compression of the double layer 
and displacement of the adsorbed citrate anions, leading to aggregation of the NPs 
(Chow & Zukoski 1994; Dougan et al. 2007; Hunter 2013; McDonagh et al. 2015). 
In the case of steric stabilization (Figure 1-5B), ligands adsorbed onto the colloid 
surfaces form barriers which prevent colloidal aggregation. For effective steric 
stabilization, the adsorbed ligand molecules should be dense and thick in order to 
entirely protect the particles (De Gennes 1987). The strength of this stabilization effect 
is much less sensitive to salt concentrations, but is determined by the molecular size and 
the capping density of the ligands (Smitham et al. 1975; Napper 1977; Lourenco et al. 
1996; Schiffelers et al. 2004). Common colloidal stabilizers include charged small 
molecules, polymers, and polyelectrolytes (De Vasconcelos et al. 2005; McDonagh et 
al. 2015).  Highly charged ligands provide dual stabilization of the NPs (i.e., 
electrostatic and steric). This effect termed electrosteric effect, involves charges that are 
distributed along the ligand chains, and this is the most effective stabilization strategy 
(Figure 1-5C). Highly charged polymeric substances (e.g. polyethylene glycol, thiol- or 
thioether-functionalized polymers) are effective stabilizers of metal NPs (Schiffelers et 
al. 2004; Yu et al. 2013). 
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Figure 1-5 Stabilization of Au NPs by different forces (each of these nanoparticles are 
surrounded by double electric layer as in the image above). 
A- Electrostatic, where charges are the main property in maintaining stability  
B- Steric, where the structure of the ligands attached to the NP surface control stability 
C- Electrosteric, combines both steric and electrostatic forces to maintain the colloidal 
stability 
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 Synthesis of Peptide Functionalized Au NPs 1.4
 
Citrate Au NPs lack the stability and functionality required in order to be used as an 
effective sensing system, especially in a biological environment, where ionic strength 
and the presence of biological molecules can affect the stability of the colloidal solution. 
Peptides are one of the most frequently used biological molecules for functionalization 
of Au NP surfaces because they can be used as biorecognition probes for various 
enzymes. In most cases, the peptides are coupled through thiol bond that can remain 
adsorbed for up to 5 weeks, under physiological conditions (Dreaden et al. 2012). The 
main methods for the preparation of peptide-functionalized Au NPs are: (1) ligand 
exchange; (2) direct synthesis; and (3) chemical coupling (Zong et al. 2017). 
1.4.1 Ligand Exchange 
 
The ligand exchange process is the most frequently used approach to prepare peptide 
functionalized Au NPs. This usually involves replacing one ligand that stabilizes the NP 
during or after synthesis, with a functional ligand or other coatings capable of providing 
colloidal stability (Hostetler et al. 1999; Templeton et al. 2000). The ligand exchange 
method has been utilized effectively to prepare a variety of Au NPs capped with 
cysteine-capped peptides. Treating citrate Au NPs with a cysteine-containing peptide 
results in a ligand exchange, which as a consequence produces peptide capped Au NPs 
(Dinkel et al. 2016). In this way, the particles can be made biocompatible, and the 
surface can be loaded with molecules for biomedical applications (Zhu et al. 2012; 
Yang et al. 2014; Plissonneau et al. 2016). As the interaction of thiol tagged peptides 
with Au NPs is much stronger than that of the citrate ions, this reaction proceeds 
preferentially. The thiolate–gold (RS–Au) bond strength is approximately 210 kJ mol−1 
( Häkkinen 2012). 
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1.4.2 Direct Synthesis of functionalized Au NPs 
 
This approach involves the direct synthesis of peptide functionalized Au NPs rather 
than a stepwise synthesis approach used in ligand exchange. This chemical strategy 
proceeds by reacting the gold salt (HAuCl4) with a reducing molecule that acts as an 
electron transfer agent (Pujols-Ayala et al. 2003). When preparing, peptide 
functionalized Au NPs using this strategy, tyrosine functions as the reducing agent of 
AuCl4− to Au0, and the free amine at the N-terminus of the peptide is coupled to the 
gold surface, resulting in a colloidal suspension (Bhattacharjee et al. 2005). This 
strategy is of limited use because of the difficulty in controlling the size of the Au NPs 
produced, especially when using excess peptides that lead to Au NP aggregation, due to 
H-bonding between the terminal amine group and the side chains of the amino acid 
residues. Another method for the direct synthesis of functionalized Au NPs uses 
reduction with heparan sulphate I (Ban et al. 2008). The gold precursor (HAuCl4) is first 
mixed with the heparan sulphate in water followed by the addition of a trisodium citrate 
solution (Na3C6H5O7). By using this approach, it was possible to use a mild conditions 
for ligand coupling thus limiting degradation of the polysaccharide as well as a method 
that would not only depend on reductive amination chemistry with the reducing end of 
the polysaccharide. 
1.4.3 Chemical Coupling 
 
This strategy entails the use of Au NPs functionalized with molecules that can act as 
sites for subsequent coupling, such as thiolated derivatives of poly ethylene glycol 
(PEG), glutathione or mercaptosuccinic acid. There are numerous procedures for cross-
linking peptides to functionalized Au NPs. Amongst the most frequently employed 
strategies is so-called click chemistry (Boisselier et al. 2008) and [1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide hydrochloride]/ N-hydroxy sulfosuccinimide 
(EDC/sulfo-NHS) coupling (Bartczak & Kanaras 2011). Synthesis of peptide capped 
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Au NPs by this strategy resulted in inefficient binding between the biomolecules and the 
capped NPs or the particle biomolecule conjugates are unstable (Pease et al. 2007). 
  Properties of Metallic Nanoparticles 1.5
1.5.1 Localized Surface Plasmon Resonance (LSPR)  
 
Au, Ag and Cu colloids have occupied 5d, 4d or 3d shells, respectively, but only half 
filled in the corresponding 6s, 5s or 4s levels and display strong absorption bands in the 
visible region, due to the energy levels of their d–d transitions. The plasmon frequency 
is driven into the visible part of the spectrum and these colloids are therefore intensely 
coloured. This intense colouration, associated with metal colloids, is a result of the 
absorption and scattering of light, as described theoretically by Gustav Mie (Link & El-
Sayed 1999). It is anticipated that the unusual effects associated with metallic NPs 
fundamentally arise from their nanometre dimensions, especially in the range of 10-100 
nm, which relates to the mean free path (the distance the electron travels between 
scattering collisions with the lattice centres) of an electron in a metal at room 
temperature. In noble metals, the decrease in size below the electron mean free path 
gives rise to intense absorption in the visible-near-UV. This result from the coherent 
oscillation of the free electrons from one surface of the particle to the other and is called 
the surface plasmon absorption (El-Sayed 2001). 
The interactions of the oscillating electric field of an incident light beam results in 
transfer of surface electrons to vacant orbitals, giving rise to a collective oscillation of 
the electrons within the conduction band, which induces the formation of a dipole in the 
NP. The boundary and surface effects of a particle become more dominant when 
dimensions of the particles approach the nanoscale. The optical properties of small 
metal NPs are dominated by collective oscillation of conduction electrons (Moskovits 
1985; Smith 2008). When the incident photon frequency is resonant with the collective 
oscillation of the conduction band electrons, the radiation is absorbed to give an 
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absorption band forms. This phenomenon is known as the surface plasmon resonance 
(SPR). The interaction between light and the conduction electrons is shown in Fig. 1-6. 
This process can be separated into two forms of interactions: scattering, in which the 
incident light changes its direction at the same wavelength after interacting with the 
medium, and absorption, in which the energy is converted into vibrations of the lattice, 
naturally noticed as heat. Together, these processes are referred to as extinction. 
Moreover, a strong electric close field is produced near the surface of the particle by the 
LSPR effect (Cobley et al. 2011). 
The position of the SPR band depends on numerous factors such as: particle size, shape, 
interparticle interactions, dielectric properties of the solution, stabilizing ligand shells as 
well as the nature of the surrounding medium (Mulvaney 1996; Link & El-Sayed 1999; 
Amendola et al. 2017).  
 
Figure 1-6 Schematic Representation of Localized Surface Plasmon Resonance 
excitation of Au NPs.  
Interaction of the electromagnetic radiation with the metal NP surface electrons induces 
dipole oscillation and hence produces surface plasmon resonance. Reprinted with 
permission from (Chou et al. 2014) 
 
The refractive index of the solvent has been shown to influence the position of the 
surface plasmon band, as predicted by the Mie theory (Mulvaney, 1994). For instance, 
colours of colloidal Au NP suspensions prepared in water and in mixtures of butyl 
24 
 
acetate and carbon disulphide displayed colour variation from pale red through to purple 
in solution. Impurities in the system can be observed since the refractive index of Au 
NPs greatly differs from that of Au oxide or Au chloride. It has been demonstrated that 
an alteration in the refractive index of the Au NP suspension leads to a corresponding 
shift in the surface plasmon band (Underwood & Mulvaney 1994).  
The surface plasmon oscillation is affected when NPs aggregate (i.e. to ≤ 2.5 times the 
particle diameter), allowing the single particles to electronically interact with each other 
(Sardar et al. 2009). It has been found that the electromagnetic coupling of NPs 
becomes effective when the interparticle distances are less than 1/5 times their 
individual diameters. Aggregation can induce the coupling of the Au NP plasmon 
modes, producing a redshift and broadening of the SPR band, associated with the 
longitudinal resonance in the optical spectrum. As a result, aggregation usually changes 
the original red colour of the Au NP dispersion into purple or blue (Link & El-Sayed 
1999). It has been demonstrated that such spectral changes, which are induced by the 
aggregation of NPs, can be employed to detect biomolecular recognition events, such as 
detection of DNA and protein biomarkers for cancer and other disease diagnosis 
(Elghanian et al. 1997). 
Changes in the shape of the particles also contribute towards observed changes in the 
absorption spectrum. For instance, the SPR band is shifted to a higher wavelength in 
elliptical particles, owing to the reduced spacing between the particles and the extent of 
the shift is an exponential function of the distance between two particles (Blatchford et 
al. 1982). 
When the radius of the particle is less than the mean free path of the conduction 
electrons, the photon scatter at the particle boundaries results in broadening and fading 
of the surface plasmons. As a result, SPR is absent for Au NPs with core diameter less 
than 2 nm, as well as for bulk Au. There is only a minor temperature effect on the 
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plasmon absorption in Au NPs, as the Fermi distribution of the electrons changes only 
gradually with temperature, and the scattering rate depends mainly on the availability of 
vacant states just above or below the Fermi level (Link & El-Sayed 1999). 
The majority of other metal colloids that are usually brown or grey in colour, do not 
have absorption bands in the visible region, and the absorption spectra emerge flat and 
featureless (Creighton & Eadon 1991). 
 
1.5.2 Quantum Size Effects 
 
It is well known that the reduction of the particle size to values comparable to the 
wavelength of an electron at the Fermi energy (~about 1 nm for a metal) leads to 
extreme confinement of electron mobility and a size quantization of its momentum 
(Kubo 1962). Reduction in particle size to a few tenths of nanometres leads to unique 
physical and optical properties (Papavassiliou 1979; Kreibig & Genzel 1985; Bohren & 
Huffman 2008; Kerker 2013). Bulk gold has a standard yellow colour, imparted by a 
decrease in reflectivity of light at the end of the spectrum. Whenever Au is partitioned 
into smaller and smaller particles, the ratio of the surface atoms to interior atoms 
increases, leading to pronounced changes in the physical and chemical properties of the 
NP (Link & El-Sayed 2000). Confinement of the system arises from size reduction of 
the particles, which has an effect on the energy level spacing. The spacing between 
neighbouring conduction energy states increases inversely with the size of the particle 
(Perenboom et al. 1981; Halperin 1986). In order to observe noticeable spacing of the 
energy levels within the conduction band, the metal particles should be reduced to a few 
nanometres size (Link & El-Sayed 2000). The free mobile electrons are trapped in the 
quantum box (the particle) and show the collective oscillation frequency of the plasmon 
resonance, giving rise to the well-known absorption between 520 - 530 nm for 5–20 nm 
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spherical Au NPs with a deep-red colour, which can be used in a variety of optical 
applications. 
1.5.3 Tuneable Surface Chemistry of Au NPs 
 
The surface of Au NPs can be tailored by ligand functionalization to impart stabilization 
against van der Waals attraction forces and to bind molecules of interest selectively 
(Grandbois et al. 1999; Dougan et al. 2007). The common approaches for 
functionalization of Au NPs are either through chemical modification of the Au NPs for 
specific protein/antibody covalent bonding or by adsorption via electrostatic forces. 
Since thiol moieties bind strongly to Au surfaces by forming dative bonds (Hermanson 
2013), the most frequently used ligands are thiol containing or thiol-modified 
molecules, such as thiolated DNA strands (Liu et al. 2009), thiolated glucose or 
galactose (Zeng et al. 2012), cysteine-containing peptides (Wang et al. 2006; Huang et 
al. 2012) which bind to the surface of the Au particles by formation of thiolate-Au 
bonds. Alternatively, biological ligands can also be coupled to the surface of Au 
particles by bioconjugate chemistry, through the coupling of amino groups on the 
biological molecules with carboxy groups at the free ends of stabilizer molecules by 
using carbodiimides, such as EDC (Hermanson 2013). 
Under certain conditions, noncovalent bonding is another strategy by which 
macromolecules can be attached to the colloidal gold surface, with a minimum change 
in the specific activity of the bound ligands. With numerous strategies that can be 
implemented for Au NP surface modification, almost all biological molecules can be 
non-covalently attached to the particle surface (Sperling et al. 2008). 
 Biomedical Applications of Au NPs 1.6
 
Au NPs are currently used in a variety of biomedical applications, due to their 
favourable properties that make them attractive candidates for biomedical use and these 
27 
 
include but are not limited to the dimensions of the metal NPs, which are comparable to 
those of biomolecules such as proteins (enzymes, antigens, antibodies) or DNA, whose 
dimensions are in the range of 2-20 nm offering great advantages for integration of 
nanotechnology to biotechnology, in addition to their biocompatibility and facile 
surface chemistry (Niemeyer 2001; Whitesides 2003; Katz & Willner 2004; Rosi & 
Mirkin 2005). In early applications, Au NPs were employed as immunocytochemical 
probes in transmission electron microscopy (Faulk & Taylor 1971). Here antibodies 
were labelled with colloidal Au in order to enable direct visualization of Salmonella 
surface antigens using an electron microscope. This was the first demonstration that a 
colloidal Au conjugate can function as an immunostaining agent. Mirkin and colleagues 
reported on the optical and melting features for an aggregate of Au NPs and their use for 
detection of oligonucleotides (Elghanian et al. 1997). They observed a colour change 
caused by assembly of 13 nm Au NPs due to a specific interaction between 
oligonucleotides attached to the Au NPs surface. Figure 1-7 depicts some aspects of the 
multidisciplinary applications of Au NP in the biological and medical fields.  
 
Figure 1-7 The versatile applications of Au NPs employed for biomedical applications 
Reprinted with permission from (Ahmed & Ikram 2016) 
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1.6.1 Biosensing Applications of Au NPs 
 
Au NPs present a remarkable platform for the development of biosensing analytical 
methods. The probe-analyte interaction can cause electronic or optical changes that can 
be detected (Penn et al. 2003; West & Halas 2003; Alivisatos 2004).  The properties of 
these NPs, can be tuned for particular applications such as molecular recognition, 
chemical sensing and imaging.  
Au NP – based sensing techniques generally involve colorimetry, fluorescence, 
electrochemistry, surface enhanced Raman scattering (SERS) and systems in which 
quartz crystal microbalance and bio-barcodes are used (Cheng et al. 2015). Among 
these sensing approaches, colorimetric assays based on target recognition induced 
aggregation or redispersion of Au NPs have been used widely, due to the ease with 
which the measurement strategy can be designed. When the particles aggregate in an 
organized fashion, colour changes can be systematically varied, from pink through 
violet to blue (Creighton & Eadon 1991; Basu et al. 2007; Bergamini et al. 2015). This 
phenomenon has been used for testing specific genetic sequences (Alivisatos 2004) and 
as a colorimetric indicator in home pregnancy tests (e.g. First Response®, marketed in 
the 1990s) (Rojanathanes et al. 2008). The latter test is based on the specific recognition 
of human chorionic gonadotropin (hCG), a hormone produced during pregnancy, by Au 
NPs conjugated with an anti-hCG antibody. 
It is the anticipated colour change during Au NP aggregation (or dispersion of an 
aggregate) that provides the basis for absorption-based colorimetric detection. Besides 
the detection of analytes, such colour changes can also be utilized to measure changes in 
the lengths of molecules. The concept of such ‘‘rulers on the nanometre scale’’ is based 
on colour changes of Au NPs dependent on distance between NPs. Different sites of a 
macromolecule can be coupled to Au NPs, by monitoring the colour of the Au NPs, the 
distance between these sites can be measured and in this way, for example, 
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conformational changes in molecules can be determined (Sönnichsen et al. 2005). 
Conjugation with pH-sensitive molecules can also transform gold nanostructures into 
all-optical pH sensors (Bishnoi et al. 2006). 
At present, there are two fundamental strategies for metal NP use in colorimetric assays: 
the use of Au NPs conjugated with thiol-modified molecules (Liu et al. 2009; Huang et 
al. 2012; Wang et al. 2014a) or aptamers (Pavlov et al. 2004; Wei et al. 2007; Hu et al. 
2015) and the use of unmodified Au NPs (Xia et al. 2010; Pan et al. 2012; Liu et al. 
2015b; He et al. 2017).The first approach relies on immobilization of a ligand or a 
biological substrate, specific to the target analyte of interest, onto the NP surface. Upon 
the addition of the target analyte, the analyte activity induces changes in the NP 
stability; these stimuli can cause the Au NPs to either aggregate or disperse, 
accompanied by a shift in the absorption spectrum of the aggregated/dispersed Au NPs, 
resulting in a visible colour change at nanomolar concentrations (Dykman & Khlebtsov 
2012).  
The second sensing approach, which employs unmodified Au NPs takes advantage of 
the observation that at high ionic strength (300 mM NaCl), single-stranded DNA 
(ssDNA) prevents bare Au NPs from aggregation, whereas double-stranded DNA 
(dsDNA) does not (Li & Rothberg 2004). It has also been shown that aptamers undergo 
ligand-induced conformational changes that can be sensed by Au NPs. This method can 
be used as a simple and promising colorimetric probe for aptamer-based sensors (Xia et 
al. 2010); in fact, the colour change of Au NPs through addition of salt can be used to 
detect the presence or absence of analytes that cause conformational changes in 
aptamers (Yarbakht & Nikkhah 2016). Many other target analytes have already been 
detected using this strategy such as enzymes, proteins, ions and other small molecules 
(Chen et al. 2010a; Chandrawati & Stevens 2014; Cheng et al. 2015).  
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The extent of aggregation/dispersion is proportional to the absorption peak shift, so the 
change in the SPR band position offers a direct measure of quantity or activity of the 
inducing agent (e.g., an active enzyme). For Au NPs, progressively increased 
aggregation is characterized by a gradual decrease in the absorbance of the plasmon 
peak at 520 nm and the appearance of a new peak at between 600-700 nm. These 
changes are associated with solution colour change from red to purple or blue 
depending on the degree of aggregation. In some instances, the LSPR spectrum may end 
up featureless and the solution turns colourless, an indication of extreme aggregation, 
where the SPR band shifts into the infra-red (IR) region and most visible light is 
reflected (Lim 2016). 
As a result of their specificity, sensitivity, and ease of visualisation, several Au NP 
assay platforms have been developed by incorporating them into test systems for hand-
held diagnostics (Figure 1-8). These test strips have found application in the detection 
of toxins, infectious agents and inflammatory diseases (Koo et al. 2005; Rasooly & 
Herold 2009; Zhang & Ying 2015). Another important advantage offered by the use of 
Au NPs is multiplex detection of several analytes simultaneously (Nash et al. 2012; 
Rawat et al. 2015; Quintela et al. 2015). For instance, Nash and colleagues reported a 
hybrid Au NP and iron oxide reagent system for multiplexed biomarker detection, as 
demonstrated with the pan-aldolase and Plasmodium Falciparum histidine-rich protein 
2 (PfHRP2) in spiked pooled plasma samples.  
 
31 
 
 
 
Figure 1-8 The operational principle of the lateral flow test strip. It can be simply 
described as follows: the sample solution is pipetted onto the sample pad and gold-
labelled antibody is added to the gold conjugate pad. The antibody migrates upward due 
to the action of capillary forces. When colloidal Au NP-antibody conjugate reaches the 
test line, the coated antigens would compete with the analyte antigens in the sample for 
binding to specific sites on the gold-labelled antibody. Results on the Au NP assisted 
immunoassay would display as positive, negative, and invalid determination because of 
the absent coloration in the control zone (www.cytodiagnostics.com). 
 
1.6.2  Targeted Drug and Gene Delivery Using Au NPs Nanostructres 
 
Drug delivery is one example of how Au nanostructures can be applied for therapy in 
addition to diagnosis in what is known as “theranostic applications” (Daniel & Astruc 
2004; Yavuz et al. 2009). Most work in this area has focused on cancer therapy, as 
functionalized Au NPs can be designed to target specific cell types and organelles such 
as the nucleus or mitochondria. Through targeting the drug to the desired site, the dose 
of the drug can be increased at the tumour site, while at the same time limiting the 
exposure of (and consequent toxicity to) healthy tissue (Peer et al. 2007).  
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Another innovative application of Au nanostructures involves the use of Au nanocages 
that are modified with polymers such as poly- (N-isopropyl acrylamide) (pNIPAAm) 
that combine the photothermal properties of Au nanocages with delivering their cargo to 
a specific site. When the Au nanocages are illuminated with a laser, the actively 
absorbed light is transformed into heat through the photothermal effect. When the 
temperature increases beyond a certain threshold, the pNIPAAm coating undergoes a 
conformational change, which in turn exposes the nanocage pores, allowing the pre-
loaded drug to be released (Yavuz et al. 2009). 
1.6.3 Gold Nanoparticles for Visualization and Labelling of Biological Molecules 
 
Au NPs have been employed extensively in diverse visualization and bioimaging 
techniques to detect chemical and biological agents (Agasti et al. 2010; Hahn et al. 
2011). The particles are directed and concentrated at the targeted site to deliver contrast 
for visualization. Au NPs are excellent contrast agents as they can be visualized with a 
variety of imaging techniques. Images are obtained via the interaction of light with Au 
NPs (Jain 2007). Au particles can also be utilized for labeling because they display 
different colours due to their ability to scatter light depending on their sizes and shapes  
(Sonnichsen, 2002; Mirkin 2001). 
 Fields in which NP-based contrast has proven to be beneficial include: tumour imaging 
for directed surgery, imaging of gene expression in vivo to identify disease development 
and to assess the efficacy of anti-cancer drugs. Specifically, the two-photon 
luminescence of Au NPs allows visualization of cancer markers on or inside cells (Durr 
et al. 2007; Park et al. 2008; Maiorano et al. 2010). 
With the help of dark-field electron microscopy, Au NPs have superior ability to 
uncover specific bio-interactions compared with fluorescent labels, as the particle 
scattering cross section is 3 to 5 times greater than that of fluorescence molecules (Hu et 
al. 2008). This principle was employed by El-Sayed’s group for development of a novel 
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diagnostic tool for cancer, with the aid of Au NPs coupled to tumour-antigen-specific 
antibodies against the membrane of cancerous cells, as compared with binding to 
healthy cells (El-Sayed et al. 2005). 
1.6.4  Photothermal Therapy Using Au NPs 
 
The efficient transfer of light into heat by Au NPs allows the highly specific thermal 
treatment of diseased or infected tissues. The basic concept of using Au NPs for thermal 
therapy depends on exposing cells to higher than normal temperatures, which lead to 
cell death via apoptosis. The sensitivity of cells to temperature offers the possibility of 
the use of photodynamic therapy in the treatment of certain forms of cancer. Malignant 
cells in tumour tissue exhibit a disorganized and packed vascular structure, and as a 
result, heat dissipation is delayed in contrast to healthy tissues (Song 1984). In practice, 
Au NPs can be functionalized with ligands that are specific to receptors overexpressed 
on cancer cells. The particles are then locally concentrated in the cancerous tissue 
illuminated with the external light source to make Au NPs a heat source for the 
surrounding cancerous tissues, without exposing healthy tissue to high temperatures 
(Sperling et al. 2008). 
Gold nanorods (Au NRs) or hollow structures are preferred when light penetration is 
required as they absorb light in the IR region (Chen et al. 2007; Huang et al. 2008). 
Heating with magnetic particles is preferred for tissues that are deep inside the body. 
Upon irradiating magnetic particles with radiofrequency (RF) fields, heat is produced 
by the repetitive cycling of the magnetic hysteresis loop (Tran & Webster 2010). Since 
chemo- and radiotherapy are still the cornerstone therapy for cancer, NPs that display 
dual functions of heat mediator foci with the capability to transport and to discharge 
medicines may extend their scope for biomedical applications (Yoo et al. 2013). 
 
34 
 
1.6.5 Gold Nanoparticles for Enzyme Activity Detection 
 
In traditional enzyme detection and quantification assays, the activity is usually detected 
either by recording absorbance or fluorescence emitted from labelled substrates, 
modified with either chromogenic or fluorogenic reporter molecules, fluorescence 
resonance energy transfer (FRET) substrates or by indirect sensor systems that depend 
on sensing the reactions of unmodified substrates, to produce a detectable spectroscopic 
signal (Gul et al. 1998; Eisenthal & Danson 2002; Goddard & Reymond 2004). 
Although these approaches, in general, are adequate for many applications (some are 
commercially available), they are less sensitive and in some cases, are limited only to in 
vitro use (Corrie et al. 2015).  
In the last two decades, Au NP-based colorimetric biosensing assays have attracted 
great attention in diagnostic applications, due to their simplicity versatility and 
biological compatibility. A variety of NP-based sensing systems have been developed, 
with varying degrees of success and sensitivity. These nanoparticulate systems are 
valuable tools for the detection and measurement of enzyme activity in real time and 
may offer a useful high-throughput screening (HTS) tool for enzyme activity and drug 
discovery (Anker et al. 2008). The most common method of measuring the rate of 
catalytic enzyme activity is the use of spectrophotometric assays. Although these assays 
are easy to use and interpret, a major limiting factor is the requirement for a fluoro-
/chromo-genic reporter. However, in most cases, this means that the activity of the 
enzyme is detected indirectly or that improved enzyme activities may be selected based 
on the use of an idealised substrate, which may not translate to the real one (Westley et 
al. 2017). 
The use of Au NPs in colorimetric assays involves two mechanisms: interparticle bond 
formation or cross-linking (CL) aggregation which represents the prototype approach 
through which Au NPs are brought together. This occurs either by using crosslinker 
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molecules that have two binding tags linking two Au NPs to each other (e.g peptides 
with thiol and/or guanidine anchors) (Figure 1-9A) or by direct interaction (without 
crosslinkers) such as antigen - antibody interactions and DNA hybridization (Figure 1-
9B). Mirkin and co-workers (1997) pioneering work on the development of 
polynucleotide sensor is a model example, in which Au NPs functionalized with a 
thiolated DNA strand are fabricated and incubated with target DNA molecules to trigger 
Au NP aggregation, by hybridizing two complementary DNA strands on Au NPs giving 
rise to colorimetric detection of oligonucleotides. This platform has also been utilized 
by many others for the detection of a wide variety of biological and chemical molecules 
(Tiwari et al. 2010; Xia et al. 2010; Pan et al. 2012; Wang et al. 2015; Liu et al. 2015a).  
 
The other approach for enzyme (protein) biosensing occurs through the removal of 
colloidal stabilization effects, which are known as non-crosslinking (NCL) aggregation. 
In such systems, Au NP aggregation is induced by the stronger interaction between 
ligands and target analyte, accompanied with the complete or partial release of the 
ligand from the surface of the NPs, without the formation of interparticle bonds (Figure 
1-10), which provides real-time measurement of enzyme activity in contrast to the 
relatively slow process induced by inter-particle crosslinking (Zhao et al. 2007). This 
strategy was first used for the detection of polynucleotide polymorphisms (Sato et al. 
2003). When a target polynucleotide is complementary to the ligand in sequence and 
chain length, it will hybridize to the DNA on Au NPs, this, in turn, alters the NP 
resistance to salt-induced aggregation. 
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Figure 1-9 Protein or enzyme detection by reversible crosslinking mechanism (CL). (A) 
Addition of crosslinker results in aggregation. (B) Removal of crosslinker results in the 
dispersion of the Au NP aggregates and the reaction is reversed. 
 
(A) 
(B) 
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Figure 1-10 Non-Crosslinking aggregation of peptide (green) modified Au NPs.  The 
presence of enzyme can cause  colloidal aggregation of the Au NPs, without cross 
linkers due to a change in stability. Such a change may occur if the dispersed particles 
are linked to cleavable molecules. Cleavage of the substrate can be initiated by a change 
in the biological environment or caused by an exogenous stimulus.  
 
 Dipeptidyl peptidase IV 1.7
 
Dipeptidyl peptidase IV (DPP-IV/CD26 EC 3.4.14.5) is a serine exopeptidase that was 
discovered and purified from pig kidney cortex by Hopsue-Havu and Glenner (1966). 
Using a synthesized chromogenic substrate, it has been shown to cleave N-terminal X-
prolyl residues from various peptides. DPP-IV/CD26 was also known as glycyl prolyl 
β-naphthylamidase because of its ability to specifically cleave the amide bond between 
the N-terminal glycyl proline and β-naphthylamine (Hopsu-Havu & Glenner 1966; Öya 
et al. 1972; Hino et al. 1975). Subsequent studies revealed that DPP-IV is a cell surface 
antigen, also known as CD26 (Hegen et al. 1990). Moreover, DPP-IV/CD26 is also 
known as adenosine deaminase complexing protein 2 (ADCP2) (Richard et al. 2000). 
DPP-IV/CD26 is a multifunctional protein, which is involved in proteolysis, signal 
transduction and modulation of the immune and inflammatory responses (Wagner et al. 
38 
 
2016). Because of this multiplicity of actions and biological functions, there is a great 
deal of pharmaceutical, biomedical and industrial communities interest in the 
biochemical behaviour of this protein (Boonacker & Van Noorden 2003).  
DPP-IV/CD26 is responsible for the truncation of many bioactive peptides by splitting 
dipeptides from proteins and peptides containing proline or alanine in the penultimate 
N-terminus amino acid position. The use of DPP-IV/CD26 inhibitors for the 
management of type II diabetes has been approved by Food and Drug Administration 
(FDA) because of their ability to reduce the inactivation of incretins, resulting in 
enhancing insulinotropic actions. It has been demonstrated that serum DPP-IV/CD26 
activity increases in prostate cancers, type 2 diabetes mellitus, hepatitis and 
hepatobiliary diseases (Wilson et al. 2000; Firneisz et al. 2001; Ahmed et al. 2015). In 
contrast, its activity decreases in patient’s sera with renal cancer, pancreatic cancer, 
systemic lupus erythematosus, rheumatoid arthritis, anorexia and bulimia nervosa (van 
West et al. 2000; de la Haba-Rodriguez et al. 2002; Pro & Dang 2004; Varona et al. 
2010). 
1.7.1 Classification 
 
DPP-IV/CD26 is a member of the S9 prolyl oligopeptidase family along with prolyl 
endopeptidase (PEP), acylaminoacyl peptidase and glutamyl endopeptidase (Buckley et 
al. 2004). The DPP family includes other members that display DPP-IV/CD26-like 
activity, such as quiescent cell proline dipeptidase (QPP), fibroblast activation protein-
alpha (FAP-α), dipeptidyl peptidase 8 (DPP8) and dipeptidyl peptidase 9 (DPP9) 
(Scanlan et al. 1994; Abbott et al. 2000). They all belong to the DASH "DPP-IV/CD26 
Activity and Structure Homologues" group of peptidases that preferentially cleave X-
proline and X-alanine at the penultimate position (scissile residue, P1-position) (Fig.1-
11) of the polypeptide substrates, which include: chemokines, neuropeptides, peptide 
hormones and incretins in weakly basic medium (pH 8) (Bušek et al. 2004). These 
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substrates play important roles in immune regulation, neurodegenerative diseases, heart 
failure, ischemic injuries, nutritional control, inflammatory and infectious diseases, 
oncological processes and nociception (Hildebrandt et al. 2001; Lambeir et al. 2008; 
Deacon 2011).  
 
Figure 1-11 Schematic representation of substrates cleaved by DPP-IV/CD26. 
Dipeptides are released from the N-terminus of peptides with Pro or Ala in the P1-
position. Certain peptides with other small amino acids in P1 position are cleaved at 
slower rates. In the P2 position, bulky, hydrophobic or basic amino acids with an 
obligate free amino group are preferred. Reprinted with permission from (Mentlein 
1999).  
 
1.7.2 Sequence and Three-Dimensional Structure of DPP-IV/CD26 
 
Human DPP-IV/CD26 is a 766-amino acid (AA) protein whose primary structure was 
determined by cloning and sequencing of cDNA of rat DPP-IV/CD26 (Ogata et al. 
1989). The protein is anchored to the lipid bilayer by a hydrophobic transmembrane 
segment composed of 22 AA residues (AA7-29) that are attached to the N-terminus six 
AA  in the cytoplasmic region, which has been shown to be involved in the enzymatic 
activity and quaternary structure by dimerization (Chung et al. 2010).  
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The opposite end of the segment is linked to the large extracellular part by a flexible 
stalk (AA, 29-48). The extracellular region is composed of a heavily glycosylated 
region (AA 49-289), a cysteine-rich region containing 9 of 12 cysteines (AA 290-510), 
and the catalytic domain (Lambeir et al. 2003). A soluble form of the protein (sDPP-
IV/CD26), lacking the intracellular part and the transmembrane region, is found in body 
fluids (Durinx et al. 2000).  
1.7.3 Mechanism of Hydrolysis by DPP-IV/CD26 
 
The catalytic active site is composed of three AAs Ser630, Asp708 and His740 and has 
dual function, binding the substrate and catalysing the reaction. Nucleophilic serine 630 
attacks the scissile bond of the substrate in the opposite position, compared to classical 
serine proteases. Substrate-assisted catalysis and a pH-dependent conformational 
enzyme isomerization are implicated in the catalytic mechanism of DPP-IV/CD26  
(Demuth & Heins 1995; Kim et al. 2006).  
DPP-IV/CD26 accepts all amino acid residues at the N-terminus, provided they are in 
the protonated form, but with more affinity for hydrophobic aliphatic residues (Kaspari 
et al. 1996). Substrate recognition by DPP- IV/CD26 is defined not only by the AA 
sequence of the substrate but also by its size. It has been demonstrated that the rate of 
substrate cleavage by DPP-IV/CD26 is inversely proportional to substrate AA chain 
length (Hoffmann et al. 1993). Peptide bonds involving the cyclic AA proline are not 
subject to proteolysis by most proteases, even those with broad selectivity (Mentlein 
1988; Yaron et al. 1993).  
1.7.4 Enzyme Localisation and availability 
 
The enzyme is a type 2 transmembrane glycoprotein expressed on the surface of many 
cell types in almost all organs and tissues of the body, with the highest concentration in 
the proximal tubule of the kidney and luminal membrane of epithelial cells of the small 
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intestine, as well as in liver hepatocytes, prostate tissue and activated leukocytes. It has 
been demonstrated that DPP-IV/CD26 is also expressed in the endocrine cells of the 
pancreatic islets (Omar et al. 2014). As mentioned earlier, the enzyme is also present in 
blood in the soluble form (sDPP-IV/CD26), which is thought to be produced as a result 
of proteolytic cleavage of the membrane-bound form or as specially encoded soluble 
variant (Iwaki-Egawa et al. 1998; Mentlein 1999). In other biological fluids, such as 
synovial fluid, cerebrospinal, seminal fluid, saliva and bile have been found to contain 
the soluble form of the enzyme (Durinx et al. 2000). Some studies argue that the soluble 
forms may originate from shedding from endothelial or epithelial cells and from 
circulating leucocytes (Lambeir et al. 2003; Cordero et al. 2009). Recently, bone 
marrow cells have been determined as one of the sources of soluble serum DPP-
IV/CD26 by transplantation studies in DPP-IV deficient rats (Wang et al. 2014c). 
  Functions of DPP-IV/CD26 1.8
 
DPP-IV/CD26 is considered as a moonlighting protein due to its multifunctional roles 
and its widespread expression (Boonacker & Van Noorden 2003). The functions of 
DPP-IV/CD26 include protease activity, in addition to acting as a co- stimulatory 
protein for both CD3 and CD2 dependent T-lymphocyte activation, tyrosine 
phosphorylation of T-cell receptor (TCR/CD3) signal transduction pathway proteins, 
adhesion molecules for collagen and fibronectin, receptor molecules for adenosine 
deaminase (ADA) on lymphocytes, regulation of glucose homeostasis and apoptosis 
(Kim et al. 2014). DPP-IV/CD26 accomplishes some of its physiological functions 
through interactions with other proteins, such as caveolin-1 and the mannose-6-
phosphate/insulin-like growth factor II receptor (M6P/IGFIIR) (Havre et al. 2008). 
It has been reported that DPP-IV/CD26 plays a role in inflammation-mediated diseases 
such as atherosclerosis and multiple sclerosis (Zhong et al. 2013). DPP-IV/CD26 is 
involved in endocrine function by cleaving growth-hormone-releasing factor (GHRF) 
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(Bercu & Walker 2012). In addition, DPP-IV/CD26 plays a role in nervous system 
function by acting as a regulatory molecule for a variety of neuropeptides such as 
neuropeptide Y (Hildebrandt et al. 2003). DPP-IV/CD26 is also relevant in diseases 
such as rheumatoid arthritis (Cordero et al. 2015) and asthma (Ohnuma et al. 2005; 
Schmiedl et al. 2010). DPP-IV/CD26 has a significant role in the allergic response of 
skin (e.g. atopic dermatitis and contact dermatitis) (Tasic et al. 2011, Komiya et al. 
2017).  
It has been proposed that DPP-IV/CD26 could be involved in the link between adipose 
tissue and obesity and metabolic syndrome, which is a cluster of conditions involving 
increased blood pressure, high blood sugar, excess body fat around the waist and 
abnormal cholesterol or triglyceride levels, that occur together (Lamers et al. 2011). 
Faster wound healing as well as faster scar formation has been reported in conditions of 
DPP-IV/CD26 deficient mice, which was attributed to rapid macrophage recruitment at 
the site of skin damage as a consequence of DPP-IV/CD26 deficiency (Baticic Pucar et 
al. 2017). Involvement in these roles makes the enzyme a valuable potential diagnostic 
and prognostic tool for various health conditions. 
1.8.1 Proteolytic Function of DPP-IV/CD26 
 
DPP-IV/CD26 has a remarkable capacity to cleave the peptide bond following a 
penultimate proline, thereby releasing proline-containing dipeptides from the N-
terminus of polypeptide chains. Thus it is one of the few enzymes able to facilitate the 
digestion of proline-rich proteins and polypeptides. As DPP-IV/CD26 is highly 
expressed in the epithelial cells of the small intestine it has a crucial role in the 
hydrolysis of proline-containing dietary proteins such as gluten, gliadin and casein 
(Table 1-2). These allergenic proteins are highly resistant to breakdown by other 
proteolytic enzymes and can cause several serious adverse food reactions including the 
enteropathic manifestations of coeliac disease (Detel et al. 2007). 
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Table 1-2 Physiological peptides/hormones identified as substrates of DPP-IV/CD26 
and subject to modulation by the enzyme (Gupta et al. 2009).  
  
 
GLP: Glucagon Like Peptide, GIP: Gastric Inhibitory Peptide, PACAP: Pituitary 
Adenylate Cyclic Activating Peptide. 
1.8.2 Co-stimulatory, Receptor, Immunological Functions of DPP-IV/CD26 
 
The exact role of DPP-IV/CD26 as a co-stimulatory molecule is not yet fully 
understood. However, it has been reported that with DPP-IV/CD26-mediated co-
stimulation, interleukin 2 (IL-2) production is higher in cells expressing wild-type DPP-
IV/CD26, suggesting that the DPP-IV/CD26 enzymatic activity might contribute to, but 
is not crucial for, signal transduction in T-lymphocytes (Morimoto & Schlossman 1998; 
Wesley et al. 2005). 
CD26 was identified as the binding protein for adenosine deaminase (ADA) that is 
responsible for irreversible deamination of adenosine and 2´-deoxyadenosine to inosine 
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and 2´deoxyinosine respectively, thereby functioning as a receptor (Oravecz et al. 1997; 
Gonzalez-Gronow et al. 2005). Complex formation between CD26 and ADA preserves 
the individual enzymatic activities of both molecules and this observation has triggered 
research into the functional implications of this in immune regulation (Franco et al. 
1998; Kim et al. 2015).  
 
The DPP-IV /CD26 protein plays a major role in the immune response as it is expressed 
on the surface of B lymphocytes, natural killer (NK) cells, and macrophages as well as 
T cells, further supporting a role for the enzyme in the immune response (Tanaka et al. 
1994; Stankovic et al. 2008). Further evidence of the crucial role of DPP-IV/CD26 
activity in T cell proliferation was found in studies involving soluble CD26 molecules.  
Studies have pointed to the association of DPP-IV/CD26 in the physiological control of 
several peptides that function as biochemical mediators between and within the cells of 
the immune and neuroendocrine system (Dang & Morimoto 2002; Ansorge & Langner 
2013). Within the immune system, DPP-IV/CD26 plays a significant role in the 
regulation of chemokine activity. This role is thought to be the result of a combination 
of its exopeptidase activity and its non-enzymatic interactions with different molecules 
such as HIV envelope glycoprotein gp120 and streptokinase (Goodwin et al. 2013). 
1.8.3 Other Miscellaneous Functions of DPP-IV/CD26 
 
The DPP-IV/CD26 gene family contains 4 peptidases, all involved in cell-extracellular 
matrix (ECM) interactions, apoptosis and tissue remodelling, but with different 
functions and substrates (Yu et al. 2006). The interaction of DPP-IV/CD26 with 
proteins of the ECM may support cell migration and DPP-IV/CD26 could perform as a 
functional collagen receptor for CD4+ T cell activation (Wilson et al. 2000). These 
interactions were found to include collagen and fibronectin. Furthermore, since 
chemokine-chemokine receptor interactions are important in haematopoiesis and 
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immune function, CD26 could be exploited to enhance the haematopoietic efficacy of 
stem cell and progenitor cell transplantation (Broxmeyer 2008).  
 DPP-IV/CD26 Protein Levels and Activity 1.9
 
Reference DPP-IV/CD26 protein levels may not accurately reflect the levels of active 
DPP-IV/CD26 enzyme; thus, it is useful to determine DPP-IV/CD26 activity rather than 
DPP-IV/CD26 level using an antibody-based assay. Standard levels of DPP-IV/CD26 
activity in serum and CSF for healthy children and adults have been assessed by various 
research groups (Durinx et al. 2001; Lambeir et al. 2003; Cordero et al. 2009; Delezuch 
et al. 2012). Overall, these studies showed that the activity of DPP-IV/CD26 in healthy 
individuals' plasma is in the range of 12.5 - 42 U /L, and is generally higher in men than 
women (Table 1-3) and it tends to decrease significantly with age (Durinx et al. 2001; 
Lambeir et al. 2003). 
Table 1-3:  Activity levels (U/L) of  human dipeptidyl peptidase IV in plasma and 
serum in men and women (Lambeir et al. 2003). 
*One unit of enzyme activity is defined as the amount of enzyme that will hydrolyze 1.0 
µmole 7-(Gly-Pro-)-amino-4-methylcoumarinamide substrate per min at 37 °C, pH 8.3. 
 
1.9.1 DPP-IV/CD26 Activity in Pathological Conditions 
 
The alterations of human DPP-IV/CD26 activity in serum and DPP-IV/CD26 protein 
levels have been demonstrated in various diseases. Table 1-4 presents a summary of 
recent articles that have reported changes in DPP-IV/CD26 activity in a variety of 
health conditions 
                      Activity in serum (U/L) * 
          Activity in citrated plasma (U/L) * 
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Table 1-4: DPP-IV/CD26 as a marker of diseases. *Some authors reported the 
activity in ng/L where average activity is around 619 ng/L. **Not statistically different.  
Disease type DPP-IV/CD26 (U/L) Citation 
Cancers 
 - Melanoma 
 - Lung cancer   
 - Gastric cancer  
 - Prostate cancer   
 - Renal cancer          
 - Colorectal carcinoma  
 - Thyroid carcinoma 
 
lower activity 21.81±6.79 
n/a 
lower activity 511±84.8* 
lower activity 
lower activity 
higher activity (> 850*) 
overexpression 
 
Matić et al. 2012  
Blanco-Prieto et al. 2015  
Boccardi et al. 2015 
Nazarian et al. 2014 
Varona et al. 2010 
De Chiara et al. 2014; 
Aratake et al. 2002; 
Rheumatoid arthritis lower activity Cordero et al. 2015 
Chronic obstruction pulmonary 
disease 
lower activity Somborac-Bačura et al. 
2012 
Diabetic nephropathy slightly higher activity** (Sun et al. 2012) 
Psychological 
- depression 
- schizophrenia 
 
lower activity 34.2±7.6 
higher activity 46.9±11.4 
 
(Maes et al. 1996) 
(Maes et al. 1996)  
Hepatitis C virus  higher activity 20.9±9.6 (Firneisz et al. 2001) 
Cholestasis higher activity 50.2±12.2 (Perner et al. 1999) 
Miscellaneous  
- anorexia and bulimia 
- alcohol abstinence 
- mucopolysaccharidoses I, II 
 
lower activity 22.7& 27.3 
lower activity 27.7±6.3 
 activity 3.5 times higher  
 
 
(Van West et al. 2000) 
(Maes et al. 1999) 
(Hetmańczyk et al. 2016) 
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1.9.1 Assay of DPP-IV Activity 
A number of methods have been developed for the measurement of DPP-IV/CD26 
activity in a variety of biological samples. Chromogenic and fluorogenic enzyme 
substrates have formed the cornerstone for the assay of DPP-IV/CD26 activity (Nagatsu 
et al. 1976; Kato et al. 1978).  Glycylproline para-nitroanilide (Gly-Pro pNA) has been 
used as a routine substrate for the chromogenic assay. In the standard assay, DPP-
IV/CD26 in glycine-NaOH buffer (pH 8.7) or in Tris-maleate buffer (pH 7) is incubated 
with Gly-Pro pNA at 37 °C for 15 minutes. The rates of para nitro aniline release from 
the substrate were expressed as the change in absorbance at 405 nm in the reaction 
solution (Equation. 1-2). The activity of DPP-IV/CD26 is expressed in term of 
unit/Litre (U/L) in which the activity is defined as the quantity of the enzyme that 
hydrolyzes 1 micromole of substrate per min at 37 °C (Lambeir et al. 2003). Gly-Pro 
pNA is a useful chromogenic substrate for the assay of the enzyme in serum and various 
tissues (Ogawa & Nagatsu 1979). Nevertheless, the sensitivity of the assay is 
inadequate for the determination of low enzyme activity, especially in samples collected 
from patients on drugs which inhibit the activity of the enzyme. 
Equation 1-2 Equation showing the cleavage of Gly-Pro-pNA by DPP-IV to from p-
nitroaniline the absorbance of which is measured at 405 nm as indication of enzyme 
activity.  
 
 
A very sensitive DPP-IV/CD26 activity assay, using the same concept of linking the 
substrate to a fluorogenic substrate (aminomethyl coumarin) is available and can be 
used to determine the enzyme activity in human CSF (Kato et al. 1978). Although 
sensitive, most fluorogenic probes suffer from poor aqueous solubility and therefore, 
 
 DPP-IV 
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require the use of organic co-solvents, which have been reported to reduce enzyme 
activity and thus limit their application to cell-free assays (Lai et al. 2007). 
Promega® have developed a bioluminescent assay for DPP-IV/CD26 that can detect 
Gly-Pro cleaving activity in human serum at very low detection limit (0.035 U/L) 
(O’Brien 2006). Using the pro luminescent DPP-IV substrate, Gly-Pro-amino luciferin, 
DPP-IV/CD26 results in cleavage of the substrate and generation of a luminescent 
signal produced by the luciferase reaction (Fig. 1-12).  
 
Figure 1-12 Principle of Luminescent DPP-IV/CD26 assay.  
H-Gly-Pro-amino luciferin is cleaved by DPP-IV to release amino luciferins. 
Aminoluciferin in turn functions as a substrate for a coupled luciferase reaction to emit 
luminescence that can be measured by a luminometer. Reprinted with permission from 
(O ’Brien 2006). 
 
Recently, an electrochemical biosensor has been developed for electrochemical analysis 
of DPP-IV activity using redox-labelled ferrocene (Fc) peptide substrates, immobilized 
on gold electrodes (Zhang et al. 2015). The addition of DPP-IV to Fc labelled peptide 
substrate induces a site-specific cleavage leading to a reduction in a number of redox 
species as the substrate cleaved, which in turn leads to a change in the Faradaic current, 
which can be measured by voltammetry. Labelling of the peptide substrates Fc offers 
improved sensitivity. However, the redox-labelled electrochemical biosensors have been 
found to encounter considerable signal loss after long-term storage due to the 
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decomposition of redox tags (Kang et al. 2009). Moreover, labelling of peptides 
increases the experimental complexity, affecting the behaviour of the protease at the 
cleavage site and increasing the cost of the analysis (Cao et al. 2013). 
Xia et al. (2016) incorporated the Au NP colorimetric technique on a solid-liquid 
interface (electrode/electrolyte), which thus transformed a liquid-phase DPP-IV 
colorimetric assay into an electrochemical analysis with enhanced sensitivity for the 
determination of the DPP-IV activity and screening for its inhibitor (Figure 1-13).  
 
Figure 1-13 Schematic illustration of the combined colorimetric/electrochemical 
method for DPP-IV activity assay.  
Modification of a gold electrode with the peptide substrate (Arg-Pro-Arg) allowed for 
the deposition of higher amounts of Au NPs on the electrode surface through the 
tripeptide-induced assembly of Au NPs due to low electron transfer resistance. 
Reprinted with permission from (Xia et al. 2016). 
 
This method was based on the design of the peptide sequence (Arg-Pro-Arg) with two 
binding tags to crosslink unmodified Au NPs (Xia et al. 2016). In this method, the Au 
NPs were not functionalized with the peptide substrate making their method prone to 
possible interferences from the sample matrix. In addition, their two-stage method is not 
amenable to real-time monitoring of enzyme activity (Laromaine et al. 2007). 
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 Research Aims 1.10
 
The primary aim of this thesis was to design and develop a rapid, selective and highly 
sensitive diagnostic assay for detection and quantitative determination of DPP-IV/CD26 
activity in biological samples, using the superior chromogenic properties of Au NPs 
together with a novel DPP-IV/CD26 targeted peptide with the objective of developing 
point of care (POC) (i.e. near-patient) sensor. Monitoring the expression of specific 
protease enzymes that are implicated in disease processes could offer a rapid diagnosis 
so treatment can be initiated as early as possible. In a recovering patient, abnormal 
enzyme expression may also give warnings of a recurrence of disease (Hetmańczyk et 
al. 2016). As the DPP-IV enzyme has been identified as a target for drug therapy, the 
test could be utilized for HTS of inhibitory drug compounds. 
Scheme 1-2 shows the basic design and optimization stages for the development of the 
colorimetric peptide modified Au NP sensor. In the following chapters, details on the 
design of different peptide sequences and functionalization of Au NP preparations, 
including various instrumental techniques used to study and validate the coupling 
process are described.  Methods were optimised for the successful conjugation of 
ligands to the Au NP surface. Validation of the developed methods was investigated 
through correlating results obtained with traditional assays already in use and by 
application to real biological samples. 
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Scheme 1-2 Experimental flow chart for the design of a peptide modified Au NPs 
colorimetric assay. 
The use of Au NPs for biosensor applications, the biochemical role of DPP-IV in health 
and disease and methods for the measurement of DPP-IV activity have been reviewed in 
Chapter 1. Chapter 2 presents the laboratory techniques used in this work. Chapter 3 
outlines the development of a peptide-functionalised assay for the detection of DPP-IV, 
a protease biomarker for many diseases. A DPP-IV substrate was designed for the 
enzyme and to subsequently change the interparticle distance, followed by a distinct 
colour change in the Au NP upon enzyme addition. Chapter 4 introduces a modified 
peptide substrate ligand with a spacer in an attempt to enhance sensitivity and the linear 
range of the assay. The modified sensor and the novel approach have promising 
applications in assay of serum samples and for HTS of DPP-IV inhibitors in vitro. 
Chapter 5 summarises the use of 3 different approaches to enhance the stability of Au 
NP systems for more reliable and reproducible results in complex biological samples. 
Chapter 6 introduces the results of preliminary trials of a developed Au NR biosensing 
method for the detection of DPP-IV/CD26 activity. 
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Chapter 2 
Experimental Techniques 
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2 Experimental Techniques  
 
A variety of spectroscopic and imaging techniques were used to characterize the 
functionalized Au NPs synthesized in this project. These are detailed below. 
 UV-Visible Spectroscopy 2.1
 
Ultraviolet-Visible (UV-Vis) spectroscopy is a technique applied to measure the light 
that is absorbed and transmitted by a material (known as the extinction, which is 
expressed as the total of absorbed and transmitted light). The technique relies on the 
interaction of electromagnetic radiation with matter (Mulvaney 1996; Aryal et al. 
2006b). The interaction of light with colloidal Au NPs induces a distinct optical feature 
known as LSPR, which results in a strong absorbance band in the visible region (500 - 
600 nm), which can be measured by UV-Vis spectroscopy (Fig. 2.1) (Mulvaney 1996; 
Klar et al. 1998; Petryayeva & Krull 2011) .   
The maximum absorbance wavelength increases (red shift) with an increase in particle 
size. The peak optical density (OD), or absorbance of the sample, is directly 
proportional to the concentration of NPs in solution (Pesika et al. 2003; Myers et al. 
2013). UV-Vis measurements can also be applied to assess the functionalization of Au 
NPs. Upon attachment of ligands to the Au NP surface, the LSPR spectrum red shifts 
and broadens. This shift is the result of a change in the local refractive index at the Au 
NP surface and forms the basis for the study of changes to Au NP size. 
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Figure  2-1 A diagram of the components of a typical spectrometer.  
 
 Transmission Electron Microscopy (TEM) 2.2
 
The most common technique for characterisation of Au NPs is high resolution TEM, 
which can be used to study Au NPs, providing the size distribution and dispersity of the 
sample. The mean number of gold atoms can also be calculated from the mean diameter, 
d, of the cores. 
TEM utilizes a beam of electrons directed at an ultra-thin specimen which illuminates 
the sample and yield a highly-magnified image. The image is formed by the 
transmission of electrons through the specimen, magnified and focused by a magnetic 
lens and captured by a fluorescent screen or to be detected by a sensor such as a charge-
coupled device. TEM is capable of imaging at a significantly 
higher resolution than light microscopes, owing to the fact that the De Broglie 
wavelength of electrons is many orders of magnitude smaller than that of photons (2.5 
pm at 200 kV) (Williams & Carter 2009).  
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By making use of electrons to magnify objects, it is possible to view objects much 
smaller than can be viewed by light microscopy, typically it is possible to achieve a 
resolution of 0.2nm and magnifications of up to 2,000,000x, whereas most light 
microscopes are limited by diffraction to about 200 nm resolution and useful 
magnifications below 2000x can be obtained. This enables the instrument user to 
observe minute detail, which is thousands of times smaller than the smallest resolvable 
object in a light microscope. Louis de Broglie demonstrated that every particle or matter 
propagates like a wave (Broglie 1924), and the concept is known as particle-wave 
duality. The wavelength of a particle or a matter can be calculated as follows. 
           
Where Ȝ is the wavelength of a particle, h is Planck’s constant (6.626 x 1034 joule per 
second), and p is the momentum of a particle. Since the momentum is the product of the 
mass and the velocity of a particle, 
  
The velocity of electrons can be calculated by: 
 
For the electron beam to move uninterrupted through the TEM it must be operated at 
low pressures to avoid electrons colliding with air particles or forming an electrical arc. 
The electrons are produced by a thermal source such as tungsten filament, lanthanum 
hexaboride (LaB6) filament or a field emission source, such as an electron gun, capable 
of generating a stream of monochromatic electrons (Lafferty 1951). The electrons are 
accelerated using voltages between 100 kV and 300 kV to guarantee that the electrons 
pass through the sample. Operating the TEM at high voltage offers better resolution 
because the electrons travel at a shorter wavelength; however, the electrons will have 
……………….…(4) 
……………….…(5) 
……………….…(6) 
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extra energy and could damage the sample. At too low a voltage, the electrons will not 
be transmitted through the sample and will not produce an image.  
A TEM is composed of several components, which incorporate a vacuum system in 
which the electrons move, an electron emission source for generation of the electron 
stream, a series of electromagnetic lenses to focus the electron beam (see Fig 2-2).  
 
Figure ‎2-2 Schematic diagram of a Transmission Electron Microscope. 
A TEM contains four parts: electron source, an electromagnetic lens system, sample 
holder, and imaging system. Adapted from http://www.edn.com. 
 
TEM is the most direct method for the determination of the size, distribution and the 
dispersity of NPs (Howie et al. 1982; Fisker et al. 2000). However, the main limitation 
is with sample representation, because only limited areas are selected from the grid, 
which might result in a non-representative image of the sample. In addition sample 
destruction, due to the high energy of the electron beam utilized is restrictive (Bovin & 
Malm 1991).  
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 Zeta-Potential Measurements 2.3
 
Zeta potential analysis is a technique for determining the surface charge of NPs in 
colloidal solution by measuring the effective electrical charge associated with the 
surface of particle/molecules in the medium. Owing to the characteristic nature of the 
NP surface electrical double layer, an electrical potential develops on the NP surface 
boundary, known as the zeta potential of the particles, with values that typically range 
from +100 mV to -100 mV (Fig. 2-3) (Hunter 2013). 
The magnitude of the zeta potential provides valuable data about the relative stability of 
a formulation of the suspensions of particles in aqueous or non-aqueous media, i.e. the 
tendency of the solid particles to aggregate (flocculate) is a function of the zeta 
potential, depending on the degree of electrostatic repulsion between adjacent, similarly 
charged particles in a dispersion. In addition to understanding the state of the NP 
surface, it provides a good indication of the stability of the NPs in the suspension 
media; particles with higher magnitude zeta potential exhibit increased stability due to a 
larger electrostatic repulsion between particles as shown in (Table 2-1). If all the 
particles in suspension have a large negative or positive zeta potential (> 30 mV) then 
they will tend to repel each other and there will be no tendency for the particles to 
come together. However, if the particles have low zeta potential values then there will 
be no sufficient force to prevent the aggregation. 
It is important to investigate zeta potential parameters during development of 
nanoparticulate biosensing systems, especially given the fact that biological matrices are 
known to alter the stability features of NPs with different mechanisms (e.g., protein 
adsorption) (Ritz et al. 2015).  
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Table ‎2-1 Classification of colloid stability according to zeta potential values. Data 
were obtained from (O’Brien et al. 1990; Hanaor et al. 2012) 
Zeta potential [mV] Stability behaviour of the colloid 
from 0 to ±10 Rapid coagulation or flocculation 
from ±10 to ±20 Incipient instability 
from ±20 to ±30 Moderate stability 
more than ±30 High stability 
 
 
 
 
Figure ‎2-3  Schematic representation of the electrical double layer that surrounds a 
particle in an aqueous medium.  
The potential that exists at the slipping plane is known as the zeta potential. Adapted 
from (Malvern 2007). 
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 Dynamic Light Scattering (DLS) 2.4
 
Dynamic light scattering (DLS) is an analytical technique applied for determining the 
hydrodynamic size and size distribution of NPs and colloids in a liquid media, by 
measurement and interpretation of the fluctuations in the intensity of scattered light data 
on a microsecond time scale, also known as photon correlation spectroscopy. Analysis 
of these intensity fluctuations permits the evaluation of the diffusion coefficients, which 
in turn provides the particle size through the Stokes-Einstein equation (Miller 1924; 
Jans et al. 2009). Stokes radius is reported interchangeably with effectively hydrated 
radius (RH) in solution (Atkins et al. 2010),  it is highly related to solute mobility, which 
is determined by the nature of the solvent. A small ion with a large hydrated shell, for 
example, may have a greater Stokes radius than a larger ion with a small shell. This is 
because the smaller ion drags a greater number of water molecules with it as it moves 
through the solution (Chu 2008). In 1905, Albert Einstein found that the diffusion 
coefficient of an ion to be proportional to its mobility constant. 
   
Where 
D is the diffusion constant; 
kB is Boltzmann's constant; 
T is the absolute temperature; 
ȝq, the electrical mobility of the charged particle; 
η is the dynamic viscosity; 
r is the radius of the spherical particle. 
This can be rearranged to solve for  r, the radius: 
 
……………….…(7) 
……………….…(8) 
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Particles in liquid media undergo random Brownian motion due to bombardment from 
the solvent molecules (Tscharnuter 2006), observed in the resultant Doppler effects on  
the wavelength of the incident light and the scattered light from the particles (Angus et 
al. 1969). The modulation of the scattered light intensity as a function of time is 
analyzed, and the hydrodynamic size of the particles can be determined. Information on 
the size, shape, and interactions of colloidal particles in liquid systems, as well as their 
structure and internal dynamics can also be determined (Figure 2-4) (Berne & Pecora 
2013). 
A significant advantage of the DLS method is that it is a non-invasive technique in that 
it does not require sample handling and does not affect the NP dispersion state, and the 
data is obtained over a large number of particles (usually 108–109) enclosed in a known 
volume (Khlebtsov & Khlebtsov 2011). DLS is a highly sensitive method for the 
determination of particle aggregation, which makes it a more reliable test, than  
absorption spectroscopy, for detection of biospecific interactions using Au NPs. This 
technique can be utilized for measurements of particle size distributions, particularly in 
the range 2–500 nm. DLS results can be distorted when the sample is not monodisperse 
because large particles existing in the sample can screen smaller ones and cause 
measurement interference (Tomaszewska et al. 2013). 
Uncritical application of the DLS method, without confirmation from other 
measurements, may result in misleading interpretation of the measurements due to the 
contribution from the rotational diffusion to the correlation function of the scattered 
intensities of aspherical Au NPs with diameters ˃ 40 nm (Khlebtsov & Khlebtsov 
2011). Therefore the measurements from other techniques such as TEM, is required. 
There is not always agreement between DLS and the TEM measurements, but the 
results from both measurements are comparable. 
61 
 
 
Figure ‎2-4 A schematic diagram showing the operation of particle size analyser and 
zeta potential instrument.  
A light source is introduced into the cell, and the scattered light is collected at either 90° 
or 173° as shown in the diagram above. The system automatically selects the optimum 
scattering angle and cell position depending on the sample concentration and intensity. 
The signal obtained from the scattered light is fed into a multi-channel correlator that 
generates a function used to determine the translational diffusion coefficient of the 
particles analyzed. Adapted from (www.Horiba.com). 
 
 
 X- Ray Photoelectron Spectroscopy XPS 2.5
 
X-ray photoelectron spectroscopy (XPS) also known as electron spectroscopy for 
chemical analysis (ESCA) is the most commonly applied surface analysis technique, as 
it can be used for the analysis of a broad range of materials and provides important 
chemical state and quantitative data from the surface of the material being investigated. 
In addition, it can be used to determine the chemisorptive properties of ligands adsorbed 
onto the Au NP surface and the oxidation states of metallic NPs.   
XPS is performed by irradiating the surface of a sample with a beam of mono-energetic 
X-rays causing photoelectrons to be emitted from the sample surface (Fig 2-5A). An 
electron energy analyser is used to measure the energy of the emitted photoelectrons. A 
photoelectron spectrum is recorded by counting ejected electrons over a range of 
electron kinetic energies. 
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The average depth of analysis for an XPS measurement is approximately 5-10 nm. 
Electrons excited further down in the material will be reabsorbed or trapped, meaning 
that XPS is generally only used to analyse the surface of materials, or approximately the 
depth of one NP. XPS requires high vacuum (P ~ 10−8 millibar) or ultra-high 
vacuum (UHV; P < 10−9millibar) conditions, although a current area of development is 
ambient pressure XPS, in which samples are analysed at pressures of a few tens of 
millibars (Ali-L̈ytty et al. 2016). 
Peaks appear in the spectrum from atoms emitting electrons of a specific energy (Figure 
2-5B). From the binding energy (i.e the energy required to detach the electron from the 
surface) and intensity of a photoelectron peak, the elemental identity, chemical state and 
quantity of a detected element can be determined. The binding energy depends on 
several factors, including the following: 
 The element from which the electron is ejected, 
 The orbital from which the electron is released, 
 The chemical environment of the atom from which the electron was emitted. 
XPS can be employed to study the surface chemistry of a material in its as-collected 
state, or after treatment, for example: cracking, slicing or grinding in air or UHV to 
expose deeper layers of the sample. XPS is routinely used to analyse inorganic 
compounds, metal alloys, semiconductors, polymers, elements, teeth, bones, medical 
implants, biomaterials and many others (Chusuei & Goodman 2002). 
XPS has been employed to investigate the surface chemistry of gold substrates before 
and after functionalization with biological molecules, as it provides valuable 
information about specific interactions between functional groups of organic molecules 
and metals, to obtain a clear picture of assembling processes allowing the 
characterization of molecule-molecule and molecule-surface interactions and the 
oxidation states of metallic NPs. Moreover, from the XPS high-resolution spectra, 
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information about the bonds formed between the different species involved in the 
functionalization, can also be determined (Gonella et al. 2005; Spampinato et al. 2016). 
Spampinato and co-workers (2016) characterized the surface chemistry of gold 
substrates before and after functionalization with thiol-modified glucose self-assembled 
monolayers and subsequent biochemical specific recognition of maltose binding protein 
by using XPS. The technique was proved to be very useful means for examining all the 
functionalization steps, including the study of the biological behaviour of the glucose-
modified particles in the presence of the maltose binding protein. 
   
Figure ‎2-5 (A) The photoemission process in XPS surface analysis. The discs represent 
electrons and the bars represent energy levels within the material being analysed. The 
equation governing the process is KE = hȞ - BE, where KE is the photoelectron kinetic 
energy, hv is the exciting photon energy, and BE is the electron binding energy. 
Adapted from www.xpssimplified.com (B) XPS survey spectrum from citrate stabilized 
Au NPs showing various gold, sodium, oxygen peaks and a silicon peak. Reprinted with 
permission from (Sierra et al. 2016). 
 
 Fourier Transform Infrared Spectroscopy (FTIR) 2.6
 
Fourier transform infrared (FTIR) spectroscopy has emerged as a useful tool for the 
qualitative analysis of the functional groups present in compounds/molecules. The basic 
concept for recording the infrared spectrum of a sample is by shining a beam of IR light 
through the sample. When the frequency of the IR light matches the vibrational 
frequency of a bond, absorption occurs. Analysis of the transmitted light indicates how 
much energy was absorbed at each wavelength.  
 
 A) 
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FTIR can be employed to obtain a direct characterization of molecular conjugation on 
the surface of Au NPs (Wulandari et al. 2008). Moreover, vibrational spectra of 
adsorbed thiolates on Au NP surfaces provide valuable data on interactions between 
molecules and on the orientation of molecules with respect to the surface (Bürgi 2015).  
IR spectra result from transitions between quantized vibrational energy states. When 
atoms/molecules in a sample irradiated by a source of IR beam, they display a number 
of vibrational modes. Each mode represents a harmonic displacement of the atoms from 
their equilibrium positions. The frequency of each vibrational mode is characteristic of a 
functional group, because for many vibrational modes only a few atoms have a large 
displacement and the rest of the molecule is stationary. Thus, the observation of a 
spectral feature in a certain area of the spectrum is generally indicative of a particular 
chemical functional group in the sample (Griffiths & De Haseth 2007). With the 
development of extensive spectra/structure correlation tables, it has become easier to 
assign IR absorption spectra in a given IR spectrum to the vibrational modes related to 
the specific functional group.  
As mentioned earlier, the surface-to-volume ratio is very high in the case of NPs, when 
compared to the bulk form of the material. The number of atoms that constitute the 
surface can influence the vibrational spectra of NPs. FTIR spectroscopy is used to 
characterize the nature of surface molecules in NPs (Baraton 2002). Since the NPs have 
a large surface area, the functionalization of the surface using organic or biological 
molecules can alter the NP surface properties. Aryal et al. (2002) studied the interaction 
of thiol with Au NPs in aqueous medium by employing FT-IR spectroscopy together 
with other spectroscopic identification techniques such as UV–vis, Raman, and NMR. 
The disappearance of S-H stretching in the IR of the protons in close proximity to the 
metal centre verified the existence of the S-Au interaction in cysteine capped Au NPs. 
65 
 
The FTIR spectra of the modified NPs have extra peaks in comparison with the FTIR 
pattern of an unmodified NP. The property change with diverse molecules can simply 
be identified with FTIR spectroscopy (Shankar et al. 2004; Correa et al. 2016). The 
main benefits of the FTIR characterization method include speed of analysis (e.g. 
minutes per measurement), high spatial resolution, availability of miniaturized 
instrumentation (Pease et al. 2007; Tsai et al. 2011).  
 Electrospray Ionization Mass Spectrometry (ESI-MS) 2.7
 
 ESI-MS is a 'soft ionization' technique used in mass spectrometry to produce ions with 
very little fragmentation, using an electrospray in which a high voltage is applied to a 
liquid to create an aerosol. It can be used to determine the molecular weight of unknown 
compounds such as proteins and peptides (Li et al. 2009). After a sample is loaded onto 
the instrument it is vaporised then charged (by exposure to a stream of electrons). The 
charged species are accelerated through magnetic fields that separate the ions by mass 
to charge (m/z). A detector determines the mass to charge ratio of those ions and the 
results are presented in a mass spectrum (see Fig 2-6).  
ESI utilizes electrical energy to assist the transfer of ions from solution into the gaseous 
state, before they are analysed by MS. Ionic species in solution can thus be analysed by 
ESI-MS with improved sensitivity. Neutral compounds can be converted to ionic form 
in solution or in the gaseous phase by protonation or cationisation (e.g. metal 
cationisation) and hence can be investigated by ESI-MS (Helfrich & Bettmer 2011). 
ESI-MS is convenient for the analysis of functionalized Au NPs, which typically are 
covered by ligands because it is a soft ionization technique and can provide information 
the ligand composition (Tracy et al. 2007). Ionic signals are displayed in MS spectrum 
according to their m/z against relative abundance with the highest signal expressed as 
100% abundance and referred to as the base peak. 
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 A molecule (M) is usually ionised by the addition of a charged species such as H+ or 
Na+ to produce the ions [M + H] + or [M + Na] +. The m/z of these species would be 
given by the molecular weight of M + 1 in the former case, or the molecular weight of 
M + 23 in the latter. This way, the molecular components in the mixture can be 
identified. 
 
Figure ‎2-6 A schematic diagram of the working principle of an ESI-MS. A high voltage 
is applied to a liquid sample to create an aerosol using an electrospray. The moderating 
influence of the solvent clusters on the reagent ions, and of the high gas pressure, 
reduces fragmentation during ionization and results in primarily intact quasi-molecular 
ions. Adapted from (Sigma-Aldrich). 
 
 
 Nuclear Magnetic Resonance (NMR) Spectroscopy 2.8
 
NMR spectroscopy is a powerful and theoretically complex analytical tool that exploits 
the magnetic properties of certain atomic nuclei. This type of spectroscopy is used 
in quality control and research for determining the content and purity of a sample, as 
well as providing a way for the elucidation of the entire structure of a molecule using 
one set of analytical measurements. NMR is based on the fact that when a population of 
magnetic nuclei is placed in an external magnetic field, NMR active nuclei (such as 1H 
or 13C) have magnetic properties that can be utilized to yield chemical information by 
absorbing electromagnetic radiation at a frequency characteristic of the isotope, it can 
give access to the features of the electronic structure of a molecule and its individual 
functional groups (Shah et al. 2006). 
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NMR has proven to be a useful tool to study Au NP surface modifications to obtain 
essential knowledge in interfacial chemical and physical phenomena that occur on the 
surface of NPs. Moreover, NMR can be applied to the investigation of changes to the 
functional groups coupled to the Au NP surface. Several studies have demonstrated the 
sensitivity of solution NMR spectroscopy to the electronic environment and structure of 
the functional groups on nanomaterial surfaces (Tataurova 2014; Coelho et al. 2015; 
Zhou et al. 2016).  
The effectiveness of the NMR technique in structural studies of functionalized Au NPs 
has been exemplified in many reports to provide insights into: Au NP formation 
mechanisms (Doyen et al. 2013), structural characterization of peptide immobilization 
to the Au NP surface (Bower et al. 2005) and investigation of a specific biomedical 
application for modified Au NPs (Coelho et al. 2015).Coelho and colleagues (2015) 
investigated the structure and physicochemical properties of Au NPs, modified with 
PEG, designed for the drug delivery of the proteasome inhibitor, Bortezomib (BTZ), in 
cancer therapy. NMR have provided valuable information on BTZ – PEG Au NPs 
interactions and the mechanism of drug incorporation and location inside the PEG Au 
NPs. 
Recently, NMR has been used as a means to: quantify the degree of ligand exchange 
between various types of thiolated molecules on the surface of Au NPs by determination 
of ligand density values for single-moiety ligand shells; to recognize trends in Au NP 
functionalization efficiency depending on ligand type, concentration, and reaction time, 
as well as for characterization of different functionalization trends, where the new 
ligand may either substitute the existing ligand shell or add to it (backfilling) (Smith et 
al. 2015).  
Although the sensitivity of NMR spectroscopy has been enhanced significantly and 
steady progress continue to be made in the application of the technique. However it is 
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still the weak link when compared with other spectroscopy techniques such as MS, and 
this limits its application in Au NP research, especially as a few milligrams of substance 
is required in order to obtain satisfactory results (Emwas 2015).  
 
 Gel Electrophoresis  2.9
 
Gel electrophoresis is a method used for separation of macromolecules 
(DNA, RNA and proteins) and their fragments, based on their size and charge. Gel 
electrophoresis has also been used to differentiate miscellaneous Au NPs varying in size 
and shape, based on the mobility of the NPs in acetate buffer (Pellegrino et al. 2007; 
Zheng et al. 2015). 
The bright red colour of Au NPs allows direct visual or spectroscopic analysis of gel 
bands, which appear as coloured lines in a gel. Compared to other separation 
techniques, such as high performance liquid chromatography (HPLC), capillary 
electrophoresis, diafiltration, or size-exclusion chromatography, gel electrophoresis 
offers much more facile identification of functionalized Au NPs from citrate-capped Au 
NPs, because the mobility of particles in a gel is dependent on the surface charge 
density and the size/molecular weight of the particles. 
Agarose gel concentration is a critical factor in the separation of NPs in order to ensure 
optimum pore size that eliminates undesirable NP-gel matrix interactions and for this 
reason the agarose gel concentration needs to be in the range of (0.5- 1.0 %) to provide 
pore diameters in the gel of Ø = 200-400 nm. The use of gel electrophoresis for the 
study of metal nanostructures, in addition to identification of functionalized NPs from 
bare NPs, allows for separation of different shapes of NPs and this application has been 
used for the visual separation and identification of a mixture of Au NPs in solution 
containing both nanospheres and nanorods. The gel showed clear separation of gold 
spheres (red) mixed with gold rods (green). The concept has also been successfully 
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applied to the separation of silver nanorods from other silver nanostructures as shown in 
Figure 2-7 (Hanauer et al. 2007). 
 
 
Figure ‎2-7 True colour photograph of a 0.2% agarose gel run for 30 min at 150 V (15 
cm electrode spacing) at pH ≈ 9.  
The dashed line at the bottom indicates the position of the gel wells. The four lanes 
contain, from left to right, Ag NPs, Au NRs (≈ 40×20 nm), gold rods and spheres mixed 
just before electrophoresis, and spherical Au NPs (Ø ≈15 nm) as indicated symbolically. 
Reprinted with permission from (Hanauer et al. 2007). Copyright American Chemical 
Society. 
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 Introduction 3.1
 
It has been suggested that the measurement of DPP-IV/CD-26 activity can be 
potentially used as a diagnostic and prognostic marker for various inflammatory 
disorders, tumours and hematological malignancies (Jones et al. 2001; Ni et al. 2003; 
Sun et al. 2012). Therefore, there is a demand for a simple, selective and sensitive assay 
that can be used to measure the activity of DPP-IV/CD26 in health and disease. 
To date, the most commonly used methods for the determination of DPP-IV enzymatic 
activity are based on the use of chromogenic, fluorogenic, bioluminescent and 
electrochemical sensors (Nagatsu et al. 1976; Kato et al. 1λ78ν O’Brien et al. 2006; Xia 
et al. 2016). A list of the methods developed for the detection and determination of 
DPP-IV enzyme activity and a comparison of their sensitivities is given in Table 3-1. It 
can be seen that electrochemical methods currently provide the best sensitivity with at 
least 2 orders of magnitude lower detection limits than those obtained by other methods. 
However, these methods required the use of complex instrumentation. A further 
drawback associated with the use of the current chromogenic substrates is that they 
contain over reactive leaving groups, which render them easily susceptible to non-
enzymatic cleavage by interfering proteins in biological samples as found in the case p-
nitro anilide substrates (Goddard & Reymond 2004).  
Au NPs with the size range of 1–100 nm, have highly sensitive distance-dependent 
optical properties, originating from the interaction between incident electromagnetic 
radiation and metal conduction electrons. Such interactions generate a substantial shift 
of absorption bands in the visible region of the electromagnetic spectrum, as a result of 
the alteration in the dielectric field of the particles in close proximity to each other 
(Figure 3-1), thus making it possible to monitor molecular events visually, without the 
need for complex instrumentation (Klajn et al. 2010; Paterson & De La Rica 2015). 
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Table 3-1 Comparison of the assay sensitivity as defined by the limit of detection 
(LOD) and limit of quantification (LOQ) of colorimetric, fluorometric and luminescent 
DPP-IV assays. 
Substrate LOD (U/L) LOQ (U/L) Type of Assay Reference 
Gly-Pro-p-nitroanilide 1.56 2.92  Colorimetric   
Gly-Pro-4-Me-β-NA) 0.10 0.26  Fluorometric   
Gly-Pro-AMC 0.18 0.27  Fluorometric  (Matheussin et al. 
2010 )* 
DPPIV-Glo™ Protease* 0.035 
 
0.040 
 
Luminescent  
 
 
Fc-Tyr-Pro-Phe-Phe-NH2 
 
3.9 x 10-5 
 
0.5 x 10-3  
 
Electrochemical  
 
(Zhang et al.2015) 
Arg-Pro-Arg Au NP 
 
0.07 
5.5 x 10-4 
 
0.1 
- 
 
Colorimetric & 
electrochemical  
 
(Xia et al. 2016) 
 
* The first 4 assay data were all obtained from one reference. 
(GP: glycyl proline; Me: methoxy; NA: naphthylamide; AMC: aminomethyl coumarin; 
 Fc: Ferrocene) 
 
Figure 3-1 Illustration of the changes induced by target interaction with substrate 
modified Au NPs represented by UV-visible spectrophotometry and TEM imaging. 
Reprinted with permission from (Aldewachi et al. 2017) 
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Nanoplasmonic colorimetric assays offer high sensitivity because of the high extinction 
coefficients of Au NPs, 102 -103 times higher than those of conventional coloured dyes 
(Ding et al. 2014). Using thiol chemistry, recognition substrates, e.g. peptides with 
cysteine residues, alkane thiolate or tiopronin (Sellers et al. 1993; Templeton et al. 
1999; Mocanu et al. 2009; Krpetic et al. 2009) can be used to functionalize the Au NP 
surface in a colloidal solution. When the enzyme is added, the stability will be affected 
due to the cleavage of immobilized peptide substrate resulting in the aggregation of the 
Au NPs with an accompanying colour change. Detection of enzymatic activity by using 
metal (typically gold) nanoparticle based colorimetric assays is an attractive alternative 
to traditional enzymatic assays because colour changes are visible to the naked eye. 
Such colour changes, caused by presence of the analyte, induce Au NP aggregation and 
forms the basis for colorimetric detection. A variety of enzymes (lipases, proteases, 
kinases and nucleases) have been detected using this approach (Zhang et al. 2014; Chen 
et al. 2014; Cheng et al. 2014; Wang et al. 2015). Label-free colorimetric assays in 
which the substrate reporter molecule is not covalently attached to the Au NPs, but 
through electrostatic and hydrophobic interactions for the detection of various 
biological targets and molecules such as  thrombin,  alkaline phosphatase, adenosine 
deaminase and cancer biomarkers have also been reported (Chen et al. 2010a; Li et al. 
2013; Liu et al. 2014; Cheng et al. 2015). 
In this chapter, the development of a rapid and simple colorimetric assay is described 
for the measurement of DPP-IV/CD26 activity, using Au NPs functionalized with a 
synthetic peptide Gly-Pro-Asp-Cys (GPDC). The substrate is hydrolysed by DPP-
IV/CD26 resulting in non-crosslinking aggregation of the Au NPs with an associated 
colour change see Fig. 3-2. This design has been chosen in order to avoid the limitations 
encountered with a colorimetric Au NP assay recently developed by Xia and his 
colleagues in which a two-step crosslinking Au NP assay for detection of DPP-IV 
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activity was used (Xia et al. 2016), and thus making their method not amenable to real-
time monitoring of enzyme activity. 
 
Figure 3-2 Schematic representation of the working principle of the GPDC peptide 
modified Au NP system for the determination of DPP-IV/CD26 activity. Cleavage of 
peptide substrate immobilized onto the NP surface results in visual colour change from 
red to blue of the NP solution induced by disturbance to the stabilizing forces of the 
colloidal Au NP dispersion. 
 
 Materials and Methods 3.2
 
3.2.1  Reagents and Materials 
 
All materials were obtained from suppliers as given below and used as received: The 
peptide GPDC (~ 90% pure) was purchased from Thermo Fisher Scientific Co. Ltd 
(Germany). A control peptide CPDC (Cys-Pro-As-Cys) was purchased from China 
peptide (China). DPP-IV/CD-26 enzyme from porcine kidney was purchased from 
Merck Chemicals (Germany). Human lysozyme, trypsin from porcine pancreas, 
hydrogen tetrachloroaurate (III) (HAuCl4.3H2O), 99.99% pure, albumin from human 
serum lyophilized powder, ≥λ7% and sodium citrate dihydrate (Na3C6H5O7.2H2O), 99% 
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pure, were purchased from Sigma-Aldrich Co. Ltd (UK) and used without further 
purification. Thrombin from bovine plasma was purchased from GE HealthCare (UK). 
Deuterated water NMR solvent was purchased from Sigma-Aldrich (UK). The DPP-
IV/CD-26 enzyme was reconstituted in 50 mM Tris buffer, pH 8.3, at an activity of 250 
U/L, aliquoted and stored at -80°C. A 10 mМ citrate buffer solution at pH 6 was used to 
solubilize the peptide. All solutions (except NMR solution which was prepared in 
deuterated water) were prepared using deionized water with a resistivity of 18.2 MΩ cm 
prepared with Milli-Q Academic Purification equipment, Millipore (UK). 
3.2.2  Preparation of Citrate-Capped Gold Nanoparticles and GPDC-Capped Gold 
Nanoparticles Bioconjugate (P-Au NPs) 
 
All glassware was washed in aqua regia (HCl: HNO3 3:1) and then washed with 
deionized water and placed in the oven to dry. 
Citrate Au NPs (∼15 nm) diameter were prepared by citrate reduction of HAuCl4 
(Grabar et al. 1995). Briefly, 10 ml of 38.8 mM sodium citrate dihydrate at 50-60ºC was 
added to 100 ml of 1 mM HAuCl4 under vigorous stirring at boiling point to form a 
ruby red coloured solution after a series of colour changes. The colour change 
manifested is caused by SPR of the forming Au NPs. The solution was brought to room 
temperature; the pH was adjusted to 7.4 using 0.5 M NaOH and the solution was filtered 
through a 0.22 µm pore diameter Millipore syringe filter to remove unreacted salts. The 
filtrate was stored at 4ºC until required. The peptide conjugated Au NPs (P-Au NPs) 
were prepared by addition of an aqueous solution of 2 mM peptide in citrate buffer pH 
6, to the solution of 8 nM citrate Au NPs (based on an extinction coefficient of 
~1.61×108 M-1 cm-1 at 520 nm for Au NPs) in a 1 to 10 (v/v). After overnight reaction at 
room temperature, excess peptides were removed by centrifugation of the Au NPs 
(13000 rpm, 30 min at 4°C) using an Eppendorf centrifuge (Eppendorf, Germany). The 
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pelleted Au NPs were resuspended in deionized water and stored at 4°C. The UV-visible 
absorption spectrum was obtained to determine the concentration of Au NPs.  
It was found that the average diameter of synthesized Au NP was 14.5 nm after the 
analysis of 689 NPs by TEM (Fig. 3-3), the elongation of the particles was typically 
between 1.01 and 1.21. The particles can, therefore, be described as spherical or 
spheroid to a good approximation. 
 
Figure 3-3 Particle diameter histogram of citrate-capped Au NPs.  
The average diameter of Au NPs was calculated from a group of representative TEM 
micrographs using ImageJ software. 
 
3.2.3  Instrumentation for Gold Nanoparticle Characterization 
 
The ultraviolet-visible (UV-vis) absorption spectrum of the samples was recorded with 
a microplate reader (Tecan 2000, San Francisco, USA) in transparent 96 well microplate 
(Nunclon, Thermo Scientific, UK). ESI-Mass spectrometry of peptides was performed 
on an API-150EX MS single quadrupole LC/MS system (Applied Biosystems, UK). 
The XPS spectra were obtained on a Kratos Axis Ultra DLD XPS spectrometer, UK. 
The X-ray source was a monochromated aluminum radiation (1486.6eV), operated with 
an X-ray emission current of 20 mA and an anode high tension (acceleration voltage) of 
12 kV. The purified samples were lyophilized and the powdered solid was submitted for 
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XPS. XPS sample analysis was carried out at the Sheffield Surface Analysis Centre, 
Sheffield University by Deborah Hammond. The powdered sample was placed on a 
standard sample stud employing double-sided adhesive tape and the take-off angle was 
fixed at 90º relative to the sample plane. Wide scans were collected between 1200 to 0 
eV at 0.5 eV resolution and 160 eV band pass energy, as shown in (Fig. 3-3A). In 
addition, high resolution scans were collected for C 1s, O 1s, N 1s, S 2p, and Au 4f 
peaks at 0.05 eV resolution and 20 eV band pass energy for varying lengths of time 
between 5 and 20 minutes per scan. The data were analysed using Vision2 software 
(Kratos Analytical, UK) and the analysis of the XPS peaks was performed using a 
commercial software package (Casa XPS v2.3.16PR1, Casa Software Ltd., UK). The 
atomic weight percentages (wt%) were determined from the experimentally calculated 
peak intensities and normalized by atomic sensitivity factors provided by Kratos 
Analytical, UK. Peak fitting was performed with no preliminary smoothing.  
Dynamic light scattering (DLS), (Malvern Zetasizer Nano-ZS, UK) for sizing 
measurements were carried out using a 10mm disposable sizing cuvette and the particle 
size measurements were performed in triplicate.  
Transmission electron microscope (TEM) Samples were sent to Leeds EPSRC 
Nanoscience and Nanotechnology Research Equipment Facility (LENNF) and were 
analysed by Zabeada Islam. TEM images were taken on a CM200 Tecnai TF20. Field 
emission gun TEM (FEGTEM) operated at an accelerating voltage of 200 kV and 
equipped with a Gatan Orius SC600A CCD camera to capture images. Samples were 
prepared by placing a drop of citrate-Au NPs solution (or P- Au NPs) on a copper grid. 
The films on the TEM grids were allowed to dry for 5 minutes under a heat bulb before 
analysis. Final statistical size distributions were arrived at by TEM-based size analysis 
of the purified particles (n ~ 700 particles). The size analysis of the particles was 
performed using Image J analysis software. 
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Mass spectrometric measurements were carried on an electrospray ionization mass 
spectrometry (ESI-MS) (Thermo Scientific, Sanjose, California, USA) in the BMRC 
labs in positive ion mode to analyse peptide cleavage products of DPP-IV substrate. 
Samples were introduced by direct infusion using the syringe pump on the instrument at 
a flow rate of 5 ȝL/min with an acquisition time of five minutes. 
1H nuclear magnetic resonance (NMR) spectra were obtained in deuterated water (D2O) 
on a Brucker AVANCE III (400 MHz) NMR spectrometer (Brucker, Coventry, West 
Midlands, UK) in the BMRC labs. 
3.2.4 Colorimetric Assay of DPP-IV/CD26 Activity  
 
For assaying DPP-IV/CD26 activity, varying activities of DPP-IV (2, 4, 6, 8, 10, 15, 20, 
25 and 30 U/L) in 50 mM Tris buffer pH 8.3 were added to 100 µL of GPDC-modified 
Au NP solution and the mixture was incubated at 37 °C for 10 minutes, in the wells of a 
transparent 96 well microtiter plate. The UV-vis absorption spectrum of the solution 
was recorded using an absorbance scan from 400-900 nm. The experiments were 
conducted in triplicate (3 different sample preparations) for the assays of detection and 
quantitative determination of DPP-IV/CD26 activity. DPP-IV/CD26 activity was 
determined kinetically during 10 min at 37 °C by measuring the absorbance ratios at 
642 and 522 nm (A642/ A522). A linear fit was used for quantitative determination of 
enzyme activity because it provides the simplest way for calculation of activity or 
concentration.  Method detection limit was used to evaluate assay sensitivity. The values 
of the Michaelis constant (KM) were determined by non-linear regression analysis using 
DynaFit software (Biokin Ltd.). 
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 Results and Discussion 3.3
3.3.1 Design of the Peptide Substrate 
 
The peptide substrate, Gly-Pro-Asp-Cys (NH2-GPDC-OH) was designed to mimic the 
structure of the chromogenic substrate Gly-Pro-p-nitroanilide, which is one of the most 
frequently used substrates for DPP-IV/CD26 detection. The main difference between 
the two is that the peptide substrate mimics natural substrates of the enzyme instead of 
linking the dipeptide to a chemical moiety. The rationale for the choice of this sequence 
included the presence of the following: (i)  the enzyme cleavage site in the dipeptide 
(NH2-Gly-Pro) for DPP-IV/CD26, as the enzyme functions selectively on a dipeptide 
sequence that contains a protonated amino group (Lambeir et al. 2003)  (ii) cysteine (C) 
as anchor to facilitate the immobilization of the peptide onto the Au NP surface and (iii) 
inclusion of aspartic acid (D) in order to enhance the negative charge on the NP surface 
and provide further distance between the substrate ligand attached to the NP surface 
which in turn enhances the stability of the colloidal solution by means of electrosteric 
stabilization.  
3.3.2 Synthesis of GPDC-Functionalized Gold Nanoparticles  
 
Evidence for the successful formation of citrate-capped Au NPs was supported by UV-
vis spectroscopy (Fig 3-4). In the inset on Fig 3-4, the peak has shifted from 520 (blue 
curve) to 522 nm (red curve) after Au NP modification with GPDC peptide. The 
extinction of GPDC capped Au NPs was slightly higher than that of the unmodified Au 
NPs (blue curve), mainly because of changes in refractive index on the Au NP surface 
resulting from the coupling of a peptide layer to the surface of the NPs. 
Independent modification of the Au NP surface provides a way to alter their optical 
behaviour. The incorporation of ligands changes the level of the electromagnetic 
interaction and as a result the optical function due to the asymmetric environment 
(Ghosh and pal 2007). 
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Figure 3-4 UV-Vis absorption spectra of dispersed citrate-Au NPs (blue) and GPDC 
capped Au NPs (red). 
 Inset: enlarged section showing the shift of the absorption spectra after peptide 
immobilization. 
 
A number of published papers have examined the effect of functionalization of Au NPs 
on its optical properties. For example; Ghosh and Pal (2007) observed that the LSPR of 
gold colloids changes variably when binding different cationic and anionic surfactants 
of variable chain length, which they attributed to different dielectric environments 
imposed by these ligands at the gold/surfactant interface. In contrast to this observation, 
Underwood and Mulvaney (1994) observed that spectra of polymer stabilized metal 
particles displayed distinct surface plasmon bands that are not influenced by the 
adsorption of epoxy groups to the metal surface. 
The effect of ligand coupling to the LSPR of gold colloids can be accounted for by 
assuming the contribution of the dielectric of the organic shell. When a metallic NP is 
coated with a ligand shell whose refractive index is different from that of the ambient 
(i.e., the Au nanocore), the field that acts on the particle becomes unhomogeneous. The 
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density of the binding ligands coating offers a dielectric covering on the particle surface, 
leading to a change in the dielectric constant of the medium and causing a red shift of 
the Ȝmax of the LSPR (Mulvaney 1996). 
It was necessary to determine the optimum pH for successful conjugation of peptides to 
Au NPs (Peng, Chen et al. 2007). The optimum pH for GPDC conjugation was 
determined by performing a preliminary titration at two different pH values namely, pH 
4.5 and 6 and examining the extent of conjugation by Bradford assay. Although the 
theoretical isoelectric point for GPDC was predicted to be 3.8 (ExPASy). A pH of 6 was 
found to be more effective for successful conjugation. Whilst the optimal pH for coating 
usually lies around the isoelectric point of the protein, there are no general rules and 
adsorption interaction isotherms should be conducted in each case (Keating et al. 1998). 
 
3.3.3 Examination of Peptide Coupling by XPS  
 
Both citrate and peptide modified Au NP solution were analysed by XPS to determine 
the elemental composition of the GPDC-Au NPs and more importantly to elucidate the 
nature of the Au-S linkage. In XPS, the nature of sulphur atoms determines their 
position in the spectrum, with the species with the lowest binding energy (162.5 eV) 
being the most reduced of the sulphur atom types, the species at ~164 eV being slightly 
more oxidized, and the species between 167-169 eV being a strongly oxidized sulphur 
species (Table 3-2).  
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Table 3-2 Sulphur binding energies (eV) in XPS spectrum referenced to adventitious 
C1s peak at 284.8eV. Adapted from www.xpssimplified.com 
 
Wide scan spectra of Au NPs modified with peptide ligand (GPDC) (Figure 3-5) was 
showing signals due to Au and S. Although the sulphur concentration was low, as 
shown in Table (3-3) due to its low availability in the peptide ligand, it was possible to 
detect the S2p peak at approximately 162.2 eV, consistent with the formation of a 
thiolate linkage between the ligand and the gold core (Fig. 3-6). Although the high-
resolution spectrum for another area suggests there may also be some untreated thiol 
with a binding energy of 164 eV (Fig. 3-7). There was no evidence for oxidised sulphur, 
which appears at ~167 eV on gold clusters (Lee et al., 1998; Schoenfish and Pemberton, 
1998). 
Binding energy values reported for sulphur in GPDC-Au NPs are consistent with a 
system in which the sulphur species is bound to the surface of gold as a thiolate, which 
usually occur in the range between 162.0 to 162.9 eV (Bourg et al.,2000; Bain et al. 
1989).  
The high-resolution Au (4f) spectra for both samples contain a doublet for Au (4f7/2) 
and Au (4f5/2) with binding energies c.a. 84 and 87.7 eV, respectively (Fig 3-8). These 
values are similar to those reported by Brust (83.8 eV and 87.5 eV) (Brust et al. 1994) 
and Yee and colleagues (84.2 eV and 87.85 eV) (Yee et al. 2003) for Au NPs capped 
with dodecanethiol. The binding energy of Au(I) in a gold thiolate is 86.3 eV and Au 
NPs that are reported to contain a fraction of their surface atoms in the Au(I) oxidation 
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state show an Au 4f7/2 peak with a binding energy of 84.9 eV (McNeillie et al. , 1980). 
The Au (4f7/2) observed at 84.0 eV in the GPDC-Au NPs suggested that the bulk of the 
gold atoms are in the Au (0) oxidation state.  
 The main gold peak was fixed at 84 eV and was chosen as the binding energy 
reference. A smaller peak at lower binding energy was regularly seen (Fig. 3-8). A 
search of the literature suggests whilst XPS of Au NPs has often seen small peaks at 
higher binding energies, suggesting Au(I) or Au(III) complexes, a peak at lower binding 
energy is less easily explained. This lower binding energy peak was typically 2 eV 
lower than the main Au peak and approximately 20% of the total area. 
Overall XPS data have provided valuable information regarding the ligands coating the 
surface of Au NPs. A wide scan spectrum confirmed the presence of sulphur and gold in 
the sample of peptide modified Au NP. The high resolution of Au (4f) spectrum showed 
a doublet for Au at Au (4f7/2) and Au (4f5/2) in the region of 84 and 87.7 eV 
respectively, which are similar to the values of gold thiolates reported in the literature 
(Brust et al. 1994; Yee et al. 2003). Furthermore, the presence of the peak for Au (4f7/2) 
shows that the bulk of the gold atoms are in the Au (0) oxidation state, confirming the 
successful synthesis of Au NPs. 
The XPS spectra for C, O and N remained unaffected during the process of Au NPs 
modification with the peptide ligands, which gives an indication that these elements 
were not implicated in any form of bonding with Au NP surface. 
Table 3-3 Surface composition in atomic % of GPDC capped Au NPs as determined by 
quantitative XPS survey scan. (Area 1 & 2 represent 2 different spots for the same 
sample). Apart from indium that appeared due to sample pressing by indium foil the 
atom % is highly representative. 
Sample Na F O In N Au C Cl S 
Area 1 3.2 0.6 24.2 0.9 6.3 13.4 49.2 1.9 0.4 
Area 2 2.8 0.5 24.6 3.5 5.9 11.6 48.6 2.0 0.7 
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Figure 3-6 S 2p narrow scan XPS spectra for GPDC capped Au NPs. The XPS spectra 
from certain area showed that all sulphur has transformed into thiolate. 
 
Figure 3-7 S 2p narrow scan XPS spectra for GPDC capped Au NPs.  In addition to the 
presence of main S peak at 162 eV, a small peak at 164 eV suggests that not all S might 
have converted into thiolate. 
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Figure 3-8 Au 4f narrow scan XPS spectra of GPDC capped Au NPs. 
 
3.3.4 Analysis of Gold Nanoparticle Size and Charge Before and After 
Functionalization Using DLS and Zeta Potential Measurement   
 
DLS measurements show that the peptide capped Au NPs has an average hydrodynamic 
diameter of 36.5 nm in comparison to 21.9 nm for the unmodified NPs. This difference 
in diameter is indicative of the surface functionalization of the Au NPs with the GPDC 
peptide. The surface modification of the Au NPs with the peptide was further verified 
by zeta potential measurements. Upon adsorption of GPDC, the zeta potential shifted 
from -9.4 ± 0.5 mV for citrate stabilized Au NPs to -23.5 ± 2.5 mV for GPDC-capped 
Au NPs (Fig 3-9). The observed alteration in the zeta potential value can be attributed to 
the increased net negative charge of the peptide immobilized to the NPs surface. The 
changes in the zeta potential of the Au NPs demonstrated the successful surface 
functionalization of the particles and resulted in functionalized Au NP formulation with 
higher stability than unmodified Au NPs which serves as a good fit for incubating the 
NPs in ionic solution. 
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Figure 3-9 Zeta potential measurements of bare Au NPs (blue) and GPDC-capped Au 
NPs (red) verified the surface functionalization of the particles. Error bars represent the 
standard deviation (n = 3) of 3 Au NP preparations. 
 
 
3.3.5  Sensitivity of GPDC-Capped Gold Nanoparticle to DPP-IV/CD26 activity  
 
The addition of DPP-IV/CD26 to GPDC functionalized Au NPs solution resulted in a 
colour change from red to pale blue and the UV-Vis spectra displayed a clear red-shift 
with accompanying band broadening. A new band appeared at about 642 nm and there 
was a gradual increase in the band intensity and decrease in the absorbance of the band 
at 522 nm with an increase in DPP-IV/CD26 activity. The colour intensity increases 
with higher DPP-IV/CD26 activity, as more of the peptide substrate was cleaved by 
DPP-IV/CD26 causing further Au NP aggregation (Fig 3-10). The shift of absorbance to 
a higher wavelength correlated well with increasing DPP-IV/CD26 activity, whilst TEM 
images demonstrated that Au NP aggregates were formed in the presence of DPP-
IV/CD26 (Fig. 3-11). 
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Figure 3-10 Effect of DPP-IV/CD26 activity on colour and absorption spectra of GPDC 
capped Au NPs. 
a) Solution colour changes after the addition of DPP-IV/CD26 (left to right) 0, 2, 4, 6, 8, 
10, 15, 20, 25 and 30 U/L (b) Absorption spectra of GPDC capped-Au NPs after 
incubation with different activities of DPP-IV/CD26.  
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Figure 3-11 TEM photo micrograph of GPDC functionalized gold nanoparticles before 
(left) and after (right) interaction with DPP-IV/CD26 enzyme. Various magnifications 
have been used to show the nature of aggregate formed after treating the modified Au 
NPs with DPP-IV/CD26 enzyme. 
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3.3.6 Investigation of the Assay Dynamic Range  
 
The linearity of the calibration graph for the assay was investigated for DPP-IV/CD26 
activity ranging from 0–30 U/L. As the activity of DPP-IV/CD26 increases, the Au NP 
biosensor system displayed gradual colour change from red to pale blue, while the 
absorption peak at 522 nm decreased and the absorption peak at 642 nm increased. 
These two wavelengths were selected to represent the relative extent of aggregation and 
dispersion of the GPDC capped Au NPs, respectively (Zhu et al. 2012; Nossier et al. 
2016; Wu et al. 2017). A linear relationship between enzyme activity and absorbance 
ratio (Abs642/Abs522), R2= 0.9924 was observed in the range 2–12 U/L, with the signal 
levelling out at higher activities (Fig. 3-12). The DPP-IV/CD26 activity in serum of 
healthy humans range between 17.0 - 52.6 U/L, with lower levels in hypertensive and 
immunocompromised patients (Bella et al. 1982; Lambeir et al. 2003). The limit of 
detection (based on 3σb/slope, where σb was the standard deviation of blank samples) 
was determined to be 1 U/L for the developed assay. 
 
Figure 3-12 Calibration curve of Abs642/Abs522 versus the activity of DPP-IV/CD26. 
(Inset): Expanded linear region (2- 12 U/L). Error bar represents the standard deviation 
(n = 3). DPP-IV/CD26 assay was performed under the optimal conditions (room 
temperature, incubation for 15 minutes).  
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3.3.7 DPP-IV/CD26 Selectivity Study  
 
In order to confirm that Au NP aggregation and interaction of the GPDC functionalized 
Au NPs is selective to DPP-IV/CD26 activity; experiments were performed with 
potential interfering proteins and enzymes including trypsin, thrombin, albumin and 
lysozyme. As shown in Figure 3-13, the signal intensities from the peptide modified Au 
NP solutions incubated with thrombin, trypsin, albumin or lysozyme were negligible, 
demonstrating the selectivity of the assay. The GPDC modified Au NPs particles did 
not produce a noticeable colour change when incubated with the denatured DPP-
IV/CD26 (heating at 80 °C for 15 minutes) demonstrating the specificity of the enzyme 
activity. 
 
 
Figure 3-13 Response of the functionalized Au NP incubated to the addition of 20 U/L 
of DPP-IV/CD26 compared to effect produced by other enzymes and proteins such as 
lysozyme (1 µg/mL), thrombin (20 U/mL), trypsin (20 µg/L), human serum albumin 
(HSA) (2 mg/mL) and denatured DPP-IV (heating at 80 °C 15 minutes) under the same 
conditions. Error bars represent the standard deviation (n = 3). 
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3.3.8 Control Studies  
 
Control experiments were conducted to ensure that the colour change after DPP-IV 
enzyme addition was due to enzymatic hydrolysis of the GPDC capped Au NPs rather 
than any nonspecific effect. Different sample mixtures were tested as shown in (Figure 
3-14). 
 
Figure 3-14 Response of the GPDC functionalized Au NP solution to the addition of 20 
U/L in control experiment.  
Response to the addition of DPP-IV enzyme to a GPDC functionalized Au NP (red), 
non-functionalized Au NP (green), Au NP mixture with a peptide substrate not 
cleavable by DPP-IV/CD26 enzyme (purple) and response to the addition of Tris buffer 
(pH 8.3) to a GPDC functionalized Au NP (blue). Error bars represent standard 
deviation (n=3). 
 
In all of the control experiments none resulted in a shift in λ max that was comparable to 
that caused by the addition of DPP-IV/CD26 enzyme. The first control experiment 
carried out by adding Tris buffer to GPDC-Au NPs without the enzyme (negative 
control) to ensure that the addition of the buffer did not cause spectral change. This 
observation indicates that the NPs aggregate as a result of the activity of DPP-IV/CD26 
and not due to other components in the solution. The second control experiment was the 
addition of 20 U/L of DPP-IV/CD26 to unmodified citrate Au NP suspensions, to test 
whether a similar response is obtained in the absence of modification of the Au NPs 
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(positive control). The final control used Au NP labelled peptide substrate that did not 
meet the requirement for proper hydrolysis by the DPP-IV/CD26. For this purpose, a 
CPDC peptide was used which bridges the ligand from both sides which make the 
substrate not amenable to hydrolysis by DPP-IV/CD26, due to loss of free amine end. 
Again, no aggregation was seen demonstrating that the colour change after DPP-
IV/CD26 addition was due to hydrolysis of the peptide and not due to dissociation of 
the peptide from the NP surface. 
The stability of the colloidal system is governed by steric hindrance and electrostatic 
repulsion forces between the charged peptide capping ligands. The DPP-IV/CD26 
induced cleavage of GPDC reduces the length of the peptide arm and thus the distance 
between particles decreases, which in turn affects the plasmon resonance of the 
functionalized NPs due to the removal of steric barriers between the particles resulting 
in irreversible aggregation. 
 
3.3.9 Study of the Reaction Time Course  
 
The reaction dynamics of peptide functionalized Au NP aggregation was studied to 
establish the optimum time for enzymatic hydrolysis of the modified Au NPs. The 
aggregation of the peptide functionalized Au NPs led to a reduction in absorption at 522 
nm (SPR band), and an increase in absorption at longer wavelengths in the UV-vis 
absorption spectrum, the ratio between 642 nm and the 522 band (A640/A522) were 
plotted at different time points to monitor the aggregation of peptide functionalized Au 
NPs as shown in Fig.3-15. As can be seen by incubating the peptide functionalized Au 
NPs with DPP-IV/CD26 at different enzyme activities, the A642/A522 increases gradually 
and then reaches a limit. The higher the DPP-IV/CD26 activity, the faster the A642/A522 
ratio reaches a plateau. Indeed, the A642/A522 with the least DPP-IV/CD26 activity 
reaches a plateau within 10 min, an indication that this method is rapid and stable 
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signals can be obtained after 10 min incubation. High DPP-IV/CD26 activity was 
associated with increased rate of substrate hydrolysis.  
DLS measurements were used to follow the changes in the size of Au NPs over time, 
following enzyme addition. The DLS data clearly shows that the hydrodynamic size of 
the Au NPs gradually increased after the addition of the enzyme and plateaued after 
about 10 minutes (Fig.3-16). The KM value for DPP-IV/CD26 of the GPDC substrate 
coupled to Au NPs was determined using the same purified DPP-IV/CD26 dilution by 
plotting end point versus enzyme activity yielding a sigmoidal curve and the KM value 
was determined to be 83.4 ± 2.2 µM. 
 
 
Figure 3-15 Effect of incubation time and DPP-IV/CD26 activity on absorbance change 
in GPDC capped Au NPs. 
Plot of ratio of absorbance of GPDC-Au NPs at 642/522 nm versus reaction time at 
various enzymatic activities of DPP-IV/CD26 (0, 2.5, 5, 7.5, 10, 12.5, 15, 20 and 25 
U/L) for 60 minutes. 
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Figure 3-16 Changes in the hydrodynamic size measured by DLS with time in the 
presence of 20 U/L of DPP-IV/CD26 measured by DLS. 
 
3.3.10 Quantifying Thiol Ligand Density 
 
The average number of gold atoms per NP (NAu/Au NP) can be calculated theoretically. 
Assuming a spherical shape and a uniform structure, the average number of gold atoms 
(N) can be calculated using Equation 9, where p is the density for gold (19.3 g/cm3)  (Lu 
et al. 2012) and M stands for atomic mass of gold (197 atomic mass unit). With an 
increase in diameter, the average number of gold atoms per gold nanoparticle (NAu/Au NP) 
will increase with cube (Liu et al., 2007).  NAu/Au ୒P = ஠஡Dయ6୑ = 30.ͺͻ6 �ଷ ……………….. (9) 
 
Based on the TEM results reported previously in chapter 3.2.2 and substituting in 
Equation 9, the average number of gold atoms per NP is calculated to be 94,190.  
 
The ligand coverage via the gold-to-sulphur ratio can be calculated based on the fact 
that the gold atoms constitute the particle core with each ligand on the NP surface 
carrying a single sulphur atom only, the number of sulphur atoms per Au NP (NS/Au NP) 
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will increase to the square of the Au NP diameter and is proportional to the maximal 
coverage factor ĸmax and can be calculated using Equation 10.  
 Ns/G୒P =  κπDଶ.  ………………………..… (10) 
 
Combining the two equations (Equation 11), it assumes that spherical NPs 
monodispersed with complete saturation with a monolayer of thiol ligands on the 
particle surface (Hinterwirth et al. 2013).  
=
ಘಙDయ6MKmax஠Dమ =kmax−భ  x 9.83 x D.  …………….. (11) 
Using equation 3, the calculated theoretical maximum number of GPDC ligands on the 
surface of Au NPs is 5.39 x 106.  
 
 
3.3.11 DPP-IV/CD26 Directed Cleavage of Peptide Substrate  
 
Supernatant from the DPP-IV treated Au NP suspension were examined by mass 
spectrometry to detect the expected peptide cleavage products (Figure 3-17). A peak at 
m/z of 173 was seen that corresponds to the [M+H]+ cleavage product, Gly-Pro, which 
indicates the cleavage of the GPDC capped Au NPs by DPP-IV/CD26 activity.  
Solution state 1H NMR spectroscopy was used to study the changes to the structure of 
peptide substrate after incubation with DPP-IV. The study focused on analysis of the 
induced alterations of a number of NMR parameters, such as chemical shifts and 
whether new signals appear as a result of peptide substrate hydrolysis. 
The NMR study was first carried out on GPDC capped Au NP samples to fully 
characterize the structure and thereafter on GPDC Au NPs + DPP-IV, allowing the 
analysis of changes induced by the enzyme addition to GPDC Au NPs, on characteristic 
NMR parameters of the species present in the sample. Representative 1H NMR spectra 
of GPDC Au NPs and GPDC Au NPs + DPP-IV in water with 50% D2O with the 
assignment of the characteristic proton resonances in the molecules presented in Fig.3-
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18. Although clear changes can be noticed after incubating the peptide substrate with 
DPP-IV/CD26 such as (peak signal at 4.4 ppm) positon but obtained results were not 
conclusive.  
 
  
 
Figure 3-17 MS spectrum of GPDC capped Au NPs after hydrolysis with DPP-
IV/CD26.  
The peak appeared at the m/z value 173 corresponding to the desired peptide sequence, 
Gly-Pro. Gly-Pro standard was used as a reference peak, which produced a signal at 173 
m/z. 
 
 
173 [M + H+] 
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Figure 3-18 400 MHz 1H NMR spectra of: (A) GPDC and (B) GPDC + DPP-IV.   
 
 
A 
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 Conclusion 3.4
 
A solution-based DPP-IV/CD26 detection assay, utilising peptide substrate conjugated 
to Au NPs, was developed and its usefulness demonstrated. The peptide substrate was 
designed to mimic the natural enzyme substrates. Several techniques have been used to 
investigate and study the coupling of the peptide to the Au NP surface including XPS, 
UV-Visible spectroscopy, zeta potential and hydrodynamic radius measurements.  
The first indication for the successful synthesis of P-Au NPs was obtained from UV-
visible spectroscopy. A slight shift in the SPR band from ~520 nm to 522 indicated a 
change in the surrounding environment of the Au NP surface. Zeta potential and 
hydrodynamic size changes further confirmed successful attachment of peptide to Au 
NP, was evidenced noticed by an increase in Au NP formulation stability and the radius 
of the modified NPs. 
XPS data provided valuable information about the ligands coupling to the surface of Au 
NPs; wide scan spectrum confirmed the presence of sulphur and gold in the sample, 
which agreed with the chemical structure. High resolution of Au (4f) spectrum showed 
a double for Au at Au (4f7/2) and Au (4f5/2) for all samples analysed in the region of 84 
and 88 eV respectively, which are similar to the values of gold thiolates reported in the 
literature (Brust et al., 1994, Yee et al., 2003). The presence of the peak for Au (4f7/2) 
shows that the bulk of the gold atoms are in the Au (0) oxidation state.  
The cleavage of the peptide substrate was demonstrated by mass spectrometry by 
comparing the m/z of the hydrolysis product Gly-Pro with a mass spectrum for a 
standard Gly-Pro dipeptide. These data verify that DPP-IV can hydrolyse GPDC when 
immobilized on Au NPs surface. This method displayed selectivity for DPP-IV over 
other serum enzymes. In the absence of DPP-IV/CD26 activity (negative control), 
GPDC- modified AuNPs are stably suspended in solution (red colour). Peptide capping 
hinders attraction of the Au NPs. While in the presence of DPP-IV/CD26 activity 
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(positive sample), after enzymatic digestion, the peptide capping is reduced, this allows 
the attraction force among Au NPs leading to aggregation (blue colour). Data obtained 
from TEM photo micrographs and DLS calculations confirmed this proposal. 
The developed assay allowed quantitative estimation of DPP-IV/CD26 activity, with a 
linear response range from 2 U/L to 12 U/L for DPP-IV/CD26 determination was 
obtained. Mass spectrometry was utilized to confirm that the cleavage site of the 
immobilized peptide could be recognized by DPP-IV. 
The relevance of this NP-based assay resides in the fact that visual detection or simple 
instrumentation can be used for the detection and determination of the enzyme activity. 
Accordingly, it could be used for the preliminary analysis of DPP-IV containing 
samples without the need for specialized instruments. Nevertheless, it provides 
sensitivity comparable or even better than that provided by the current chromogenic 
Gly-Pro-pNA method. However, it is less sensitive than luminescent Promega® assay 
and much less than those based on the fluorescent or the NP-based recently reported by 
Xia and co-workers (Xia et al. 2016) or that based on electrochemical sensing which 
depend on immobilizing ferrocene peptide to the surface of a gold electrode reported by 
Zhang (Zhang et al. 2015). Also, none of the above mentioned techniques can be used 
by untrained personnel. 
There are a few areas where this work could be improved upon; such as enhancing the 
stability of peptide functionalized Au NP especially for use in high ionic strength 
solutions. A possible solution would be the incorporation of a short stabilizer ligand to 
enhance colloidal stability. In spite of these limitations, the development of an Au NP 
based colorimetric assay for DPP-IV/CD26 detection was successfully used in the 
studies conducted later in this thesis. This work led to the development of an assay with 
improved parameters in terms of practicality, range of enzyme activity detection and 
linearity as described in Chapters 4 and 5. 
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Assay Development: Incorporation of Spacer for 
generation of Peptide Functionalized Gold 
Nanoparticle for use in Colorimetric 
Measurement of Dipeptidyl Peptidase IV Activity  
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 Introduction 4.1
 
DPP-IV inhibitors (DPP-IVi) as therapeutic agents appear to have a potential in the 
management of type 2 diabetes, either singly or in combination with existing 
medication, such as metformin. DPP-IVi have their hypoglycaemic effect by blocking 
the action of DPP-IV, which is responsible for the inactivation of incretin hormones, 
thereby prolonging the half-life of glucagon-like peptide-1 and glucose-dependent 
insulinotrophic polypeptide leading to increases in insulin and C-peptide, with 
subsequent decrease in glucagon and improvements in oral glucose tolerance.  
Research efforts have been directed toward further potential pharmacological 
applications of DPP-IV/CD26 inhibitors in the management of ischaemic heart injury, 
atherosclerosis and osteoporosis (Jungraithmayr et al. 2012). Therefore, there is the 
need to develop a simple quantitative and sensitive HTS method for the potential DPP-
IVi candidates.  
Currently, Au NP-based colorimetric enzyme assays rely on the design of short peptide 
substrates to discriminate between different proteases, depending on the reactivity of the 
enzyme (Sato et al. 2003). Colour changes resulting from the aggregation or dispersion 
of the Au NPs, induced by the presence of the enzyme, can be used to measure enzyme 
activity. Stevens and colleagues, for example, reported a protease detection method 
based on the re-dispersion of Au NP assemblies induced by the enzymes (Laromaine et 
al. 2007). However, the use of Au NP aggregates as probes can result in poor access of 
the enzyme to the peptide substrates, affecting both the detection time and assay 
sensitivity. Recently, Sun and co-workers have devised a new approach for protease 
detection based on Au NP aggregation induced by enzyme-hydrolyzed peptides, 
through the introduction of multiple charged residues, in order to improve the stability 
of the colloidal Au NP solutions (Chen et al. 2014). 
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Kim and colleagues (2017) have recently introduced a new approach to enhance Au NP 
platform sensitivity based on centrifugation and silver enhancement. These 
modifications have resulted in a threefold improvement in detection limit, but the 
additional steps are time consuming and add to cost (Kim et al. 2017b). Their strategy 
for improving enzyme activity assays relied on a method that combines centrifugation 
and silver staining for the self-assembly of Au NPs. The idea is based on the principle 
that self-assembled aggregated Au NPs settle quickly after centrifugation, resulting in 
weak silver staining of the supernatant. Alternatively, dispersed Au NPs are strongly 
stained with silver enhancement in the supernatant after centrifugation. 
The stability of Au NP solutions can be controlled by functionalizing the NP surface 
with diverse thiol-containing peptides. Most of the Au NP-based assays for the 
measurement of enzyme activity are largely dependent on enzyme reactions to initiate 
Au NP aggregation (Wang et al. 2006; Zhang et al. 2014). There are a number of 
considerations in the design of the enzyme activity measurement platforms. The length 
of the peptide substrate is one of the essential parameters in the design of enzyme 
activity measurements using Au NP platforms. Besides conferring steric stabilization on 
the Au NP colloidal solutions, it is essential to maintain optimum distances between the 
Au NP and the substrate to ensure effective enzyme- substrate interaction (Ramezani et 
al. 2015). NP curvature sometimes interferes with peptide cleavage or hydrolysis due to 
steric hindrance imposed on large enzymes. To overcome this problem, the use of 
spacers in order to increase the distance of the hydrolysable moiety from the NP surface 
is considered in order to reduce steric hindrance and thus result in improved and faster 
aggregation of the Au NPs. In this chapter, a highly sensitive assay for DPP-IV/CD26 
using Au NPs functionalized with designed peptide probe Val-Pro-NH-(CH2)2-NH-Asp-
Cys (VP-EN-DC) was developed and used for the measurement of DPP-IV/CD26 
activity levels.  
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 Experimental  4.2
4.2.1  Reagents and Materials 
 
The enzyme, gold and citrate salts were all supplied and used as described in Chapter 3. 
The peptide (VP-EN-DC)
 
~ 95% pure was purchased from Cambridge Research 
Biochemicals (UK). The peptide was dissolved in 50 mМ glycine buffer solution (pH 
10.3). Vildagliptin was purchased from Cayman Chemicals (USA). DPP-IV/CD26 
assay kit for biological samples was purchased from Enzo Life Sciences (USA). Normal 
human serum control was purchased from Thermo Scientific (UK). All solutions were 
prepared using deionized water with a resistivity of 18.2 MΩ cm-1 purified on Milli-Q 
Academic purification system (Millipore, UK). 
4.2.2 Preparation of Citrate-Capped Gold Nanoparticle and Peptide Coupled Gold 
Nanoparticle Bioconjugate (P-Au NP) 
 
Citrate Au NPs (∼15 nm) diameter was prepared as described previously in Chapter 3 
(section 3.2.2).The peptide modified Au NPs (P-Au NPs) were prepared by addition of 
an aqueous solution of 2 mM (VP-EN-DC) peptide in 50 mМ glycine buffer pH 10, to 
the solution of citrate Au NPs in a volume ratio of 1 to 10. After overnight reaction at 
room temperature, excess peptides were removed by centrifugation (14500 rpm, 20 min 
at 4°C) using an Eppendorf centrifuge (Eppendorf, Germany), the pellets containing the 
modified Au NPs were resuspended in Tris buffer pH 8.3 and stored at 4ºC. 
4.2.3  Instrumentation for Gold Nanoparticle Characterization 
 
The same UV-visible spectroscopy and TEM instrumentation methods were used as 
described in Chapter 3 (section 3.2.3). 
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4.2.4  Colorimetric Assay of DPP-IV/ CD26 Activity 
 
 To perform the colorimetric assays for DPP-IV/ CD26, 100 µL aliquots of P-Au NPs 
were mixed with 100 µL of the enzyme at varying activities in 50mM Tris buffer at pH 
8.3 in the wells of a transparent 96-well microtiter plate. The contents were gently 
mixed using a plate shaker at 300-400 rpm for 60 seconds and then incubated at 37°C 
for 15 minutes. The UV-vis absorption spectrum of the solution was recorded using an 
absorbance scan from 400-900 nm. To study the reaction dynamics, P-Au NPs were 
exposed to a range of activities of DPP-IV/ CD26 (0, 2.5, 5, 7.5, 10, 15, 20, 25, 30, 35 
and 40 U/L) and the aggregation of the P-Au NPs was monitored by UV/Vis 
spectrophotometry. 
To evaluate the inhibition ability of the potential inhibitor, DPP-IV was first mixed with 
the tested inhibitor for 15 min at 37 °C. Then, VP-EN-DC capped Au NPs were added 
into the mixture to react for 30 minutes. The detection procedures are the same as those 
for DPP-IV (see section 3.2.4). The inhibitory ratio (%) of the potential inhibitors on 
enzymatic activity was expressed as follows: inhibitory ratio (%) = (R3 - R2)/(R1 - R2) 
× 100%, where R1 is the A700/A525 ratio (the absorbance ratios at 700 and 525 nm) of P- 
Au NPs in the absence of DPP-IV, R2 is the A700/A525 ratio of P-Au NPs in the presence 
of DPP-IV, R3 is the A700/A525 ratio of  P- Au NPs in the presence of DPP-IV and 
inhibitor. 
4.2.5 Monitoring of DPP-IV Activity using Gly-Pro-pNA Based Assay Protocol. 
 
Initially, 20 ȝL of DPP-IV standards with various activities in 50 mM Tris buffer (pH 
8.3) or blank serum sample was added into a mixture containing 70 ȝL of 50 mM 
Glycine buffer (pH 8.7) and 10 ȝL of 100mM of Gly-Pro-pNA in DMSO as the 
substrate. Then, the resulting mixture was incubated 10 min at 37 °C. After that, UV− 
absorbance of the mixture was measured at 405  nm. 
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 Results and Discussion 4.3
4.3.1 Design of the Peptide Substrate 
 
The peptide substrate, [Val-Pro-NH-(CH2)2-NH -Asp-Cys] was designed with the 
following considerations: (i) the cysteine (C) residue is to enable the attachment via 
thiol-gold chemistry of the peptide substrate to the surface of the Au NPs; and (ii) the 
valine (Val) and proline (Pro) dipeptide residues constitute the cleavage point for DPP-
IV/ CD26  and (iii) ethylene diamine  was incorporated into the structure in order to act 
as a spacer, so that possible steric hindrance, caused by the curvature of the Au NPs is 
reduced. A schematic diagram of the enzyme reaction followed by Au NP aggregation 
is shown in Fig.4-1. 
 
 
 
Figure ‎4-1 Schematic representation of the working principle for the measurement of 
DPP-IV/CD26 activity with peptide-conjugated Au NPs. 
 DPP-IV/CD26 hydrolyses the amide bond between Val-Pro and ethylene diamine (ED) 
leading to a reduction in the Au NP colloid stabilization and hence resulting in their 
aggregation accompanied by a colour change from red to blue. 
 
 
 
 
 
Au NP 
 Aggregated Au NP 
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4.3.2 Investigation of Peptide Coupling to Gold Nanoparticle Surface Using DLS and 
Zeta Potential Measurements 
 
The absorption peak was shifted slightly from 522 nm for the unmodified Au NPs to 
525 nm after Au NP modification with the VP-EN-DC peptide. DLS measurements 
showed that the peptide modified Au NPs have an average hydrodynamic diameter of 
45.1 nm in comparison to 21.9 nm for the unmodified NPs. This difference in diameter 
is indicative of the surface functionalization of the Au NPs with the peptide. The extent 
of the Au NP surface modification was assessed by zeta potential measurements, which 
changed upon the addition of the substrate. The zeta potential shifted from -9±1.5 mV 
for citrate stabilized Au NPs (blue) to -28±4 mV for VP-EN-DC capped (red), 
respectively as shown in Fig. 4-2. The observed alteration in the zeta potential value 
indicates displacement of negatively charged citric acid by the VP-EN-DC peptide. The 
enhancement of negative charges is most likely due to negatively charged aspartic acid 
residue on the surface after ligand exchange. Another explanation of the increase in zeta 
potential in the presence of the modified peptide arises from the possibility of a change 
in the medium dielectric constant and/or viscosity, which is known to affect the zeta 
potential measurements (Alkilany et al. 2014). 
 
Figure ‎4-2 Zeta potential measurements of citrate stabilized Au NPs (blue), VP-EN-DC 
modified Au NPs (red). Error bar represents the standard deviation of the measurement 
(n = 3) 
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4.3.3 Sensitivity of VP-EN-DC Capped Au NPs to DPP-IV activity  
 
The addition of DPP-IV/CD 26 to the VP-EN-DC functionalized Au NPs resulted in 
colour change from red to pale blue. The absorbance of the surface plasmon resonance 
band (SPR) at 525nm decreased with accompanying band broadening beyond 650nm 
(Fig.4-3) indicative of the formation of aggregates. Greater band broadening was 
obtained in the case of VP-EN-DC Au NPs when compared with that observed with 
GPDC Au NPs aggregation. The reason for this can be attributed to the formation of Au 
NP aggregates with a higher than 400 nm size aggregates, which result in both 
transversal and longitudinal surface plasmon resonance effects (Suresh et al. 2015). 
Furthermore, increased DPP-IV activity was associated with the gradual increase in the 
absorbance at higher wavelength (700 nm) and decrease at lower absorbance 
wavelength (525 nm) with a resultant colour change and band broadening. Results from 
the DLS technique show that the dispersed VP-EN-DC functionalized Au NP 
aggregates in the presence of DPP-IV/CD26, have a tenfold increase in the average 
hydrodynamic diameter from 45.1 nm to 413 nm (Figure 4-4). DLS data were in good 
agreement with band broadening observed with UV-visible spectroscopy showing that 
the size of formed aggregates was larger than that obtained with GPDC Au NP 
aggregates. The possible explanation for large aggregate formation might be due to 
neutral charge of spacer (ethylene diamine) remaining on the surface of Au NPs. TEM 
results data are consistent with the DLS results, with the addition of DPP-IV; Au NPs 
tend to aggregate (Figure 4-5). 
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Figure  4-3 UV−vis Absorption spectra of VP-EN-DC Au NPs after incubation with 
different activities of DPP-IV ranged from 0 to 40 U/L. (Inset: Colour changes with 
increasing DPP-IV/CD26 activity (left to right) to the VP-EN-DC Au NPs assay. 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
400 500 600 700 800 900
Control
2.5 U/L
5 U/L
10 U/L
15 U/L
20 U/L
25 U/L
30 U/L
35 U/L
40 U/L
Wavelength (nm) 
A
b
so
rb
a
n
ce
 
1
1
0
 
    
 
Figu
re
 ‎4
-4
         i 
Figu
re
 ‎4
-5
 
    
- DPP-IV + DPP-IV 
Figure 4-4 Hydrodynamic size distribution for modified Au NPs. before (left) and after 
(right) incubation with DPP-IV/ CD26. 
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Figure ‎4-5 TEM photo micrograph of VP-EN-DC functionalized gold nanoparticles 
before (left) and after (right) interaction with DPP-IV/CD26 enzyme with various 
magnifications. 
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4.3.4 Selectivity Study 
 
To further assess the selectivity of the method, experiments were performed with 
potential interfering proteins and enzymes such as trypsin, thrombin, lysozyme, HSA 
and denatured DPP-IV/CD26, to examine whether this treatment with any of these 
compounds could trigger Au NP aggregation. As shown in Fig. 4-6, the proteases 
thrombin and trypsin and the non-protease HSA and lysozyme produced signals that 
were commensurate with the background, revealing that the assay is selective and DPP-
IV/CD26 enzyme activity-dependent. 
 
Figure ‎4-6 Response of the VP-EN-DC functionalized Au NPs solution incubated with 
20 U/L of DPP-IV/CD26 compared to effect produced by  other enzymes, including 
lysozyme (1µg/mL), thrombin (20 U/mL), trypsin (20 µg/mL), HSA (2mg/mL) and 
denatured DPP-IV/CD26 (heating at 80°C, 15 minutes) under the same conditions, 
demonstrating the specificity of the Au NP-based assay solely mediated by DPP-
IV/CD26 activity. Error bar represents the standard deviation (n = 3). For proteins, 
concentration units and for enzyme, activity units were used. 
 
4.3.5 Investigation of the DPP-IV/CD26 Assay Linear Dynamic Range 
 
Linear regression analysis was performed by plotting a calibration graph of the ratio of 
the absorbance readings at 525 nm and 700 nm for each standard (were chosen to 
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represent both dispersed and aggregated Au NPs respectively) against DPP-IV/ CD26 
activity after incubation at 37°C for 15 minutes. The calibration plots displayed a good 
linear relationship between the red shifts of the LSPR peak (ΔȜ max) and DPP-IV/ 
CD26 activities in the range from 0 to 40 U/L, with a detection limit (LOD) of 1.5 U/L 
based on 3σb/slope, where σb was the standard deviation of blank samples. The 
straight-line equation between the points was (y = 0.0198x + 0.2232, R2 = 0.9761) as 
shown in Fig.4-7. 
 
Figure ‎4-7 Calibration curve of A700/A525 versus the different activities DPP-IV 
incubated with VP-EN-DC functionalized Au NPs. Error bars represent the standard 
deviation (n=3). 
4.3.6  Stability of the Modified Au NP Formulation  
 
The stability of the peptide modified Au NP platform after prolonged storage is another 
important concern to provide an acceptable shelf life for a diagnostic assay. The 
stability of the peptide modified Au NPs over time was investigated. When not in use, 
the modified Au NP was stored at (4°C) and tested monthly with a 20 U/L DPP-
IV/CD26. No significant change in UV-visible absorption spectra were observed after 
storage for 3 months (Fig.4-8), demonstrating the modified Au NP long-term stability. 
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Figure ‎4-8 The stability of the functionalized Au NP during storage for 3 months.  
UV-vis absorption spectra of the colorimetric assay toward 0 U/L DPP-IV/CD 26 (blue 
curve) and 20 U/L DPP-IV/CD 26 (red curve) after the Au NP was stored for 0, 1, 2, 3 
months, respectively). Error bars represent the standard deviation of the measurement (n 
= 3).  
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4.3.7 Determination of the Optimum pH of the Assay 
 
pH is an important factor that has to be considered in the evaluation of enzyme activity 
and Au NP stability. Numerous studies have been conducted to evaluate the effect of pH 
modification on altering the aggregation state of Au NP formulations (Li et al. 2003; 
Shim & Gupta 2007). A standard DPP-IV/CD26 enzyme activity (25 U/L) was used in a 
series of 50 mM Tris buffer solution with pH values ranging from 6.7 to 10.3, which 
were added to VP-EN-DC capped Au NP solution to study the optimal environment for 
the colorimetric assay (Fig 4-9). The underlying goal of these studies was to evaluate 
the effect of pH alteration on the formation or disruption of stabilizing forces such as 
hydrogen bonds and electrostatic interactions between modified Au NPs.  
 
 
Figure ‎4-9 Effect of pH changes on the VP-EN-DC capped Au NPs assay for the 
detection of DPP-IV enzyme.  
All incubations were done in the presence of 50 mM Tris buffer at the indicated pH 
values at 37°C for 30 min. The activity is expressed as A700/ A525. Error bars represent 
the standard deviation (n = 3). 
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4.3.8 Application of the Colorimetric Assay using Modified Au NPs for Detection of 
DPP-IV Activity in Biological Samples  
 
Normal serum human DPP-IV activity ranges between 17 and 52.6 U/L (Lambeir et al. 
2003). The developed colorimetric VP-EN-DC functionalized Au NP assay would, 
therefore, be suitable for the qualitative and quantitative determination of DPP-IV 
activity in human serum samples since the range of detection of the optimal assay is 1.5 
-40 U/L. Human serum samples were spiked with varying DPP-IV amounts to give 
activities of (5, 10, 15, 20 and 25 U/L) to investigate the recoveries of the colorimetric 
assay (Fig. 4-10). With the addition of different activities of DPP-IV/CD26, the 
absorption of the SPR band decreases while the absorption at longer wavelengths 
increases. When the activity of DPP-IV/CD26 is continuously increased, a new broad 
band appears at 745 nm, and grows corresponding as the activity of DPP-IV/CD26 
increases. By plotting the A750/A525 of P-Au NPs versus the DPP-IV/CD26 activity, it 
can be noticed that A750/A525 increases corresponding to the DPP-IV/CD26 activity 
(Fig. 4-11). 
 The recoveries of the spiked samples were in the range 83.6 –114.9% (Table 4-1). The 
very good recoveries and precision values are an indication of the reliability of the 
proposed method for the detection of DPP-IV/CD26 in biological samples. 
Table 4-1 Recoveries of DPP-IV/CD26 activity in spiked human serum samples using 
the P-Au NPs 
Added (U/L) Found (U/L)* Recovery (%) RSD** (%) 
5 5.04± 0.19 100.8 3.23 
10 8.36± 0.23 83.6 2.37 
15 15.89± 0.33 105.9 2.1 
20 22.99± 0.91 114.9 4 
25 26.77± 0.34 107 1.31 
* Mean of three sample determinations ± standard deviation. 
** RSD: Relative standard deviation. 
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Figure ‎4-10 UV-vis absorption spectra of the colorimetric assay using human serum 
samples spiked with DPP-IV standards (0, 5, 10, 15, 20 and 25 U/L DPP-IV/CD26).  
 
 
Figure ‎4-11 Ratio plots of A750/A525 versus DPP-IV/CD26 activity. Error bars represent 
the standard deviation (n = 3). Ratio of absorbance for simulated (spiked) samples were 
chosen at 750 nm due to larger shift that was noticed in these samples. 
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4.3.9 Method Comparison 
 
The developed VP-EN-DC Au NPs colorimetric assay was compared with the 
commonly used commercial Gly-Pro-pNA colorimetric assay (see section 1.9.1). The 
new method showed a good correlation with the standard assay when comparing the 
measured activity in human serum samples. This was demonstrated by linear regression 
analysis. Linear regression analysis of VP-EN-DC Au NPs compared with Gly-Pro-pNA 
showed a curve with the following equation: (y = 0.8484x + 0.1852). Fig. 4-12 displays 
the results with the standard samples using both methods. Evaluation of these 
experimental data reveals a strong positive correlation between the two methods, with a 
correlation coefficient of 0.975, demonstrating that the results obtained from the 
developed novel method reported here correlated well with those from the commercial 
standard DPP-IV/CD26 assay. These results indicate that the Au NP-based colorimetric 
assay is reliable for detection of DPP-IV/CD26 activity in human serum samples. 
 
Figure ‎4-12 Comparison of the assay results for DPP-IV/CD26 in human serum 
samples using the developed colorimetric assay and the Gly-Pro-pNA based 
commercial method, respectively. Error bars represent the standard deviation (n = 3). 
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4.3.10 Inhibition of the DPP-IV/CD26 Enzyme  
 
DPP-IV/CD26 is sensitive to inhibition by many classes of serine protease inhibitors. 
DPP-IVi have been used for the management of type 2 diabetes because of their ability 
to raise the levels of active incretins, ultimately leading to increased insulin secretion 
and lower blood glucose levels (Green et al. 2006; Deacon 2011). 
Experiments were conducted with 3-N-[((2S,3S)-2-Amino-3-methylpentanoyl]-1,3-
thiazolidine fumarate known as (P32/98) obtained from the DPP-IV/CD26 assay kit for 
biological samples (Enzo Life Science), which acts as a reversible competitive DPP-IV 
enzyme inhibitor. These experiments were unsuccessful as the purchased P32/98 
inhibitor was dissolved in DMSO, which might have caused a general inhibition of 
DPP-IV activity.  
Inhibition experiments were conducted using Vildagliptin, which belongs to the gliptin 
group of pharmaceuticals used as adjunctive medicines for type 2 diabetes. A stock 
solution of 100 mM Vildagliptin in deionized water was diluted in Tris buffer pH 8.3 at 
concentrations ranging from 10 µM to 10 mM (final concentrations in the assay: 1 µM–
1mM). The resulting DPP-IV/CD26 activity was measured using the colorimetric Au 
NP assay (developed in this chapter) with slight modifications. A standard amount of 
DPP-IV/CD26 enzyme (20 U/L) was incubated with various concentrations of 
Vildagliptin in Tris buffer for 15 minutes at 37°C. The functionalized Au NPs were 
added to the enzyme plus inhibitor mixture and allowed to incubate for 15 minutes. UV-
Visible spectroscopy was used to evaluate the residual DPP-IV activity quantitatively. 
As expected the inhibition increased with increasing concentration of Vildagliptin. The 
maximum inhibition of Vildagliptin was found to be 89.7% using 1 mM of the inhibitor. 
The IC50 value, the inhibitor concentration required to reduce enzyme activity by 50%, 
was obtained from the plot of inhibitory ratio versus inhibitor concentration for 20 U/L 
DPP-IV was calculated to be 44.8 µM (Fig 4-13). 
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Figure ‎4-13 Inhibitory ratio of different concentrations of Vildagliptin on DPP-
IV/CD26 (20 U/L) activity. 
 
Validation of an assay to determine its suitability for HTS was conducted by evaluating 
its performance based on the acceptable limits of Z factor and assay sensitivity (Inglese 
et al. 2007). The Z factor or value defines a characteristic parameter of the capability of 
the active compound identification for each given assay at the defined screening 
conditions (Table 4-2).  
Table 4-2 Categories of screening assay quality by the value of the Z-factor. 
 
The Z-factor is defined in terms of four parameters: the means and standard deviations 
of both the positive and negative controls. Given these values, the Z-factor is defined as: 
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Given the data obtained in VP-ED-DC assay, the Z-score was determined to be 0.578 
which is considered as an acceptable value for a screening assay (Zhang et al. 1999). 
 
 Conclusions 4.4
 
In this study, a novel, simple, real-time and one-step colorimetric detection method for 
the measurement of DPP-IV/CD26 enzymatic activity, based on the aggregation of 
functionalized Au NPs in the presence of the enzyme, was developed. The relevance of 
this NP-based assay resides in the fact that visual detection or simple instrumentation 
can be used for this analysis.  
In principle, aggregation of VP-EN-DC functionalized Au NPs can be used to measure 
the activity of DPP-IV/CD26 after hydrolysis of the peptide-functionalized Au NPs. 
The aggregation of the Au NPs induced a gradual colour change that was observed by 
the naked eye. Under the optimized conditions, a linear response range from 0 U/L to 40 
U/L for DPP-IV/CD26 determination was obtained, and the calculated LOD was 1.5 
U/L, making it suitable for the detection of DPP-IV/CD26 activity in serum (Lambeir et 
al. 2003).  
The VP-EN-DC Au NP and GPDC Au NP (Chapter 3) assays to determine DPP-
IV/CD26 activity both perform well, concerning qualitative and quantitative 
determination of DPP-IV/CD26 activity. Nonetheless, an enhancement in the linear 
detection range of DPP-IV/CD26 was achieved with the VP-EN-DC substrates by a 
factor of 3.5-4. This method have been validated in terms of screening assay quality and 
proved to be potential tool for identification of DPP-IV inhibitors. 
This method displays selectivity for DPP-IV/CD26 over a selected number of serum 
proteins. More importantly, the selectivity and sensitivity of this method was used to 
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measure the DPP-IV/CD26 activity in human serum. The recovery of DPP-IV/CD26 
levels in serum samples spiked with varying concentrations of DPP-IV/CD26 was 
determined to be in the range, 83.6 - 114.9% with a relative standard deviation of 1.31 - 
4%. The proposed method could also be used for measurement of effectiveness of DPP-
IV inhibitors. A deviation to higher wavelength (750 nm instead of 700 nm) in spiked 
serum samples might be due interference from non-analyte constituents in the sample. 
A possible improvement to this system would be the addition of a self-cleavable spacer 
that could be spontaneously cleaved from the attached substrate ligand when DPP-
IV/CD26 hydrolyses the first two amino acid residues as used by Diez‐Torrubia et al. 
(2012). Cyclization self-cleavage spacers can be linked to the dipeptide through an 
amide bond (cleavable by DPP-IV/CD26) and coupled from the other end to the OH 
group of the ligand capped Au NP through a metabolically labile ester linkage, which 
will undergo spontaneous chemical hydrolysis after cleavage of the terminal amino 
acids. These results indicate that colloidal stability of NP conjugates must be an 
important consideration for solution-based NP detection assays, if they are to be used in 
a clinical setting. Also, that further work must be done in order to determine if other 
strategies can be investigated to enhance stability with minimum effect on assay 
sensitivity. 
Compared to the traditional (fluorogenic and luminescent) commercial DPP-IV/CD26 
assays, this system has the advantage of portability, simplicity for the end user 
application without the need for complex instrumentation. The developed method offers 
a new approach for developing simple, fast, reliable and sensitive sensors for DPP-IV 
detection that is an easy to access diagnostic and/or prognostic tool for different 
diseases. 
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5 Chapter 5 
Enhancing Gold Nanoparticle Stability for 
Colorimetric Detection of DPP-IV/CD26 
Activity 
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 Introduction 5.1
 
To be suitable for use in biological assays, colloidal Au NP solutions must remain stable 
over a wide range of ionic strength particularly in biological environments such as 
serum, which has high ionic strength. Therefore, it is essential that attention is paid to 
the choice of the capping ligands as these surface bound ligands are responsible for NP 
stabilization against aggregation and provide the desired NP properties (e.g. 
hydrophilicity/hydrophobicity, surface charge, ligand arrangement, chemical reactivity, 
etc.) (Boisselier & Astruc 2009; Zhou et al. 2009; Balasubramanian et al. 2010). A 
general method of stabilizing Au NPs is the use of electrostatic repulsion between Au 
NPs, which are modified with charged ligands such as citrate (Martin et al. 2010) or 
triphenylphosphine (Ju-Nam et al. 2006). However, the stability of electrostatically 
stabilized Au NPs is affected by numerous factors in solution, including pH, ionic 
strength, and temperature (Wang et al. 2013).  
In order to improve the stability of Au NPs under biological conditions, several methods 
have been developed. These methods generally involve the functionalization of Au NPs 
with ligands that provide either steric or electrostatic stabilization and hence impart 
further stability to Au NP formulation. One of the most commonly used approaches 
involves the modification of the Au NP surface by assembling a monolayer of peptide 
capping ligands (Lévy 2006). A combinatorial design approach enables the synthesis of 
very stable Au NPs with properties in aqueous media that are determined by the amino 
acid sequence of the appended cysteine-terminated pentapeptide (Wang et al. 2005).  
The design strategy of these peptides takes into account the ability of certain amino acid 
residues to self-assemble into a dense layer that excludes water, and a hydrophilic 
terminus to ensure solubility and stability in water (Lévy et al. 2004). This type of NP-
peptide probe has been utilized in the development of a colorimetric kinase activity 
assay (Wang et al. 2006) in which the kinase-substrate was detected by specific binding 
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of Au NPs to the phosphorylated product immobilized on a microarray (Sun et al. 
2007). The method is based on labeling specific recognition or phosphorylation events 
on a microarray with Au NPs using avidin-biotin chemistry followed by silver 
enhancement and resonance light scattering detection. This format allows the 
production of highly stable Au NP platforms. 
 
Another widely applied method is the incorporation of a thiol-containing polyethylene 
glycol (dithiol-PEG) moiety into the functional ligand, because of its good solubility, 
biocompatibility and anti-fouling properties, which render NPs resistant to non-specific 
protein adsorption (Eck et al. 2008; Manson et al. 2011). Number of workers have 
utilized functional PEGylated Au NPs in targeted drug delivery and as biosensors in 
complex media (Schiffelers et al. 2004; Dreaden et al. 2009; Free et al. 2009). Dougan 
and colleagues investigated the effect of using multiple thiol linker system on 
minimizing undesirable aggregation events caused by thiol desorption, resulting in the 
loss of function of the probe (Dougan et al. 2007).  
 
Dithiols have also been used because of their higher coupling efficiency to Au NP 
surfaces, compared to monothiol and so enhance monolayer stability (Susumu et al. 
2007; Hermanson 2013). A number of dithiols such as dihydrolipoic acid derivatives 
have been assessed for the functionalization of Au NPs (Abad et al. 2005; Garcia et al. 
2005; Eck et al. 2008) and di- or polythiol PEGs (Wang et al. 2007; Kumar et al. 2008) 
in order to impart further stability. 
In this chapter, the effect of incorporating stabilizer moieties into the assay format and 
their effect on DPP-IV detection by three distinct methods was assessed. Table 5-1 
displays the complete sequence of the peptide constructs used in these experiments.  
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Table 5-1 Peptide sequences trialled to enhance Au NP stability. 
Name Sequence No of amino 
acids  
C/G dipeptide Cys-Ala-Leu-Asn-Asn & Gly-Pro-Asp-Cys 5 & 4 
GPG-EN-PEG4-LA Gly-Pro-Gly-ethylenediamine-PEG4-lipoamide  3 
GPDCALNNC Gly-Pro-Asp-Cys-Ala-Leu-Asn-Asn-Cys 9 
 
 
These approaches were chosen because they are well established in their use in NP 
systems and also for their predictable stability properties (Zhu et al. 2012; Wang et al. 
2013). The aim of this study is to enhance the stability of functionalized Au NPs by 
incorporating stabilizers and to evaluate their effect on DPP-IV detection (see Table 5-
2). 
The first trial involved a biofunctionalization (a biorecognition ligand and separate 
stabilizer ligand), while the second approach involved the modification of the functional 
ligand by incorporating a stabilizer in the sequence (PEGylation or penta peptide 
CALNN incorporation). The use of immobilized PEG coating on the gold surface via 
dithiol anchor groups on one end of the PEG chain and coupling of biological molecules 
via carboxy groups on the external side of the PEG ligand was investigated 
GPDC was chosen as the functional ligand when using bifunctionalization as it provides 
a fast and simple approach for the detection of DPP-IV activity (discussed in Chapter 
3), on the other hand CALNN was chosen as a stabilizing ligand with established high 
stability index (Lévy 2006).  
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 Experimental  5.2
5.2.1 Materials and Methods 
 
The enzyme, gold and citrate salts were all supplied and used as described in section 
3.2.1. GPDC (~ 95% purity) and GPDCALNNC peptide (>90% purity) were purchased 
from Thermo Fisher Scientific GmbH (Germany). GPG-ethylenediamine-PEG4-
lipoamide (95% pure) was purchased from Cambridge Research Biochemicals (UK). 
CALNN peptide (90% pure) was purchased from China peptide (China). 
The citrate stabilized Au NPs were synthesized by using the Grabar method as 
described in section 3.2.2. All glassware and magnetic stirrer bars used in the syntheses 
were thoroughly cleaned in aqua regia (HCl/HNO3 3:1, v/v), rinsed in distilled water, 
and oven-dried prior to use.  
5.2.2 Au NPs modified with capping ligands preparation:  
 
5.2.2.1 CALNN, GPDC bifunctionalized Au NPs (C/G Au NPs)  
 
C/G Au NPs were prepared by addition of peptide mixture (CALNN and GPDC) in 
various ratios to the solution of Au NPs. GPDC is employed as a functional group which 
has been evaluated as substrate for DPP-IV (Chapter 3); CALNN is used as a stabilizer 
because pure GPDC modified Au NPs exhibit poor stability under physiological 
condition (ionic strength of 50–200 mM). The stability of C/G -Au NPs is increased by 
increasing the molar ratio of CALNN to GPDC in the peptide mixture. Bifunctionalized 
peptide Au NPs were prepared as in the reported procedure of (Wang et al. 2006) with 
slight modification. Different proportions of CALNN in the ligand shell were obtained 
by adjusting the ratio of CALNN to GPDC (1:4, 1:6, 1:8 and 1:10) in the peptide 
mixture. An aqueous solution of peptide mixture (CALNN and GPDC) for each 
concentration ratio was added to the solution of Au NPs.  
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5.2.2.2 Gly-Pro-Gly-ethylenediamine-PEG4-lipoamide (GPG-EN-PEG4-LA) 
 
In order to use (GPG-EN-PEG4-LA) the ring (1,2-dithiolane) has to be opened to form a 
bidentate thiol anchoring group. Ring opening was achieved by incubation of the ligand 
with 50 mM Tris (2-carboxyethyl) phosphine hydrochloride (TCEP) as a reducing agent 
in 10:1 (v/v) ratio for one hour at room temperature. Functionalized Au NPs were 
prepared by adding an aqueous solution of PEGylated ligand to the solution of 15 nm 
Au NPs.  
5.2.2.3 GPDCALNNC peptide 
 
Au NPs functionalized with GPDCALNNC peptide were prepared by adding 1 mM 
peptide solution dissolved in sodium phosphate buffer (pH 7.4) to the solution of 15 nm 
Au NPs in a 1:10 (v/v) ratio.  
5.2.3 Purification 
The gold conjugates were purified from excess protein and nanoparticles before using 
for any experiment or storing. After overnight incubation at room temperature, excess 
peptides were removed by two centrifugations (14,500 rpm) for 15 minutes using a 
5415D Eppendorf centrifuge (Eppendorf, Germany). These speeds and times were 
optimised and determined experimentally. The final product was a loose red precipitate. 
The pellet was resuspended and stored in deionized water and stored at 4°C.  
5.2.4 Instrumental Techniques  
 
All zeta potential analysis was carried out using the Malvern Zetasizer Nano ZS. The 
scattered light was detected at 135° angle, with Non-Invasive Backscatter (NIBS) 
technology. The refractive index of the particle (1.59) polystyrene standard, refractive 
index (1.33) and the viscosity (0.88) of ultrapure water were taken at 25°C for 
measurements. All the data analyses were performed in automatic mode. Measured size 
range was presented as the mean value of 4 runs. For zeta potential measurements, 
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universal dip cell with applied voltage less than 5 V was used and the Smoluchowski 
approximation was employed by the instrument’s software to calculate zeta potential 
values for aqueous solutions of AuNPs (F(Ka) value = 1.5). 
FTIR spectra were obtained using a PerkinElmer spectrum 100 Fourier Transform 
Infrared Spectrometer (PerkinElmer, USA). The KBr pellet technique has been most 
commonly adopted for recording the spectra. However, in this work, the purified 
samples were lyophilized and the powdered solid were characterized directly in their 
free-standing state. 
The type of gel electrophoresis, used in this study, is agarose gel; TAE (Tris-acetate-
EDTA) buffer was used for running the samples through the gel. An electrical current is 
placed across the gel to mobilise the Au NPs preparations. The voltage, the amount of 
time under current and the amount of agarose used in the gel all affect how far the Au 
NP will travel and must be optimised for good separation. The Au NP samples were 
loaded on 1.5% agarose gels, 1 × TAE buffer, and run for 75 minutes at 100 V. 
5.2.5 Assay of DPP-IV/CD26 activity  
 
To perform the colorimetric assays for DPP-IV/CD26, Aliquots of each modified Au 
NP preparation were incubated with the enzyme at varying activities in Tris buffer (50 
mM, pH 8.3), in the wells of a transparent 96-well microtiter plate. The contents were 
gently mixed using a plate shaker at 300-400 rpm for 60 seconds; and then incubated at 
37 °C for 15 minutes. The UV-vis absorption spectrum of the solution was recorded 
using an absorbance scan from 400-900nm. 
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 Results and Discussion 5.3
5.3.1  Investigation of Peptide Coupling using UV-Visible Spectroscopy 
 
UV-vis absorption spectroscopy allowed monitoring of the interaction of the various 
ligand substrates with Au NPs, since SPR is highly sensitive to the NP environment. 
The Au NP colloid was found by TEM to be mainly comprised of 14 nm gold spheres 
exhibiting an extinction maximum at 523-524 nm (Figure 5-1), following NP 
conjugation and coupling reaction with functional ligands (GPDCALNNC or GPG- EN-
PEG4-LA) a slight shift in the absorption maximum was observed between 2.5 and 1.7 
nm respectively while C/G modified Au NPs displayed an absorption band shift of 2.9 
nm. This shift in Ȝ max of Au NPs was due to the modification of the Au NPs with the 
various ligands. The coupling of the stabilizing ligands alters the level of the 
electromagnetic modelling of the optical function due to the asymmetric environment. 
The effect of ligand coupling on the LSPR shift of gold colloids can be accounted for by 
assuming the contribution of the dielectric of the organic shell (Ghosh et al. 2007). 
 
Figure 5-1 UV-Vis absorption spectrum of modified Au NPs [black: GPDCALNNC 
(A), blue: GPG- EN-PEG4-LA (B) and red: C/G capped Au NPs (C)]. 
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5.3.2 Evaluation of Ligand Coupling by Gel Electrophoresis  
 
Nanoparticles were observed as a red band passing through the gel while running. Au 
NPs were not stained by Coomassie blue R-250. The coupling of the peptide to Au NPs 
can be observed by gel electrophoresis (Liu et al. 2007; Bartczak & Kanaras 2011; Zhao 
et al. 2012). 
Proper gel shift and the difference between modified and unmodified Au NPs in the gel 
were noticed by comparing the band migration for modified NPs and citrate 
(unmodified) NPs as shown in Fig 5-2. The bands of the unmodified and peptide-
capped Au NPs were directly visible by the red colour of the Au colloid. The C/G 
capped NPs and GPDC functionalized NPs had greater mobility than unmodified Au 
NPs due to change in the charge and/or size occurred as a result of the peptide coupling. 
Tailing was observed in the case of citrate Au NPs due to Aggregates of the Au NPs not 
penetrated the gel and small amounts of free gold gave background staining.  
 
 
Figure 5-2 Agarose gel electrophoresis of citrate and peptide capped Au NPs. 
True colour photograph of a 1.5% agarose gel run for 75 min at 100 V. The six lanes 
contain, (lanes 1 to 4); C/G capped Au NPs prepared in different ratios (1:4, 1:6, 1:8 and 
1:10), (lanes 5 and 6); GPDC capped Au NPs and citrate Au NPs.  
                1         2            3          4                                 5           6               
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5.3.3 Evaluation of Ligand Coupling to Gold Nanoparticle Surfaces by FTIR and 
Raman Spectroscopy 
 
FTIR spectroscopy was employed to detect changes to the characteristic bands of thiol 
after Au NP coupling, as free thiol is expected to bind to the Au NP surface via thiolate 
bonds. Generally, amino acids exist as zwitterions and display spectra featuring both 
primary amine and carboxylate functional groups. The bands for NH3+ stretch (very 
broad), NH bend (asymmetric/symmetric), and COO −  (carboxylate ion) stretch 
(asymmetric/symmetric) a typical for this type of compounds (Pavia et al. 2014). In the 
case of GPDCALNNC peptide composed of nine amino acids, the main focus was to 
look for changes in the thiol group in the cysteine.  Fig. 5-3 shows the FTIR spectra of 
the GPDCALNNC before and after coupling to Au NPs. Bands seen in the spectra are 
identified as follows. The band in (spectra A) at 1652 and 1385 cm−1 corresponds to the 
asymmetric and symmetric stretching of COO−. A band at 1522 cm−1 corresponds to N-
H bend and the very broad band of NH3+ stretch was observed in the 3000–3500 cm−1 
range. In addition, a weak band near 2550 cm−1 confirms the presence of the SH group 
in the cysteine molecule. These values are in good agreement to those reported by Aryal 
et al. (2006b) for cysteine capped Au NPs. 
These results are in good agreement with IR spectra of a peptide or amino acids, but 
characteristic SH band around 2500-2600 cm−1 seems to be very weak beacuase of the 
low amount of sulphur in the peptide. However, small changes in the absorption spectra 
were detected in the case of GPDCALNN capped Au NPs (spectra B). A shift in the 
position of COO− and NH3+ stretching is likely due to a change in their dipole moment, 
when cysteine binds on a metal surface with high electron density. Although significant 
band changes due to SH were not observed in the spectra of free and NP coupled 
peptide, other bands of COO− and NH3+ in spectra B encountered a displacement that 
may indicate the peptide coupling to Au NP surface.  
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Raman spectroscopy failed to demonstrate any changes in vibration when the peptide 
was bound to the Au NPs, which might be attributed to the concentration of Au NPs in 
the solution. 
 
 
Figure 5-3 Infrared spectra of stabilized ligand GPDCALNNC (A) and GPDCALNNC 
capped Au NPs (B). Functional ligands inside red circles represent the shift in the band 
position and disappearance of thiol band suggesting a formation of thiolate-gold bond.  
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5.3.4 Stability of Modified Au NPs in High Ionic Strength Solutions 
 
In order to enhance the stability of the Au NP platforms, several stabilizing groups or 
separate stabilizing ligands were chosen and their stability evaluated in buffer solutions 
with varying ionic strength.  The aggregation of Au NPs was used as a means of 
investigating the stability of the 3 different platforms (bifunctionalized ligand, 
PEGylated ligand and CALNN containing ligands). The semi-quantitative measurement 
of the aggregation process of colloidal NPs was calculated by measuring the variation of 
the integrated absorbance between 500 to 700 nm (Aryal et al. 2006a). As the 
absorbance of the Au NP solution shifts to longer wavelengths upon particle 
aggregation, the flocculation parameter increases with the extent of particle aggregation. 
Figure 5-4 shows the aggregation parameter as a function of NaCl concentration for 
different stabilizing ligands. 
 
Figure 5-4 Effect of introducing different stabilizing groups on the stability of Au NPs 
at different ionic strengths. The aggregation parameter is defined as follows: AP = (A - 
A0)/A0, where A is the integrated absorbance between 500 and 700 nm of the sample 
and A0 is the integrated absorbance between 500 and 700 nm of the initial, fully 
dispersed solution of NPs. 
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The incorporation of stabilizing groups enhanced the stability of Au NPs with the 
highest stability achieved with the C/G capped Au NPs. The coupling of CALNN ligand 
separately with the functional biorecognition ligand offered a stable Au NP up to a 
NaCl concentration of 1 M, with no evident change in the UV-Vis absorbance spectrum. 
NaCl-induced reversible aggregation (Yang et al. 2012) occurred at 1.25 M NaCl and 
was more pronounced at 1.5 M, as can be seen in (Fig 5-5). As predicted, high stability 
was achieved due to the formation of a compact self-assembled peptide layer (Lévy et 
al. 2004).  
The other systems investigated were GPDCALNNC-capped NPs and PEGylated ligand 
tagged with biorecognition element GP, in which good stability was achieved, but to a 
lesser extent than that obtained by bifunctionalization of the ligand. 
 
 
Figure 5-5 UV-Vis study of C/G capped Au NP stability as a function of NaCl 
concentration (Inset: stability of C/G capped Au NPs (1:4, 1:6, 1:8 and 1:10) compared 
to GPDC capped Au NPs in NaCl solutions with various ionic strengths. As higher 
concentrations of the salt were added, a greater screening of charges stabilizing the 
modified Au NPs occur leading to the red shift of absorption band and band broadening. 
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5.3.5 Investigation of Zeta potential and Hydrodynamic Radius 
 
To further assess the stability of the modified Au NP formulations, the zeta potential 
was measured to give further insight into understanding of the state of the NP surface 
and predicting the long-term stability of the NP solution. Table (5-3) summarizes the 
zeta potential values and hydrodynamic radii of the different functionalized Au NP 
preparations. The zeta potential values further confirm that highest stability is achieved 
with the bifunctionalized Au NP preparation. 
Table 5-3 Average zeta potential and hydrodynamic radius of different peptide 
stabilized Au NPs 
Sample Zeta potential (mV) Average hydrodynamic radius (nm) 
GPDC: CALNN 4:1 -46.1 22.88 
GPDC: CALNN 6:1 -38.9 23.68 
GPDC: CALNN 10:1 -39.0 35.42 
GPDCALNNC -35.9 39.5 
GPG-PEG4-LA -16.5 38.1 
 
The stability of C/G capped Au NPs is improved by increasing the molar ratio of 
CALNN to GPDC in the peptide mixture as can be seen in Table 5-3. These data are in 
good agreement with the stability noticed in high ionic strength solutions. However, it 
should be noted that PEGylated ligand displays the lowest zeta potential, which does 
not coincide with the stability it demonstrates in saline solutions and this can be 
interpreted by steric repulsion imparted by coiled PEG whilst the zeta descriptor 
measures the electrostatic potential that exists between the shear plane of a NP and the 
solvent (Jokerst et al. 2011). 
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5.3.6 Detection of DPP-IV Activity using Functionalized Au NPs 
 
The C/G capped Au NPs showed a typical SPR peak at 525 nm, i.e., a red shift of 3 nm 
with respect to the unmodified Au NPs, and good stability in phosphate buffer saline 
PBS. After carefully adjusting the molar ratio of CALNN to GPDC, the molar ratio of 
CALNN to GPDC at 1:10 in the reaction mixture was selected in order to evaluate the 
sensitivity of the method to DPP-IV/CD26, as this mixture found to be stable (as shown 
in Table (5-3) whilst simultaneously having the highest ratio of bound functional ligand. 
A perceptible colour change from red to faint purple was only obtained with 15 U/L of 
DPP-IV activity and it became more evident with increasing activity to 30 U/L (Figure 
5-6). The ratio of absorption at 750 and 525 nm was used to evaluate the response of 
dipeptide capped Au NPs to DPP-IV/CD26 (Figure 5-6).  
Similar conditions were applied to measure DPP-IV/CD26 activity using the PEGylated 
Au NP system or by GPDCALNNC Au NP system but neither caused colour changes 
nor significant UV-Visible spectral shift were observed, even with high activities DPP-
IV (˃ 50 U/L). The total lack of response was attributed to steric hindrance caused by 
the compact structure of the remaining ligands (whether PEG or CALNN) bound to the 
NP consequently preventing NPs aggregation. Another potential reason for the lack of 
response to DPP-IV/CD26 in the case of GPDCALNNC is the presence of two cysteine 
residues in the sequence that may form disulphide bridges leading to a variable 
percentage of dimerized products (Chen et al. 2001). 
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Figure 5-6 UV−Visible absorption spectra of C/G capped Au NPs after incubation with 
different activities of DPP-IV/CD26. The DPP-IV/CD26 activity ranged from 10 to 30 
U/L. Lower DPP-IV/CD26 activities did not induce spectral changes. 
 
5.3.7 Quantitative Determination of DPP-IV/CD26 Activity  
 
Results of the Au NP assay revealed that the colour change was directly proportional to 
the DPP-IV activity present. The assay provided quantitative estimation of total DPP-IV 
activity in the range of 10 - 30 U/L. The ratios of spectral absorbance A750/A525 of the 
reacted Au NP solutions were plotted as a function of the corresponding standard 
activities of DPP-IV (U/ L). These two absorbance values, A750 and A525 were chosen to 
represent the relative amount of aggregated and dispersed Au NPs respectively. The 
increase in the absorbance at 750 nm indicates the formation of the Au NPs 
clusters/aggregates, while the peak at 525 nm represents the Ȝmax of suspended C/G Au 
NPs (Chen et al. 2014; He et al. 2017). Fig. 5-7 shows that the absorption ratio 
(A750/A525) of C/G -Au NPs is increased by increasing the activity of DPP-IV/CD26 
from 10 to 30 U/L.  
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Figure 5-7 Calibration curve of A750/A525 versus the different activities DPP-IV 
incubated with C/G capped Au NPs. Error bars represent the standard deviation (n=3). 
 
 Conclusion 5.4
 
Three approaches for enhancing modified Au NP system stability were developed and 
their performance evaluated. These approaches involved different strategies to enhance 
the stability of Au NP for colorimetric detection of DPP-IV in high ionic strength 
medium. 
The first strategy used the incorporation of a PEGylated sequence with a dithiol anchor 
because the surface properties of these systems can be engineered through the 
introduction of functional ligands to create biorecognition ligands (Dixit et al. 2006; 
Eck et al. 2008).  
The other two strategies used a peptide sequence (CALNN) designed by Lévy et al. 
(2004). This peptide was selected from 58 peptide sequences tested, for its high stability 
and resistance to electrolyte induced Au NP aggregation. In one strategy CALNN 
peptide was introduced separately as a stabilizer with the previously tested functional 
ligands, while the third approach involved decoration of CALNN peptide with the 
GPDC ligand. 
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The stability of these three systems were evaluated against high ionic strength solution 
and exhibited high resistance to aggregation in solutions with up to 0.5 M NaCl, with 
the highest stability achieved by C/G capped Au NP. Further stability studies were 
conducted by zeta potential measurements. C/G capped Au NPs displayed the highest 
zeta potential value which coincides with its highest stability in saline solution whilst 
the PEGylated ligand expressed low zeta potential value, which might be attributed to 
the low surface charge of the ligand. 
Detection of DPP-IV/CD26 activity using the three approaches were conducted under 
optimal conditions and only C/G capped Au NPs showed a response with a colour 
change when incubated with DPP-IV/CD26. C/G capped Au NPs were less sensitive 
than the mono functionalized systems described in Chapters 3 and 4, with a dynamic 
range of 10-30 U/L but with very high stability in ionic solutions. This could be 
attributed to the presence of compact dense layers of CALNN which hampered effective 
Au NP aggregation and hence reduced analytical sensitivity.  
In spite of these limitations, the developed bifunctionalized assay was successfully 
evaluated by gel electrophoresis, zeta potential and hydrodynamic radius measurements 
and tested for the assay of DPP-IV activity. These Au NP systems gave an insight into 
different stabilization systems and their effect on the aggregation process. There are a 
number of parameters to be considered when incorporating a stabilizer such as the 
length of the stabilizer residue, the compact density of the stabilizer and stabilizer to 
functional ligand ratio (Lin et al. 2005). 
Other approaches that can be tried to produce Au NPs that withstand nonspecific 
aggregation include surface modification by polysaccharides, mixed charge self-
assembly, or zwitterionic polymers (Yang et al. 2009, Nowinski et al. 2014, Ho et al. 
2015). One of these approaches developed by Nowinski and colleagues was composed 
of a peptide-capped Au NP platform that resists aggregation in human serum at 37° C 
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for 24 h. This system was based on imitating natural proteins by designing a low fouling 
peptide composed of interchanging negatively charged glutamic acid and positively 
charged lysine residues on their surface. The EK sequence creates a strong hydration 
layer of zwitterionic materials imparting resistance to nonspecific protein adsorption. 
Furthermore, the EK sequence mimics the surfaces of human proteins which have 
adapted to avoid nonspecific adsorption and display stability in complex media (Fig. 5-
8). 
 
 
Figure 5-8 (a) Schematic depicting the design of the stealth peptide sequence inspired 
by the analysis of human protein surfaces, which contain E and K as the most prevalent 
amino acids on the surface (indicated by red and blue spheres). (b) All-in-one natural 
peptide sequence with three distinct functions: (1) biomolecular recognition via cyclic 
RGD (purple); (2) ultralow fouling via EK (red and blue); and (3) surface anchoring via 
PPPPC (green). Reproduced with permission from (Nowinski et al. 2014). 
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Gold Nanorods as Potential Alternative for the 
Development of DPP-IV Colorimetric Sensors 
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 Introduction 6.1
 
Gold nanorods (Au NRs) are elongated NPs with unique optical properties, which 
depend on their their length-to-width ratio (Sau et al. 2010; Li et al. 2014). Au NRs 
hold great potential as the next-generation of sensor systems because of their elongated 
nanostructure, sharp/polarized near-infrared resonance and tunable plasmon resonance 
spectra (Chen et al. 2013; Park et al. 2014).  
In particular, its localized surface plasmon resonance (LSPR) absorption is extremely 
sensitive to the size, composition, distance, and the surrounding media, based on which 
great progress in colorimetric sensors have been made. This allows the ability to tune 
the NR absorption as shown in Fig. 6-1 from 550nm to 1400nm through different 
manufacturing processes. This tuning results in the ability of Au NRs to scatter at 
wavelengths across the visible and near-IR regions (Tong et al. 2009).  
                                                                                                             Absorption (nm) 
 
Figure ‎6-1 Gold nanorod peak absorption and scattering (extinction) can be tuned 
across the visible and near IR spectra as shown on a plot of SPR to wavelength. 
Adapted from Sigma-Aldrich. 
Au NRs have two principal plasmon absorption bands: a transverse LSPR band located 
in the visible region around 520 nm and a longitudinal LSPR band, located in a longer 
wavelength region usually between (800 - 900 nm) which can be modified by varying 
the aspect ratio (length/width) of the Au NRs from the visible to the near-IR region 
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(Truong et al. 2012; Alkilany et al. 2012). The difference in the absorption 
characteristics of Au NRs and Au NPs can be identified by UV-visible spectroscopy 
(Fig 6-2).  
 
Figure ‎6-2 Comparison of the UV-visible spectra of Au NPs and Au NRs. Reproduced 
with permission from (Chakraborty et al. 2011) 
 
6.1.1 Au NR Synthesis 
Au NRs synthesized by seed-mediated growth method have a strong capping of bilayer 
cetyl trimethyl ammonium bromide (CTAB) surfactant, which provides the surface of 
NRs with a cationic surface charge and this ensures their stability in aqueous solution 
via electrostatic repulsion. However, the CTAB-stabilized Au NRs aggregate rapidly in 
buffer or cell culture media because of the screen produced by high salt concentration, 
which can reduce the repulsive interactions between individual Au NRs (Gao et al. 
2003).  
6.1.2 Biomedical Applications of Au NRs 
 
The unique properties of Au NRs find applications in the fields of imaging, therapy and 
sensing (Kim et al. 2017a; Sun et al. 2017; Aioub et al. 2017). Due to the strong light 
scattering in the NIR region, Au NRs can be used for bioimaging using dark field 
Au NR 
Au NR 
Au NP 
Au NP 
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scattering microscopy. By conjugating specific ligands to the Au NRs, they have been 
widely used for cancer imaging with dark field imaging. For example, Huang et al. 
(2006) used monoclonal anti-epidermal growth factor receptor (anti-EGFR) antibodies 
conjugated to Au NRs for distinguishing cancer cells from normal cells with a dark-
field microscope due to EGFR over-expressed in many malignant epithelial tumour 
cells. In contrast to organic fluorophores and quantum dots, Au NRs have considerable 
advantages such as biocompatibility, no photobleaching or decomposition, and an 
enhanced absorption and scattering signal (Ma et al. 2013). 
Au NRs are very attractive means for photothermal therapy due to their modifiable 
absorption in the NIR region and higher optothermal conversion efficiency than most 
other shapes of gold nanostructures, such as Au NPs and gold nanoshells. Tong et al. 
(2007) investigated the photothermal effects of folate-conjugated Au NRs to human 
malignant nasopharyngeal carcinoma cells and found that the photothermolysis of 
cancer cells with a high expression of folate receptors was much more effective than 
that of normal cells with fewer folate receptors. 
Apart from photothermal therapy, Au NRs represent a good option for drug delivery 
and the photothermal effect can be used to actively release drugs. Alkilany et al. (2008) 
employed the hydrophobic region near the Au NR surface provided by CTAB bilayer to 
sequester a model drug-1-naphthol. Alper et al. (2009) studied the controlled release 
behaviour of fluorescence dye loaded Au NRs under laser irradiation. 
In terms of the detection sensitivity of plasmon spectroscopy, Au NRs exhibit higher 
refractive index sensitivities, which is typically ∼250 nm per refractive index unit 
compared with ∼60 nm per refractive index unit for spherical nanostructures, which 
make the use of Au NRs the platform of choice when increased sensitivity is required 
(Chen et al. 2008; Guo et al. 2015). 
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 Experimental 6.2
 
6.2.1 Materials and Methods 
CTAB and Au NRs stabilized with CTAB aqueous solution were purchased from Sigma 
Aldrich, UK. The mean size of the NRs was 45 ± 5 and 10 ± 1 nm in longitudinal and 
transverse directions, respectively. 
6.2.2 Preparation of NRs  
 
To remove the excess amount of CTAB included in the stock dispersion of the NRs, the 
dispersion was centrifuged (11, 000 rpm for 15 min at 37 °C). The supernatant was 
decanted and the precipitated NRs were dispersed in 10 mM HEPES (pH 7.2) with a 
final optical density of 0.2. Since the obtained NR dispersion was stable for 24 hours, 
the dispersion was used for the assay within 2 h after the preparation. 
6.2.3 Functionalization of Au NRs with Peptide Ligands 
 
GPDC and VP-EN-DC peptides were evaluated for their coupling to Au NR and their 
potential in development of effective sensing system for DPP-IV/CD26 activity. The Au 
NRs, stabilized with CTAB, were further modified with GPDC peptide in the first trial 
and with VP-EN-DC in the second trial at room temperature to form the molecular 
probes for target detection. Each peptide was incubated with the Au NRs solution 
separately in a 1:10 (v/v) and the reaction mixture was set aside to react for 2 hours at 
room temperature.  After incubation, the suspensions were centrifuged twice using 5000 
rpm for 10 min using an Eppendorf centrifuge (Eppendorf, Germany), decanted and 
redispersed in deionized water. 
6.2.4 Instrumental technique 
 
The same UV-Visible spectroscopy instrumentation methods were used as in section 
3.2.3. 
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 Results and Discussion 6.3
 
In general, Au NRs exhibit two SPR bands, namely, the transverse band and the 
longitudinal band, corresponding to the oscillation of electrons along the short and long 
axis Au NR respectively. In this study, the Au NRs showed a strong and broad 
longitudinal absorption band at 840 nm and the transverse absorption band at 510 nm 
(Fig. 6-3). Au NRs were further modified with peptide ligand to form molecular probes 
used for the target detection. 
 
Figure ‎6-3 UV–visible absorption spectrum of Au NRs (Sigma Aldrich 716839). 
The figure shows a transverse absorption band at 510 nm and a longitudinal absorption 
band at 840 nm corresponding to the oscillation of electrons along the short and long 
axis of Au NRs respectively. 
 
Coupling of GPDC peptide to the Au NRs resulted in a formation of one large peak at 
976 nm and (Fig. 6-4) and disappearance the small peak and fading of the brown 
coloration of the Au NR suspension suggesting that the coupling process led to 
aggregation of the Au NRs and that this may have taken place due to the cationic nature 
of Au NRs, derived from an adsorbed CTAB, used in this study. The NRs were 
aggregated by addition of anionic substrate peptide (GPDC) due to neutralization of the 
surface charge. 
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Figure ‎6-4 UV-Vis absorption spectra of GPDC capped Au NRs 
 
UV–visible spectra of Au NRs after conjugation with VP-EN-DC peptide ligands show 
that there was a slight red shift in both longitudinal and transverse absorption peaks 
after conjugation with capture probes (Fig. 6-5). This is due to the change in the 
refractive index of the medium upon the binding the VP-EN-DC peptide with the Au 
NRs. The slight broadening in the peaks has taken place due to the increase in size of 
the conjugates after interaction of the Au NRs with peptide ligand.  
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Figure ‎6-5 UV-Visible absorption spectra of dispersed -Au NRs (blue) and VP-EN-DC 
capped Au NPs (red). 
 
The addition of DPP-IV/CD26 to the VP-EN-DC functionalized Au NRs resulted in 
discoloration of the Au NRs and clear alteration of the absorption spectra, which may 
indicate the Au NR solution was not stable enough and to further support this claim, a 
buffer solution without enzyme was added to the Au NRs solution and caused a similar 
discoloration of the Au NR solution (Fig. 6-6).  
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Figure ‎6-6 DPP-IV/CD26 activity detection using a VP-EN-DC modified Au NR assay. 
Addition of DPP-IV/CD26 to the peptide modified Au NR (red) resulted in a shift and 
of the absorption band and discoloration of the solution (green). 
 
 Conclusion 6.4
 
Spherical Au NPs have been used in various biomedical applications. However, they 
have not been optimized because spherical gold nanoparticles have limited peak 
absorptions (maximum ~580nm for 100nm diameter particles) which fall below the 
transmission window of 650 – 900nm for biological entities (skin, tissue and 
hemoglobin). Au NRs behave similarly to the gold nanoparticles, but are elongated to 
optimize their peak absorption and scattering characteristics. This allows the ability to 
tune the NR absorption from 550nm to 1400nm through different manufacturing 
processes 
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A preliminary study on development of Au NR colorimetric sensing assay for the 
detection of DPP-IV/CD26 activity was conducted. Although the assay was still needs 
further optimization for detection of the target enzyme in terms of achieving an 
alternative and more powerful sensing methods, but it still provided a basis for further 
exploration and investigation.  
The effect of ligand (peptide) net charge is one of important issue that need to be 
considered in the design of Au NR sensor as has been observed in this study. A possible 
explanation for the discoloration seen with the GPDC peptide is the electrostatic 
attraction of a negatively charged peptide with the positively charged CTAB capped Au 
NRs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
153 
 
 
 
 
 
 
 
Chapter 7 
 
Conclusions and Future Work 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
154 
 
7 Conclusions and Future Work 
 
The design and use of nanomaterial platforms functionalized with peptide substrates in 
the development of a fast, robust and reproducible colorimetric tool for detection and 
quantitation of DPP-IV/CD26 activity is reported in this thesis. The enzyme has great 
potential to be used in the prognosis or diagnosis of diseases in which DPP-IV/CD26 
are implied as well as for HTS of pharmaceutical targets for DPP-IV/CD26 activity. 
The research involved the design of potential DPP-IV peptide substrates and their use in 
the functionalization of Au NPs. The application of these functionalized Au NP systems 
in the assay of DPP-IV/CD26 activity was assessed both qualitatively and 
quantitatively. Various optimization and validation experiments were conducted to 
determine and validate the sensitivity, stability and enzyme kinetics. 
 
In Chapters 3 and 4 the successful development of two individual approaches, both 
utilising Au NP-peptide conjugates, for the detection of the peptidase activity were 
presented (Table 7-1). The goal was to develop an accurate, sensitive and easily 
prepared assay for the detection of the peptidase activity. The design of the assay 
reflected these goals at each step of the process. The use of peptide substrates that can 
be hydrolysed by DPP-IV/CD26 enzyme relied on a thorough literature review about 
the mechanism of action of the enzyme besides investigating problems associated with 
the use of traditional substrates with the aim of providing stable Au NP colloidal 
solutions as well as serving as the bio recognition element for the enzyme. Comparing 
the level of enzyme activity that can be measured using the developed assays mentioned 
in table 7-1 with the enzyme activity in various pathological conditions (Table 1-4) it 
can be  concluded that with the use of appropriate dilutions it possible to use these 
assays can as diagnostic and prognostic tool for many disease conditions.  
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Table 7-1 Summary of the performance of developed assays 
Assay LOD U/L Dynamic range 
Gly-Pro-Asp-Cys Au NPs 1 2-12 
Val-Pro-ED-Asp-Cys Au NPs 1.5 0-40 
Conjugation of peptides and proteins to Au NPs mainly depends upon different 
mechanisms such as, dative binding between the gold conducting electrons and sulphur 
atoms which are present in cysteine residues (if present) in the protein and ionic 
attraction between the gold nanoparticles and the proteins (Bast́s et al. 2009). In some 
proteins, the sulphydryl functionality may be in the form of a disulphide group and in 
other proteins sulphydryl sites may be buried within the protein structure, and therefore 
inaccessible to the Au NPs (Maus et al. 2010). The coupling process of peptides to the 
NP surface in this work relied on a ligand exchange process, in which thiolate or 
cysteine-capped peptide substituted citrate, as the former has stronger binding efficiency 
with the metal surface (Häkkinen 2012).  
It was also observed that conjugation of peptides to NPs was higher with the 
concentrated preptide solution than diluted one. Peptide conjugation efficiencies were 
improved by gentle agitation of the mixture after addition of the peptide, since 
generating air bubbles by vigorous agitation may denature the peptide solution or 
promote oxidation of thiol groups catalysed by atmospheric oxygen (Hainfeld 1988). 
However, once the optimal conditions were identified, the coating process was usually 
reproducible and was easy to scale-up. 
Factors, such as pH, ionic strength and the structure of the substrate, that influence the 
assay efficiency were investigated in order to optimize these parameters to provide a 
well-designed biosensing platform, that can function in complex biological samples. It 
was found that the assay is responsive over an acceptable range of pH (7-9), at lower pH 
it loses responsiveness gradually, whilst at pH˃ 9 colour changes were not observed, 
156 
 
which can be attributed to conformational changes in the enzyme itself and not the 
functionalized Au NPs. 
Several analytical tools have been employed to investigate and confirm attachment of 
the different peptides or thiol containing molecules to the Au NP surface and these 
included direct and indirect methods. XPS was utilized to provide direct evidence of 
thiolate interaction with the metal surface, by studying changes in the binding energy of 
the involved elements. Moreover, further characterization was conducted using a range 
of techniques including UV-Visible spectrophotometry, hydrodynamic radius 
measurements by DLS, zeta potential, FTIR and gel electrophoresis, to investigate 
changes to the physical and chemical properties of the modified Au NPs. These 
techniques provided further information about size, charge and molecular weight 
changes after modification of the NP surface with various ligands.  
Results showed that upon the addition of DPP-IV/CD26, the peptides were cleaved 
resulting in detectable optical changes due to the distance-dependent change between 
neighbouring molecules. The SPR based colour shift was due to the coupling of Au NPs 
mediated by the specific interaction of DPP-IV/CD26 and designed peptide molecules, 
demonstrated that the NPs can be potentially used as molecular labels for detection of 
DPP-IV/CD26 associated diseases.  
As this colorimetric assay was based on aggregation of colloidal particles, it was critical 
to have a design that offers easy surface modification and a fast-colorimetric response 
and for this purpose, a non-crosslinking aggregation of Au NPs was chosen. In contrast 
to the DPP-IV/CD26 colorimetric Au NP assay recently developed by Xia and 
colleagues (2016), which relied on the formation of crosslinked aggregates, the design 
of a non-crosslinking aggregation method for detection of DPP-IV enzyme activity was 
considered to be more appropriate as it overcomes the limitation encountered with 
crosslinking aggregation as it offers more robust assay for use in biological fluids, 
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eliminates the need for designing target analytes with two or more binding sites and 
creates a hindrance free environment for the peptidase  activity of the enzyme.  
 
Herein, a new concept is demonstrated that overcomes this limitation by achieving 
enzyme-responsive nanoparticle systems that are not only sensitive and reliable, but 
also universal, simple, and economical in operation. The recognition sites of proteases 
are typically short, as shown in Chapter 4; our system was composed of two elements: 
functional Au NP probe and an appropriate diamine linker that can couple with both 
distal bio recognition site from one hand and with anchoring part from the other hand. 
Quantification of the enzymatic hydrolysis of the peptide substrates and relating the 
value to the enzyme activity was developed using a UV- visible spectrophotometer that 
was able to show in real-time the increase in absorbance at higher wavelengths (650 nm 
or more) and decrease in absorbance at around (520 nm) with the addition of DPP-
IV/CD26.  
The first method developed for the assay of DPP-IV/CD26 (GPDC Au NPs) was able to 
quantify the detection of DPP-IV/CD26 activity ranging from 2 U/L to 12 U/L. In order 
to enhance the quantification capability of this assay, another ligand was designed, 
which incorporated a spacer molecule (ethylene diamine) as the spacer, which should 
increase the distance of the hydrolysable moiety from the NP surface and impart further 
stability on the Au NP system. This system (VP-EN-DC Au NPs) met these 
expectations by increasing the linear dynamic range of the assay by a factor of 3.5-4, so 
that changes in DPP-IV/CD26 activity over a broader range (0-40 U/L) thus providing a 
method that can be used to determine the levels of DPP-IV/CD26 in physiological fluids 
such as serum and plasma. This assay was also used to evaluate a DPP-IV inhibitor 
potency, which demonstrates its use as a HTS tool for pharmaceuticals. 
In the development of colorimetric sensing assays for routine use in biological samples, 
it is important to take cognisance of the fact that the interferences caused by cellular 
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components and macromolecules can affect the analytical performance of the sensor. 
Nevertheless, some reports of measurement of enzyme activity via Au NPs in cell 
lysates have shown promising results (Oishi et al. 2007, Kang et al. 2010).  In complex 
samples, such as serum, saliva or cerebrospinal fluid, Au NPs surfaces are exposed to 
biomolecules, cells, and tissues which can potentially impair the performance of the 
measurement. The occurrence of nonspecific binding and ligand exchange should be 
taken into account when developing biosensing applications. These interferences must 
be carefully studied during method validation. Potential interferences can occur when 
charge bearing ligands interact non-specifically with other charged biomolecules 
(Aldewachi et al. 2018).  
 Significantly, it is expected that this approach can be directed toward a wide variety of 
enzymes by simply changing the recognition sequence found beyond the diamine linker. 
Furthermore, this system enables assaying of DPP-IV activity and screen its inhibitors. 
The unique optical properties of Au NPs and the recognition sequence of the protease 
make this novel assay not only sensitive and reliable, but also universally applicable in 
its operation and easily adaptable to HTS. In addition, the assay presented here is 
simpler in format than that presented by Xia et al. (2016). It involves only a single step 
for detection of DPP-IV activity, which offers the advantages of simplicity and cost 
efficiency.  
Validation experiments were conducted by comparing the performance of developed 
nano platform assay described in Chapter 4 with the standard Gly-Pro-pNA assay, 
which is still considered as the gold standard method for detection and evaluation of 
DPP-IV/CD26 activity. Linear regression analysis showed that results obtained from the 
VP-EN-DC capped Au NP assay correlated well with the standard commercial 
colorimetric assay.  
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The potential instability of Au NPs in high ionic strength solutions was of concern after 
the GPDC modified Au NPs experienced an electrolyte induced aggregation, reported in 
Chapter 5.  Many approaches have been trialled to overcome this problem, which 
included the incorporation of stabilizer peptide sequence or PEGylated ligand molecules 
decorated with the biorecognition element or bifunctionalization of Au NPs by 
modifying the NPs surface with two different peptide sequences. Although much more 
stable Au NP systems were achieved by all of these three approaches, a colorimetric 
response was only achieved using the bifunctionalized Au NP assay. The major problem 
observed was that at times the colloidal solution was too stable because the hindrance 
effect caused by non-functional (stabilizer) ligand in the case of bifunctionalized Au NP 
was observed. 
In Chapter 6 the work conducted on the development of an Au NR colorimetric 
detection assay for the DPP-IV/CD26 activity was reported. The assay sought to create 
a highly sensitive detection assay for protease detection. The Au NR experiments were 
unsuccessful in the detection of DPP-IV/CD26 activity due to limited trials and 
difference in the surface charge of Au NRs, which is governed by the surfactant coating 
of CTAB, but the knowledge that was gained of the peptide functionalisation could 
pave the way for further investigation of Au NRs to the development of highly sensitive 
and stable assay for detection of the protease activity. 
Biological tests detecting the activity of target analytes have become faster, more 
sensitive and more flexible when nanoscale particles are used as sensors, with several 
benefits over more conventional methods, such as fluorescence and chemiluminescence 
technology (Baptista et al. 2008). The system developed here is portable and would 
permit on-site analysis of samples, reducing the need for laboratory testing. It is also 
sensitive and rapid and could be useful for a range of applications. Additional features 
of this assay include fast response time, less interference from non-analyte components, 
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and kinetic data is obtained with high resolution and real time monitoring of enzyme 
activity. The final result of this project was the development of a convenient 
colorimetric biosensor for the identification of disease-related DPP-IV/CD26 protease 
enzyme, which offers a real alternative approach from traditional assays, without the 
need for complex instrumentation. 
The Integration of labelled Au NPs in microfluidics testing device is another important 
concern to pave the road to efficient strategies with enhanced performance and reduced 
complexity, e.g., Aptamers were tethered to Au NPs as part of a lateral flow assay-like 
dry-reagent assay strip to detect thrombin (Xu et al. 2008). Noble metal NPs are 
attractive for lateral flow POC diagnostics because they are visible without an external 
excitation source or emission sensor, and unlike small-molecule dyes, resist 
photobleaching. These sensing schemes have the potential to be involved in designing 
Au NP coupled microfluidic chips for POC biochemical assays. The logical next step in 
this research would be the continuation of experiments to transform this test into a 
lateral flow assay format that could offer an early detection tool for disease management 
in resource restrained parts of the world.  
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